<SEC-DOCUMENT>0001178913-22-001919.txt : 20220512
<SEC-HEADER>0001178913-22-001919.hdr.sgml : 20220512
<ACCEPTANCE-DATETIME>20220512082009
ACCESSION NUMBER:		0001178913-22-001919
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		29
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220512
DATE AS OF CHANGE:		20220512

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		22915815

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>zk2227748.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:cmmb="http://www.anchiano.com/20220331" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"  >
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
  <title>Chemomab Therapeutics Ltd. - 1534248 - 2022</title>
</head>
<body>

<div style="display:none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20220101to20220331" id="FFact_288" >false</ix:nonNumeric>
    <ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="C_20220101to20220331" id="FFact_289" >--12-31</ix:nonNumeric>
    <ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20220101to20220331" id="FFact_290" >Q1</ix:nonNumeric>
    <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20220101to20220331" id="FFact_292" >0001534248</ix:nonNumeric>
    </ix:hidden>
  <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cmmb-20220331.xsd"/>
    </ix:references>
  <ix:resources>
    <xbrli:context id="C_20220101to20220331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220511">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-05-11</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210101to20210331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20201231">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210331">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-16</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210314to20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-14</xbrli:startDate>
        <xbrli:endDate>2021-03-16</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210314to20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:FormerChemomabSecurityHoldersMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-14</xbrli:startDate>
        <xbrli:endDate>2021-03-16</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210316">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-16</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-25</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210314to20210316">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-14</xbrli:startDate>
        <xbrli:endDate>2021-03-16</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:FormerChemomabSecurityHoldersMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-16</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210301to20210315">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-15</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210315">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2021-03-15</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210401to20210430_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20210501to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period>
      </xbrli:context>
    <xbrli:context id="C_20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
          </xbrli:segment>
        </xbrli:entity>
      <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period>
      </xbrli:context>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Unit1">
      <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Unit12">
      <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unit>
    <xbrli:unit id="Unit14"><xbrli:divide>
      <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator>
      <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide>
      </xbrli:unit>
    <ix:relationship fromRefs="FFact_108" toRefs="FN20220505093535462"/>
    <ix:relationship fromRefs="FFact_109" toRefs="FN20220505093535462"/>
    <ix:relationship fromRefs="FFact_112" toRefs="FN20220505093535462"/>
    <ix:relationship fromRefs="FFact_113" toRefs="FN20220505093535462"/>
    <ix:relationship fromRefs="Fxbrl_20220504161436664" toRefs="FN20220505094619846"/>
    <ix:relationship fromRefs="Fxbrl_20220504161607482" toRefs="FN20220505094619846"/>
    <ix:relationship fromRefs="Fxbrl_20220504161812745" toRefs="FN20220505094619846"/>
    <ix:relationship fromRefs="Fxbrl_20220504161847247" toRefs="FN20220505094619846"/>
    <ix:relationship fromRefs="Fxbrl_20220504162107281" toRefs="FN20220505094749710"/>
    <ix:relationship fromRefs="Fxbrl_20220504162206824" toRefs="FN20220505094749710"/>
    <ix:relationship fromRefs="Fxbrl_20220504162211985" toRefs="FN20220505094749710"/>
    <ix:relationship fromRefs="Fxbrl_20220504162217288" toRefs="FN20220505094749710"/>
    <ix:relationship fromRefs="Fxbrl_20220505093740414" toRefs="FN20220505094619846"/>
    <ix:relationship fromRefs="Fxbrl_20220505093940758" toRefs="FN20220505094749710"/>
    </ix:resources>
  </ix:header></div>

<div>

<div> <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
</div>

<p style="font-family:Times New Roman, Times, serif;font-size:14pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><br /><span style="font-weight:bold">UNITED
STATES</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:14pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">WASHINGTON,
DC 20549</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:14pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">FORM
</span><span style="font-weight:bold"><ix:nonNumeric id="FFact_1" name="dei:DocumentType" contextRef="C_20220101to20220331">10-Q</ix:nonNumeric></span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">(Mark
One)</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_2" name="dei:DocumentQuarterlyReport" contextRef="C_20220101to20220331" format="ixt:booleantrue">&#9746;</ix:nonNumeric>
<span style="font-weight:bold">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">For
the quarterly period ended </span><span style="font-weight:bold"><ix:nonNumeric id="FFact_3" name="dei:DocumentPeriodEndDate" contextRef="C_20220101to20220331" format="ixt:datemonthdayyearen">March
31, <ix:nonNumeric id="Fxbrl_20220509210752112" name="dei:DocumentFiscalYearFocus" contextRef="C_20220101to20220331">2022</ix:nonNumeric></ix:nonNumeric></span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">OR</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_4" name="dei:DocumentTransitionReport" contextRef="C_20220101to20220331" format="ixt:booleanfalse">&#9744;</ix:nonNumeric>
<span style="font-weight:bold">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">For
the transition period from to</span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">Commission
File Number: </span><span style="font-weight:bold"><ix:nonNumeric id="FFact_5" name="dei:EntityFileNumber" contextRef="C_20220101to20220331">001-38807</ix:nonNumeric></span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:16pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonNumeric id="FFact_6" name="dei:EntityRegistrantName" contextRef="C_20220101to20220331">Chemomab
Therapeutics Ltd.</ix:nonNumeric></span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(Exact
Name of Registrant as Specified in its Charter)</span></p>

<div>

<table cellpadding="0" style="border-spacing:0;margin:auto" width="100%">
  <tr>
    <td style="width:49%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonNumeric id="FFact_7" name="dei:EntityIncorporationStateCountryCode" contextRef="C_20220101to20220331" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></span></p>
        </td>
    <td style="width:2%;vertical-align:bottom">&#160;</td>
    <td style="width:49%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonNumeric id="FFact_8" name="dei:EntityTaxIdentificationNumber" contextRef="C_20220101to20220331">81-3676773</ix:nonNumeric></span></p>
        </td> </tr>
  <tr>
    <td style="width:49%;vertical-align:bottom">&#160;</td>
    <td style="width:2%;vertical-align:bottom">&#160;</td>
    <td style="width:49%;vertical-align:bottom">&#160;</td> </tr>
  <tr>
    <td style="width:49%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(State
        or other jurisdiction of</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">incorporation
        or organization)</span></p> </td>
    <td style="width:2%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">&#160;</p> </td>
    <td style="width:49%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(I.R.S.
        Employer</span></p>
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Identification
        No.)</span></p> </td> </tr>
  <tr>
    <td style="width:49%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:-6pt;margin-bottom:0pt">&#160;</p> </td>
    <td style="width:2%;vertical-align:bottom">&#160;</td>
    <td style="width:49%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:-6pt;margin-bottom:0pt">&#160;</p> </td>
        </tr>
  <tr>
    <td colspan="3" style="width:100%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonNumeric id="FFact_9" name="dei:EntityAddressAddressLine1" contextRef="C_20220101to20220331">Kiryat
        Atidim</ix:nonNumeric></span><span style="font-weight:bold">, </span><span style="font-weight:bold"><ix:nonNumeric id="FFact_10" name="dei:EntityAddressAddressLine2" contextRef="C_20220101to20220331">Building
        7</ix:nonNumeric></span></p> </td> </tr>
  <tr>
    <td colspan="3" style="width:100%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold"><ix:nonNumeric id="FFact_11" name="dei:EntityAddressCityOrTown" contextRef="C_20220101to20220331">Tel
        Aviv</ix:nonNumeric></span><span style="font-weight:bold">, </span><span style="font-weight:bold"><ix:nonNumeric id="FFact_12" name="dei:EntityAddressCountry" contextRef="C_20220101to20220331" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span><span style="font-weight:bold">&#160;</span><span style="font-weight:bold"><ix:nonNumeric id="FFact_13" name="dei:EntityAddressPostalZipCode" contextRef="C_20220101to20220331">6158002</ix:nonNumeric></span></p>
        </td> </tr>
  <tr>
    <td colspan="3" style="width:100%;vertical-align:bottom">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">(Address
        of principal executive offices including zip code)</span></p> </td> </tr>
  </table> </div>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">Registrant&#8217;s
telephone number, including area code: +</span><span style="font-weight:bold"><ix:nonNumeric id="FFact_14" name="dei:CityAreaCode" contextRef="C_20220101to20220331">972</ix:nonNumeric></span><span style="font-weight:bold">-</span><span style="font-weight:bold"><ix:nonNumeric id="FFact_15" name="dei:LocalPhoneNumber" contextRef="C_20220101to20220331">77-331-0156</ix:nonNumeric></span></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:12pt;margin-bottom:0pt"><span style="font-weight:bold">Securities
registered pursuant to Section 12(b) of the Exchange Act:</span><br />&#160;</p>

<div>

<table cellpadding="0" style="border-spacing:0px;margin:auto" width="100%">
  <tr>
    <td style="width:40%;vertical-align:middle;border-width:1px;border-style:solid;border-color:black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Title
        of each class</span><br />&#160;</p> </td>
    <td style="width:24%;vertical-align:middle;border-top:1px solid black;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Trading
        Symbol(s)</span><br />&#160;</p> </td>
    <td style="width:36%;vertical-align:middle;border-top:1px solid black;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-weight:bold">Name
        of each exchange on which registered</span><br />&#160;</p> </td> </tr>
  <tr>
    <td style="width:40%;vertical-align:top;border-left:1px solid black;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_16" name="dei:Security12bTitle" contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">American
        Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric><br />&#160;</p> </td>
    <td style="width:24%;vertical-align:top;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_17" name="dei:TradingSymbol" contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">CMMB</ix:nonNumeric></p>
        </td>
    <td style="width:36%;vertical-align:top;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_18" name="dei:SecurityExchangeName" contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric>
        Capital Market</p> </td> </tr>
  <tr>
    <td style="width:40%;vertical-align:top;border-left:1px solid black;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_19" name="dei:Security12bTitle" contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">Ordinary
        shares, no par value per share</ix:nonNumeric><br />&#160;</p> </td>
    <td style="width:24%;vertical-align:top;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_20" name="dei:TradingSymbol" contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">n/a</ix:nonNumeric></p>
        </td>
    <td style="width:36%;vertical-align:top;border-bottom:1px solid black;border-right:1px solid black;height:20px">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_21" name="dei:SecurityExchangeName" contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric>
        Capital Market*</p> </td> </tr>
  </table> </div>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:11pt;margin-bottom:0pt">*Not for trading;
only in connection with the registration of American Depository Shares<br />&#160;</p> <hr style="background:rgb(0, 0, 0);width:100%;border-top:2px solid black;page-break-after:always" />

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:12pt;text-indent:18pt;margin-bottom:0pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.<br />&#160;</p>

<div>

<table cellpadding="0" style="border-spacing:0;margin:auto" width="100%">
  <tr>
    <td style="width:100%;vertical-align:top">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_22" name="dei:EntityCurrentReportingStatus" contextRef="C_20220101to20220331">Yes</ix:nonNumeric>
        &#9746;&#160; &#160; No &#9744;</p> </td> </tr>
  </table> </div>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:12pt;text-indent:18pt;margin-bottom:0pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).<br />&#160;</p>

<div>

<table cellpadding="0" style="border-spacing:0;margin:auto" width="100%">
  <tr>
    <td style="width:100%;vertical-align:top">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_23" name="dei:EntityInteractiveDataCurrent" contextRef="C_20220101to20220331">Yes</ix:nonNumeric>
        &#9746;&#160; &#160; No &#9744;</p> </td> </tr>
  </table> </div>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:12pt;text-indent:18pt;margin-bottom:0pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.<br />&#160;</p>

<div>

<table cellpadding="3" style="border-spacing:0;margin:auto" width="100%">
  <tr>
    <td style="vertical-align:top;width:19%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Large accelerated
        filer</p> </td>
    <td style="vertical-align:top;width:2%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#9744;</p> </td>
    <td style="vertical-align:top;width:31%">&#160;</td>
    <td style="vertical-align:top;width:22%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Accelerated filer</p>
        </td>
    <td style="vertical-align:top;width:1%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#9744;</p> </td>
    <td style="vertical-align:top;width:25%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:19%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_24" name="dei:EntityFilerCategory" contextRef="C_20220101to20220331" format="ixt-sec:entityfilercategoryen">Non-accelerated
        filer</ix:nonNumeric></p> </td>
    <td style="vertical-align:top;width:2%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">&#9744;</p> </td>
    <td style="vertical-align:top;width:31%">&#160;</td>
    <td style="vertical-align:top;width:22%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Smaller reporting
        company</p> </td>
    <td style="vertical-align:top;width:1%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_25" name="dei:EntitySmallBusiness" contextRef="C_20220101to20220331" format="ixt:booleantrue">&#9746;</ix:nonNumeric></p>
        </td>
    <td style="vertical-align:top;width:25%">&#160;</td> </tr>
  <tr>
    <td style="vertical-align:top;width:19%">&#160;</td>
    <td style="vertical-align:top;width:2%">&#160;</td>
    <td style="vertical-align:top;width:31%">&#160;</td>
    <td style="vertical-align:top;width:22%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt">Emerging growth company</p>
        </td>
    <td style="vertical-align:top;width:1%">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt"><ix:nonNumeric id="FFact_26" name="dei:EntityEmergingGrowthCompany" contextRef="C_20220101to20220331" format="ixt:booleantrue">&#9746;</ix:nonNumeric></p>
        </td>
    <td style="vertical-align:top;width:25%">&#160;</td> </tr>
  </table> </div>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:12pt;text-indent:18pt;margin-bottom:0pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric id="FFact_27" name="dei:EntityExTransitionPeriod" contextRef="C_20220101to20220331" format="ixt:booleanfalse">&#9744;</ix:nonNumeric></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:18pt;margin-bottom:0pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).<br />&#160;</p>

<div>

<table cellpadding="0" style="border-spacing:0;margin:auto" width="100%">
  <tr>
    <td style="width:100%;vertical-align:top">
        <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt">Yes &#9744;&#160;
        &#160; No <ix:nonNumeric id="FFact_28" name="dei:EntityShellCompany" contextRef="C_20220101to20220331" format="ixt:booleanfalse">&#9746;</ix:nonNumeric></p>
        </td> </tr>
  </table> </div>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:18pt;margin-bottom:0pt">As
of May 11, 2022, the registrant had&#160;<ix:nonFraction id="FFact_29" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_20220511" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">11,404,515
</ix:nonFraction> American Depositary Shares outstanding.<br />&#160;</p> <hr style="background:rgb(0, 0, 0);width:100%;border-top:2px solid black;page-break-after:always" />

<p style="text-align:center"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">CHEMOMAB
THERAPEUTICS LTD.</span>&#160;</span></strong></p>

<div style="text-align:center;line-height:1.25"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif">QUARTERLY
REPORT ON FORM 10-Q</span></strong></div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">FOR
THE QUARTER ENDED MARCH 31, 2022</span>&#160;</span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">TABLE
OF CONTENTS</span>&#160;</span></div>

<div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="line-height:1.25"><strong><a href="#PARTI.FINANCIALINFORMATION"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">PART
        I. &#8211; FINANCIAL INFORMATION</span></a></strong></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTI.FINANCIALINFORMATION"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Item
        1.Financial Statements</span></a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">1</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#Item2.MA">Item
        2.Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">11</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#Item3.Q">Item
        3.Quantitative and Qualitative Disclosures About Market Risk.</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">20</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#Item3.Q">Item
        4.Controls and Procedures.</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">20</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="line-height:1.25"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTII">PART II.
        &#8211; OTHER INFORMATION</a></span></strong></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">21</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">&#160;</td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTII">Item
        1.Legal Proceedings</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">21</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">&#160;</td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTII">Item
        1A.Risk Factors</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">21</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">&#160;</td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTII">Item
        2.Unregistered Sales of Equity Securities and Use of Proceeds.</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">21</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">&#160;</td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTII">Item
        3.Defaults Upon Senior Securities.</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">21</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">&#160;</td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTII">Item
        4.Mine Safety Disclosures.</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">21</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">&#160;</td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#PARTII">Item
        5.Other Information.</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">21</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-indent:28pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#Item6.Exhibits.">Item
        6.Exhibits.</a></span></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">22</span></div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:11%;vertical-align:bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:89%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="line-height:1.25"><strong><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#SIGNATURES">SIGNATURES</a></span></strong></div></td>
    <td style="width:11%;vertical-align:bottom;background-color:#CCEEFF">
        <div style="text-align:right;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">23</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">CAUTIONARY
NOTE ABOUT FORWARD-LOOKING STATEMENTS</span>&#160;</span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">This
quarterly report contains forward-looking statements. All statements other than statements of historical fact are &#8220;forward-looking
statements&#8221; for purposes of this Quarterly Report on Form 10-Q. These statements involve known and unknown risks, uncertainties
and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance
or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by
terms including &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221;
&#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221;
&#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these terms or other similar expressions. Forward-looking
statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties.
Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions
due to certain factors, including, without limitation, the risks set forth under the caption &#8220;Risk Factors&#8221; below, which are
incorporated herein by reference as well as those business risks and factors described elsewhere in this report and in our other filings
with the Securities and Exchange Commission (the &#8220;SEC&#8221;), specifically our most recent Annual Report on Form 10-K, and our
Quarterly Reports on Form 10-Q filed Current Reports on Form 8-K filed subsequently to our most recent Annual Report on Form 10-K. All
forward-looking statements speak only as of the date made, and we undertake no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law.</span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:bold">CERTAIN
TERMS USED IN THIS QUARTERLY REPORT ON FORM 10-Q</span>&#160;</span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">As used in this Quarterly Report
on Form 10-Q, unless the context otherwise requires:</span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">references to &#8220;Chemomab Therapeutics Ltd.&#8221;, &#8220;Chemomab,&#8221;
        the &#8220;Company,&#8221; &#8220;us,&#8221; &#8220;we&#8221; and &#8220;our&#8221; refer to Chemomab Therapeutics Ltd. an Israeli company
        and its consolidated subsidiaries, although with respect to the presentation of financial results for historical periods that preceded
        the Merger (as defined below), these terms refer to the financial results of Chemomab Ltd., which was the accounting acquirer in the Merger;</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">references to &#8220;ordinary shares,&#8221; &#8220;our shares&#8221;
        and similar expressions refer to the Company&#8217;s ordinary shares, no nominal (par) value;</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">references to &#8220;ADS&#8221; refer to the American Depositary
        Shares listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;CMMB,&#8221; each representing twenty (20) ordinary
        shares;</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">references to &#8220;dollars,&#8221; &#8220;U.S. dollars&#8221;
        and &#8220;$&#8221; are to U.S. Dollars;</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">references to &#8220;NIS&#8221; are to New Israeli Shekels;</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">references to the &#8220;SEC&#8221; are to the U.S. Securities
        and Exchange Commission; and</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8226;</span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt;font-family:Times New Roman, Times, serif">references to the &#8220;Merger&#8221; refer to the merger
        involving Anchiano Therapeutics Ltd. and Chemomab Ltd., whereby a wholly owned subsidiary of Anchiano Therapeutics Ltd. merged with and
        into Chemomab Ltd., with Chemomab Ltd. surviving as a wholly owned subsidiary of Anchiano Therapeutics Ltd. Upon consummation of the Merger,
        Anchiano Therapeutics Ltd. changed its name to &#8220;Chemomab Therapeutics Ltd.&#8221; and the business conducted by Chemomab Ltd. became
        primarily the business conducted by the Company.</span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div>

<div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><a id="PARTI.FINANCIALINFORMATION"></a><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>PART
I. &#8211; FINANCIAL INFORMATION</strong></span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><div style="font-weight:bold;display:inline"><a id="Item1.FINANCIALSTATEMENTS160"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Item
1. FINANCIAL STATEMENTS</span></span></span></span></div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:100%;vertical-align:top">
        <div style="line-height:1.25"><span style="font-family:Times New Roman, Times, serif;line-height:1.25">&#160;</span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:14pt"><strong><span style="font-family:Times New Roman,Times,serif">Chemomab
        Therapeutics Ltd. and</span></strong></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:14pt"><strong><span style="font-family:Times New Roman,Times,serif">its
        subsidiaries</span></strong></div>
        <div style="line-height:1.25;font-size:14pt"><span style="font-family:Times New Roman, Times, serif;line-height:1.25">&#160;</span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:14pt"><strong><span style="font-family:Times New Roman,Times,serif">Condensed
        Consolidated Interim</span></strong></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:14pt"><strong><span style="font-family:Times New Roman,Times,serif">Financial
        Statements</span></strong></div>
        <div style="line-height:1.25;font-size:14pt"><span style="font-family:Times New Roman, Times, serif;line-height:1.25">&#160;</span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:14pt"><strong><span style="font-family:Times New Roman,Times,serif">As
        of March 31, 2022</span></strong></div>
        <div style="line-height:1.25;font-size:14pt"><span style="font-family:Times New Roman, Times, serif;line-height:1.25">&#160;</span></div>
        <div style="text-align:center;margin-right:14.2pt;margin-left:14.2pt;line-height:1.25;font-family:Times New Roman, Times, serif;font-size:14pt"><strong><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></strong></div></td></tr>
  </table></div></div></div>

<div>

<div style="margin:0pt">&#160;</div>

<div style="margin:0pt">&#160;</div>

<div style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">1</div></div>

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div>

<div style="text-align:right"><br /><span style="font-size:10pt;font-family:Times New Roman, Times, serif">Chemomab Therapeutics Ltd.</span></div>

<div style="text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">and its subsidiaries</span></div>

<div style="text-align:right">&#160;</div>

<div style="border-bottom:0pt solid windowtext;padding:0cm 0cm 1pt">

<div style="margin-top:0pt;margin-bottom:0pt;border:none;padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong>Unaudited
Condensed Consolidated Interim Financial Statements as of March 31, 2022</strong></span><hr style="background:rgb(0, 0, 0);width:100%;border-top:2px solid black" />

<p><strong>Contents</strong></p></div></div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman,Times,serif;font-size:10pt;margin-left:0px;width:100%">
  <tr>
    <td style="font-size:10pt;font-family:Times New Roman, serif;padding:0px;width:91%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font-size:10pt;font-family:Times New Roman, serif;padding:0px;width:9%">
        <div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span>Page</span></strong></span></div></td></tr>
  <tr>
    <td style="font-size:11pt;font-family:Times New Roman, serif;padding:0px;width:91%">&#160;</td>
    <td style="font-size:11pt;font-family:Times New Roman, serif;padding:0px;width:9%">&#160;</td></tr>
  <tr>
    <td style="font-size:11pt;font-family:Times New Roman, serif;padding:0px;width:91%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#CondensedConsolidatedBalanceSheets"><span><span>Condensed
        Consolidated Interim Balance Sheets</span></span></a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font-size:11pt;font-family:Times New Roman, serif;padding:0px;width:9%">
        <div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#160;&#160;
        3</span></div></td></tr>
  <tr>
    <td style="font-size:11pt;font-family:Times New Roman, serif;padding:0px;width:91%">&#160;</td>
    <td style="font-size:11pt;font-family:Times New Roman, serif;padding:0px;width:9%">&#160;</td></tr>
  <tr>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:91%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#CondensedConsolidatedInterimStatementsofOperations"><span><span>Condensed
        Consolidated Interim Statements of Operations</span></span></a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:9%">
        <div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#160;&#160;&#160;
        4</span></div></td></tr>
  <tr>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:91%">&#160;</td>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:9%">&#160;</td></tr>
  <tr>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:91%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#CondensedConsolidatedInterimStatementsofChangesinEquity"><span><span>Condensed
        Consolidated Interim Statements of Changes in Equity</span></span></a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:9%">
        <div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">5</span></div></td></tr>
  <tr>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:91%">&#160;</td>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:9%">&#160;</td></tr>
  <tr>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:91%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#CondensedInterimStatementsofCashflows"><span><span>Condensed
        Consolidated Interim Statements of Cash Flow</span></span></a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:9%">
        <div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right">6</div></td></tr>
  <tr>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:91%">&#160;</td>
    <td style="font-family:Times New Roman, serif;font-size:11pt;padding:0px;width:9%">&#160;</td></tr>
  <tr>
    <td style="font-size:10pt;font-family:Times New Roman, serif;padding:0px;width:91%"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><a href="#NOTESTOCONDENSEDCONSOLIDATEDFINANCIALSTATEMENTS"><span><span><span>Notes
        to the Condensed Consolidated Interim Financial Statements</span></span></span></a> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font-size:10pt;font-family:Times New Roman, serif;padding:0px;width:9%">
        <div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt;font-family:Times New Roman, Times, serif">7-10</span></div></td></tr>
  </table>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-weight:normal;font-style:normal">2</span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div>

<div>

<div>

<div style="text-align:right;line-height:1.25;margin-top:10px">

<p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics
Ltd.</span></span> </div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
its subsidiaries</span></span>

<p style="margin:0pt">&#160;</p> </div>

<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold"><a id="CondensedConsolidatedBalanceSheets"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
Consolidated Balance Sheets</span></span></div>

<div style="line-height:1.25;font-weight:bold"> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" />
</div> </div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands (except
share amounts)</span></span></div> </div> </div>

<table cellpadding="0" style="border-spacing:0px;margin:auto;border:0px;width:100%">
  <tr>
    <td style="width:100%;vertical-align:bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
        </tr>
  <tr>
    <td style="width:100%;vertical-align:bottom">&#160;</td> </tr>
  </table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;border:0px;font-size:10pt;margin:auto" width="90%">
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left" valign="bottom">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td style="padding:0cm 7px;height:18px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right" valign="top">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:9pt"><strong>March
        31,</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:9pt"><strong>December
        31,</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left" valign="bottom">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td style="padding:0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black" valign="top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:9pt"><strong>Note</strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;border-bottom:1.5pt solid black;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:9pt"><strong>2022</strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:right;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;border-bottom:1.5pt solid black;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:9pt"><strong>2021</strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:center">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1.5pt solid black;width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1.5pt solid black;width:9%;width:8%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Unaudited</strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1.5pt solid black;width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);text-align:right;border-bottom:1.5pt solid black;width:9%;width:8%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Audited</strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Assets</strong></span></span></span></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Current
        assets</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Cash
        and cash equivalents</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_30" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">13,827</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">15,186</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Short
        term bank deposits</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_32" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">43,579</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_33" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">45,975</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Other
        receivables and prepaid expenses</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_34" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,934</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_35" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,527</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        current assets</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_36" name="us-gaap:AssetsCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">59,340</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_37" name="us-gaap:AssetsCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">62,688</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Non-current
        assets</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Long
        term prepaid expenses</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="Fxbrl_20220504175928392" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">864</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_40" name="us-gaap:PrepaidExpenseNoncurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">908</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Property
        and equipment, net</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_42" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">358</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_43" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">357</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Restricted
        cash</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_44" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_45" name="us-gaap:RestrictedCashNoncurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">55</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Operating
        lease right-of-use assets</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_46" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">309</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_47" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">345</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        non-current assets</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_48" name="us-gaap:AssetsNoncurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,616</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_49" name="us-gaap:AssetsNoncurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,665</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        assets</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_50" name="us-gaap:Assets" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">60,956</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_51" name="us-gaap:Assets" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">64,353</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Current
        liabilities</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Trade
        payables</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_52" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,487</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_53" name="us-gaap:AccountsPayableTradeCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,336</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:black">Accrued
        expenses</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_54" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,248</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_55" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">555</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Employee
        and related expenses</span></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_56" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">666</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_57" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">653</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span style="color:black">Operating
        lease liabilities</span></span></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_58" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">116</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_59" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">106</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        current liabilities</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_60" name="us-gaap:LiabilitiesCurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">3,517</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_61" name="us-gaap:LiabilitiesCurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,650</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Non-current
        liabilities</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Operating
        lease liabilities - long term</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_62" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">203</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_63" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">237</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:11px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:11px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:11px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:11px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        non-current liabilities</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_64" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">203</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_65" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">237</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Commitments
        and contingent liabilities</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220505111616330" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20220331" unitRef="Unit1" xsi:nil="true"></ix:nonFraction></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220505111621715" name="us-gaap:CommitmentsAndContingencies" contextRef="C_20211231" unitRef="Unit1" xsi:nil="true"></ix:nonFraction></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        liabilities</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_66" name="us-gaap:Liabilities" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">3,720</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_67" name="us-gaap:Liabilities" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,887</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Shareholders'
        equity </span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;text-align:center;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:115%"><span style="line-height:115%">Ordinary
        shares <ix:nonFraction id="FFact_680" name="us-gaap:CommonStockNoParValue" contextRef="C_20211231" unitRef="Unit14" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="FFact_68" name="us-gaap:CommonStockNoParValue" contextRef="C_20220331" unitRef="Unit14" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction>
        par value - Authorized: <ix:nonFraction id="FFact_700" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20211231" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="FFact_70" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20220331" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">650,000,000</ix:nonFraction></ix:nonFraction>
        shares as of March</span><span style="line-height:115%"> 31, 2022 and as of December 31, 2021;</span></span></span></span></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>-</span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Issued
        and outstanding: <ix:nonFraction id="FFact_742" name="us-gaap:CommonStockSharesIssued" contextRef="C_20211231" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="FFact_741" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20211231" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="FFact_740" name="us-gaap:CommonStockSharesIssued" contextRef="C_20220331" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="FFact_74" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20220331" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">228,090,300</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>
        ordinary shares as of March 31, 2022 and as of December 31, 2021</span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="Fxbrl_20220505093047469" name="us-gaap:CommonStockValue" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:6px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093055381" name="us-gaap:CommonStockValue" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:black">Additional
        paid in capital</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_78" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">98,513</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_79" name="us-gaap:AdditionalPaidInCapital" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">97,639</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;background-color:rgb(255, 255, 255);width:64%">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span>Accumulated
        deficit</span></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>(<ix:nonFraction id="FFact_80" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">41,277</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>)</span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="FFact_81" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">36,173</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;background-color:rgb(255, 255, 255);width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:4px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:4px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:4px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:4px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        shareholders&#8217; equity</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:17px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:17px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_82" name="us-gaap:StockholdersEquity" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">57,236</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="height:17px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;background-color:rgb(255, 255, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_83" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">61,466</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:64%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>Total
        liabilities and shareholders&#8217; equity</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="top">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_84" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">60,956</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_85" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">64,353</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  </table>

<p style="margin-top:0px;margin-bottom:0px">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">The accompanying notes are an integral
part of the condensed consolidated interim financial statements.</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </div>

<div>

<div style="width:100%;clear:both">

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">3</span></span></p>
</div> <hr style="border-top:1.5pt solid #000000;page-break-after:always" /> </div>

<div>

<div>

<div style="text-align:right;line-height:1.25;margin-top:10px">

<p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics
Ltd.</span></span> </div>

<div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
its subsidiaries</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="line-height:1.25;font-weight:bold"><a id="CondensedConsolidatedInterimStatementsofOperations"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
Consolidated Interim Statements of Operations (Unaudited)</span></span></div>

<div style="line-height:1.25;font-weight:bold"> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" />
</div> </div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands</span></span></div>
</div> </div>

<div>&#160;</div>

<div>

<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border:0px;font-size:10pt;margin-left:0px;margin-right:0px;width:100%;margin:auto" width="90%">
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:16px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:16px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="line-height:9pt"><strong><span>Three
        months</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:16px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="line-height:9pt"><strong><span>Three
        months</span></strong></span></span></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:17px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="line-height:9pt"><strong><span>Ended</span></strong></span></span></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:17px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="line-height:9pt"><strong><span>Ended</span></strong></span></span></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:19px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:19px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="line-height:9pt"><strong><span>March
        31</span></strong>,</span></span></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:19px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="line-height:9pt"><strong><span>March
        31</span></strong>,</span></span></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
        </tr>
  <tr>
    <td style="padding:0cm 7px 0cm 0px;height:19px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;width:76%" valign="top">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:19px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%;border-bottom:1.5pt solid black" valign="top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:9pt"><strong>2022</strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="padding:0cm 0px 0cm 7px;height:19px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%;border-bottom:1.5pt solid black" valign="top">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:9pt"><strong>2021</strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%;width:78%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>Operating
        expenses</strong></span></span></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;width:8%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;width:8%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Research
        and development</span></span></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_88" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,745</ix:nonFraction></span></span></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_89" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,157</ix:nonFraction></span></span></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:19px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>General
        and administrative </span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:1.5pt solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_92" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,575</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:1.5pt solid black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_93" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">542</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>Total
        operating expenses</strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_96" name="us-gaap:OperatingExpenses" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">5,320</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_97" name="us-gaap:OperatingExpenses" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,699</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:19px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>Financing
        expenses (income), net</span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%;border-bottom:1.5pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>(<ix:nonFraction id="FFact_100" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">216</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span>)</span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(204, 238, 255);width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;background-color:rgb(204, 238, 255);width:9%;border-bottom:1.5pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_101" name="cmmb:FinanceIncomeExpensesNet" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:19px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong>Net
        loss for the period</strong></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span><ix:nonFraction id="FFact_104" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5,104</ix:nonFraction></span></span></strong></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%;border-bottom:4px double black" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_105" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,704</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Basic
        and diluted loss per Ordinary Share*</span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_108" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_20220101to20220331" unitRef="Unit14" decimals="INF" format="ixt:numdotdecimal">0.022</ix:nonFraction></span></span></span></span></strong></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_109" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_20210101to20210331" unitRef="Unit14" decimals="INF" format="ixt:numdotdecimal">0.011</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:76%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:9%" valign="bottom">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Weighted
        average number of Ordinary Shares outstanding, basic, and diluted*</span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_112" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_20220101to20220331" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">228,090,300</ix:nonFraction></span></span></span></span></strong></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="FFact_113" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_20210101to20210331" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">156,751,771</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%;width:1%">&#160;</td>
        </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">&#160;<br /><span><span><span><span><span><span>*&#160;
&#160; &#160; &#160; &#160; &#160; &#160;&#160;</span><span><span style="color:black"><span id="FN_6114f0b1c8b5719ae3a3c215">
    <ix:footnote id="FN20220505093535462" xml:lang="en-US">Number of shares has been retroactively adjusted based on the equivalent number of shares received
                    by the accounting acquirer&#8217;s shareholders in the reverse recapitalization transaction (refer to Note 1B).</ix:footnote></span></span></span></span></span></span></span></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span>The
                    accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></span></span></span></span></p>
                    </div>

                    <div>

                    <div style="width:100%;clear:both">

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">4</span></span></p>
                    </div> <hr style="border-top:1.5pt solid #000000;page-break-after:always" /> </div>

                    <div>

                    <div>

                    <div style="text-align:right;line-height:1.25;margin-top:10px">

<p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics Ltd.</span></span>
                    </div>

                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
                    its subsidiaries</span></span></div>

                    <div style="line-height:1.25">&#160;</div>

                    <div style="line-height:1.25">

                    <div style="line-height:1.25;font-weight:bold"><a id="CondensedConsolidatedInterimStatementsofChangesinEquity"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
                    Consolidated Interim Statements of Changes in Equity (Unaudited)</span></span></div>

                    <div style="line-height:1.25;font-weight:bold"> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" />
                    </div> </div>

                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands (except
                    share amounts)</span></span></div> </div> </div>

                    <div>&#160;</div>

                    <div>

                    <div>

                    <div>

                    <table border="0" cellpadding="0" cellspacing="0" style="width:100%;border-collapse:collapse;border:0px;font-size:10pt;margin:auto" width="90%">
  <tr>
    <td style="padding:0cm 0px;height:15px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left" valign="bottom">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td colspan="6" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;padding-bottom:0px;vertical-align:bottom;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Ordinary<br />Shares</strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Additional<br />paid
        in<br />capital</strong></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;vertical-align:bottom;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Accumulated<br />Deficit</strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>Total<br />Shareholders&#8217;<br />equity</strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%">&#160;</td> </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px;height:15px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;width:40%" valign="bottom">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;width:1%;width:1%">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span style="line-height:normal"><span><span><span style="color:black">Number</span></span></span></span></strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;width:1%;width:1%">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span style="line-height:normal"><span><span><span style="color:black">USD</span></span></span></span></strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;width:1%;width:1%">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span style="line-height:normal"><span><span><span style="color:black">USD</span></span></span></span></strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;width:1%;width:1%">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span style="line-height:normal"><span><span><span style="color:black">USD</span></span></span></span></strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;border-bottom:1.5pt solid black;width:1%;width:1%">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><span style="line-height:normal"><span><span><span style="color:black">USD</span></span></span></span></strong></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-family:Times New Roman, Times, serif;text-align:left;width:40%;background-color:rgb(204, 238, 255);vertical-align:baseline">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal"><strong><span style="color:black">For
        the three-month period ended on March 31, 2022</span></strong></span></span></span></p> </td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td colspan="2" style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td colspan="2" style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td colspan="2" style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td colspan="2" style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td colspan="2" style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
    <td style="font-family:Times New Roman, Times, serif;text-align:center;width:1%;background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(255, 255, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span><span><span style="color:black">Balance
        as of January 1, 2022 *</span></span></span></strong></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;padding-top:0px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504161436664" name="us-gaap:SharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">228,090,300</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;padding-top:0px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220505093740414" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;padding-top:0px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504161607482" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">97,639</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;padding-top:0px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>(<ix:nonFraction id="Fxbrl_20220504161812745" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">36,173</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>)</strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;padding-top:0px;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504161847247" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">61,466</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;padding-top:0px;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(204, 238, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><span><span><span style="color:black">Share-based
        compensation</span></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093821193" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504161917493" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">874</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093815054" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504161939600" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">874</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(255, 255, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><span><span><span style="color:black">Net
        loss for the period</span></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;border-bottom:1.5pt solid black;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093843525" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505093847704" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504162015389" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5,104</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:16px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;border-bottom:1.5pt solid black;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504162029289" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5,104</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:12px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(204, 238, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><strong><span><span><span style="color:black">Balance
        as of March 31, 2022</span></span></span></strong></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:12px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162054050" name="us-gaap:SharesOutstanding" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">228,090,300</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:12px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220505093917037" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:12px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162134224" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">98,513</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:12px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>(<ix:nonFraction id="Fxbrl_20220504162140381" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">41,277</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>)</strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:12px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162145961" name="us-gaap:StockholdersEquity" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">57,236</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(255, 255, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>For
        the three-month period ended on March 31, 2021</strong></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(204, 238, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><strong><span><span><span style="color:black">Balance
        as of January 1, 2021 (**)</span></span></span></strong></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162107281" name="us-gaap:SharesOutstanding" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">9,274,838</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220505093940758" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162206824" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">34,497</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>(<ix:nonFraction id="Fxbrl_20220504162211985" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">23,695</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>)</strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:21px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162217288" name="us-gaap:StockholdersEquity" contextRef="C_20201231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">10,802</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(255, 255, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><span><span><span style="color:black">Share-based
        compensation</span></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505094011117" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504162242016" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">43</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505094006095" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220504162250216" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">43</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(204, 238, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Effect
        of reverse capitalization transaction</span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220509163550193" name="cmmb:EffectOfReverseCapitalizationTransactionShares" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">152,299,702</ix:nonFraction></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220509172328807" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">-</ix:nonNumeric></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220509172946846" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">2,476</ix:nonNumeric></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220509164008995" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">-</ix:nonNumeric></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(204, 238, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="Fxbrl_20220509163651908" name="cmmb:EffectOfReverseCapitalizationTransaction" contextRef="C_20210101to20210331">2,476</ix:nonNumeric></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(255, 255, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Issuance
        of shares and warrants, net of issuance costs</span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220509163909641" name="cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">52,385,400</ix:nonFraction></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220509165714258" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220509163916692" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">43,547</ix:nonFraction></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220509164000245" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:13px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;background-color:rgb(255, 255, 255)">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220509163919739" name="cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">43,547</ix:nonFraction></span></span></p>
        </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(204, 238, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><span><span><span style="color:black">Net
        loss for the period</span></span></span></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>-</span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505094033172" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><ix:nonFraction id="Fxbrl_20220505094023997" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504162305425" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,704</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255);width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black;background-color:rgb(204, 238, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>(<ix:nonFraction id="Fxbrl_20220504162313633" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,704</ix:nonFraction></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(204, 238, 255);width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>)</span></span></span></span></td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:40%;background-color:rgb(255, 255, 255)">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="line-height:normal"><strong><span><span><span style="color:black">Balance
        as of March 31, 2021</span></span></span></strong></span></span></span></span></span></p> </td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162109962" name="us-gaap:SharesOutstanding" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">213,959,940</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220505094051101" name="us-gaap:StockholdersEquity" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162332928" name="us-gaap:StockholdersEquity" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">80,563</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>(<ix:nonFraction id="Fxbrl_20220504162338080" name="us-gaap:StockholdersEquity" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">25,399</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong>)</strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:4px double black;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
    <td colspan="1" style="height:15px;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:4px double black;background-color:rgb(255, 255, 255)"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong><ix:nonFraction id="Fxbrl_20220504162343720" name="us-gaap:StockholdersEquity" contextRef="C_20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">55,164</ix:nonFraction></strong></span></span></span></span></td>
    <td style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;background-color:rgb(255, 255, 255);height:15px;width:1%">&#160;</td>
        </tr>
  </table> </div>

<div>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>(*)

    <ix:footnote id="FN20220505094619846" xml:lang="en-US">Number and type of equity instruments reflects the capital of the legal parent (the Company).</ix:footnote></span></span></span></span></span></span></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span id="FN_6189558214d5910d568a796f"><span><span><span>(**)
                    </span><span><span style="color:black">
    <ix:footnote id="FN20220505094749710" xml:lang="en-US">Number of shares has been retroactively adjusted to reflect the share reverse split effected on
                    March 16, 2021 (refer to Note 1B).</ix:footnote></span></span></span></span></span></span></span></span></span></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><span><span>The
                    accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></span></span></span></span></span></span><br />&#160;</p>
                    </div>

                    <div>

                    <div style="width:100%;clear:both">

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">5</span></span></p>
                    </div> <hr style="border-top:1.5pt solid #000000;page-break-after:always" /> </div> </div> </div>

                    <div>

                    <div>

                    <div style="text-align:right;line-height:1.25;margin-top:10px">

<p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Chemomab Therapeutics Ltd.</span></span>
                    </div>

                    <div style="text-align:right;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">and
                    its subsidiaries</span></span></div>

                    <div style="line-height:1.25">&#160;</div>

                    <div style="line-height:1.25">

                    <div style="line-height:1.25;font-weight:bold"><a id="CondensedInterimStatementsofCashflows"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Condensed
                    Interim Statements of Cash flows (Unaudited)</span></span></div>

                    <div style="line-height:1.25;font-weight:bold"> <hr style="height:2px;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" />
                    </div> </div>

                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In USD thousands</span></span></div>
                    </div> </div>

                    <div>&#160;</div>

                    <div>

                    <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;border:0px;width:100%;font-size:10pt;margin:auto" width="90%">
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px;height:18px;background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:left;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;border-bottom:1.5pt solid black;width:1%">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>Three
        months</span></strong></span></span></span></span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>ended</span></strong></span></span></span></span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>March
        31,</span></strong></span></span></span></span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>2022</span></strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
    <td colspan="2" rowspan="1" style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;border-bottom:1.5pt solid black;width:1%">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>Three
        months</span></strong></span></span></span></span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>ended</span></strong></span></span></span></span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>March
        31,</span></strong></span></span></span></span></span></p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:right;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span>2021</span></strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-family:Times New Roman, Times, serif;text-align:center;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%;width:78%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Cash
        flows from operating activities</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;width:8%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;width:8%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Net
        loss for the period</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(<ix:nonFraction id="FFact_193" name="us-gaap:ProfitLoss" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">5,104</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_194" name="us-gaap:ProfitLoss" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,704</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Adjustments
        for operating activities:</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Depreciation</span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_195" name="us-gaap:Depreciation" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_196" name="us-gaap:Depreciation" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Change
        in other receivables and prepaid expenses</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(<ix:nonFraction id="FFact_197" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">363</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_198" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">57</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Change
        in </span></span></span><span>operating&#160;</span><span><span><span>lease liability</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="Fxbrl_20220504154909746" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220504154924941" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Change
        in trade payables</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_199" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">151</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_200" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">281</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Change
        in accrued expenses</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_201" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">693</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_202" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">62</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Change
        in employees and related expenses</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_203" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_204" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">85</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Share-based
        compensation</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_205" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">874</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_206" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">43</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:19px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_207" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,393</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_208" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">411</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:19px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:76%">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Net
        cash used in operating activities</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(<ix:nonFraction id="FFact_209" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">3,711</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:19px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_210" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,293</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:76%">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:76%">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Cash
        flows from investing activities</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:76%">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Investment
        in deposits</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_211" name="cmmb:ProceedsFromInvestmentInDepositsInvestingActivities" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,396</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_212" name="cmmb:ProceedsFromInvestmentInDepositsInvestingActivities" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:76%">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Purchase
        of property and equipment</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(<ix:nonFraction id="FFact_215" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:baseline;width:9%;border-bottom:1.5pt solid black"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_216" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:baseline;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Net
        cash </strong></span></span></span><span><strong>provided by (</strong></span><span><span><span><strong>used in) investing activities</strong></span></span></span></span></span></p>
        </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_217" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,382</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_218" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">2</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Cash
        flows from financing activities</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Cash
        acquired in reverse recapitalization</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="Fxbrl_20220504155015779" name="cmmb:CashAcquiredInReverseRecapitalization" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_221" name="cmmb:CashAcquiredInReverseRecapitalization" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,427</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Issuance
        of shares and warrants, net of issuance costs</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_227" name="us-gaap:ProceedsFromOtherEquity" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_228" name="us-gaap:ProceedsFromOtherEquity" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">45,372</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Net
        cash provided by financing activities</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_229" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_230" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">47,799</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Change
        in cash, cash equivalents and restricted cash</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>(<ix:nonFraction id="FFact_231" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,329</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%;width:1%"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>)</strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td colspan="1" style="height:18px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_232" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">46,504</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Cash,
        cash equivalents and restricted cash at beginning of period</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_233" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">15,241</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="height:20px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:1.5pt solid black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_234" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">11,727</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:17px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Cash,
        cash equivalents and restricted cash at end of period</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:21px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:4px double black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="FFact_235" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">13,912</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:21px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:4px double black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_236" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">58,231</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong>Supplemental
        disclosure of non-cash investing and financing activities:</strong></span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Liabilities
        assumed, net of non-cash assets received in reverse merger</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:21px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:4px double black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="Fxbrl_20220505095521944" name="cmmb:LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:21px;background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:4px double black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_237" name="cmmb:LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">49</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm 7px 0cm 0px;height:21px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:76%" valign="bottom">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>Accrued
        share issuance expenses</span></span></span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:21px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:4px double black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><ix:nonFraction id="Fxbrl_20220505095540169" name="cmmb:AccruedShareIssuanceExpenses" contextRef="C_20220101to20220331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></strong></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;border-bottom:4px double black;width:1%">&#160;</td>
    <td colspan="1" style="height:21px;background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:9%;border-bottom:4px double black" valign="top"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_239" name="cmmb:AccruedShareIssuanceExpenses" contextRef="C_20210101to20210331" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,825</ix:nonFraction></span></span></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%;width:1%">&#160;</td>
        </tr>
  </table>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>The
accompanying notes are an integral part of the condensed consolidated interim financial statements.</span></span></span></span></span></p>
</div>

<div>

<div style="width:100%;clear:both">

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6</span></span></p>
</div> <hr style="border-top:1.5pt solid #000000;page-break-after:always" /> </div>

<div>

<p style="margin-top:0px;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center">&#160;</p>

<p style="margin-top:0px;margin-bottom:0px;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="text-decoration:underline"><span style="color:black">CHEMOMAB
THERAPEUTICS LTD&#160;AND ITS SUBSIDIARIES</span></span></strong></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">(FORMERLY
ANCHIANO THERAPEUTICS LTD.)</span></span></span></strong></span></span></span></p>

<div style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">NOTES
TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS</span></span></span></strong></span></span></span></div>

<div style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><a id="NOTESTOCONDENSEDCONSOLIDATEDFINANCIALSTATEMENTS"></a>&#160;</div>
</div> <ix:nonNumeric id="Fxbrl_20220505134250696" name="us-gaap:NatureOfOperations" contextRef="C_20220101to20220331" escape="true">

<div>

<div>

<div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>Note 1 - General.</span></strong></span></span></span></div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman,Times,serif;font-size:10pt;margin-left:1px;width:100%">
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman, Times, serif;line-height:normal">A.
        </span></strong></p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">Chemomab
        Therapeutics Ltd. (hereinafter - "the Company") is an Israeli based company incorporated under the laws of the State of Israel in September
        2011. The Company&#8217;s registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company
        discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.</span></span></td>
        </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"><strong>B.</strong></td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">On March&#160;16, 2021, the Company,
        then known as Anchiano Therapeutics Ltd. (&#8220;Anchiano&#8221;), completed its merger with Chemomab Ltd., a privately-held Israeli limited
        company (&#8220;Chemomab Ltd.&#8221;). Pursuant to the Agreement and Plan of merger (the &#8220;Merger Agreement&#8221;) dated as of December&#160;14,
        2020, by and among Anchiano, CMB Acquisition Ltd., an Israeli limited company and wholly-owned subsidiary of Anchiano (&#8220;Merger Sub&#8221;),
        and Chemomab Ltd. Upon completion of the merger transaction, pursuant to which Merger Sub merged with and into Chemomab Ltd., with Chemomab
        Ltd. being the surviving entity and a wholly owned subsidiary of Anchiano (the &#8220;Merger&#8221;), the Company changed its name from
        &#8220;Anchiano Therapeutics Ltd.&#8221; to &#8220;Chemomab Therapeutics Ltd.&#8221; and the business conducted by Chemomab Ltd. became
        the primarily business conducted by the Company.</p> </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:normal">For
        accounting purposes, Chemomab Ltd. is considered to have acquired Anchiano based upon the terms of the Merger as well as other factors
        including; (i) Chemomab Ltd.'s former shareholders owned approximately 90% of the combined Company&#8217;s outstanding ordinary shares
        immediately following the closing of the Merger, and (ii) Chemomab Ltd. management holds key management positions of the combined Company.
        The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as
        the assets acquired and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets
        acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date
        of completion of the Merger.</span></p>
        <p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">Immediately
        prior to the effective date of the Merger, all preferred shares of Chemomab Ltd. were converted into ordinary shares of Chemomab Ltd.
        on a one-for-one basis.</span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">In
connection with the Merger, and following the effective time of the Merger, the Company effected a reverse share split of its ordinary
shares at a ratio of <ix:nonFraction id="Fxbrl_20220512125515025" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_20210314to20210316" unitRef="Pure" scale="-2" decimals="2" format="ixt:numdotdecimal">4</ix:nonFraction>:<ix:nonFraction id="Fxbrl_20220512125522757" name="cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" contextRef="C_20210314to20210316" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">1</ix:nonFraction>
(the &#8220;Reverse Split&#8221;) and increased the number of ordinary shares underlying each American Depositary Share ("ADS") from 5
to 20. At the effective time of the Merger, each Chemomab Ltd. ordinary share outstanding immediately prior to the effective time of the
Merger automatically converted into the right to receive approximately <ix:nonFraction id="Fxbrl_20220512125459632" name="cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger" contextRef="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">12.86</ix:nonFraction>
ADSs, each representing <ix:nonFraction id="Fxbrl_20220512125506799" name="cmmb:NumberOfOrdinarySharesConsistedInDS" contextRef="C_20210314to20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">20</ix:nonFraction>
ordinary shares of the Company, plus a warrant to purchase ADSs that may become exercisable only under certain circumstances (the &#8220;exchange
ratio&#8221;).</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">The
exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd.
The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and unvested, under the Chemomab Share Incentive
Plan (the &#8220;2015 Plan&#8221;), with such options representing the right to purchase a number of ADSs equal to approximately 12.86
multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.</p> </div>

<div>

<div><ix:exclude>

<div style="width:100%;clear:both">

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center"><br />7</p> </div> <hr style="border-top:1.5pt solid #000000;page-break-after:always" />

<div>

<div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="text-decoration:underline"><span style="color:black">CHEMOMAB
THERAPEUTICS LTD&#160;AND ITS SUBSIDIARIES</span></span></strong></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">(FORMERLY
ANCHIANO THERAPEUTICS LTD)</span></span></span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">NOTES
TO CONDENSED CONSOLIDATED </span></span></span></strong></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="text-decoration:underline"><span style="color:black">INTERIM&#160;</span></span></strong></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">FINANCIAL
STATEMENTS</span></span></span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>Note
1 - General.</span></strong><strong><span><span style="color:black"> (Cont.)</span></span></strong></span></span></span></p> </div> </div>
</ix:exclude></div>

<div>

<div>

<p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:110%">The
accompanying unaudited condensed consolidated financial statements and notes to the unaudited condensed consolidated financial statements
give retroactive effect to the exchange ratio and the Reverse Split for all periods presented.</span></span></span><br />&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
equity structure reflects the legal acquirer's equity structure. The balance sheet has been adjusted to reflect the par value of the outstanding
shares of the legal acquirer, including the number of shares issued in the Merger. Any difference is recognized as an adjustment to the
additional paid in capital.</span></span></span></p>

<p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">Immediately
after completion of the Merger, on March 16, 2021, the Company had <ix:nonFraction id="FFact_245" name="cmmb:NumberOfSharesDilutedAfterMerger" contextRef="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">8,078,727</ix:nonFraction>
ADS issued and outstanding (<ix:nonFraction id="FFact_246" name="cmmb:SharesConvertiblePerShareOfAcquireeEntity" contextRef="C_20210314to20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">9,003,357</ix:nonFraction>
on a fully diluted basis). In addition, immediately after the Merger, Chemomab Ltd. former shareholders owned approximately <ix:nonFraction id="FFact_247" name="cmmb:ShareholdingPercentageImmediatelyFollowingMerger" contextRef="C_20210314to20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember" unitRef="Pure" scale="-2" decimals="2" format="ixt:numdotdecimal">90</ix:nonFraction>%
of the number of issued and outstanding ordinary shares of the Company and the shareholders of the Company immediately prior to the Merger
owned approximately 10% of the number of issued and outstanding ordinary shares of the Company (all on a fully diluted basis). </span></span></span></p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">On
March 16, 2021, immediately prior to the effectiveness of the Merger, Anchiano had <ix:nonFraction id="Fxbrl_20220512125752182" name="cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" contextRef="C_20210314to20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">65,675,904</ix:nonFraction>
ordinary shares outstanding (prior to the effect of the Reverse Split) and a market capitalization of $<ix:nonFraction id="Fxbrl_20220512125807117" name="us-gaap:Capital" contextRef="C_20210316" unitRef="Unit1" scale="6" decimals="-5" format="ixt:numdotdecimal">58.7</ix:nonFraction>&#160;million.
The estimated fair value of the net assets of Anchiano on March 16, 2021, prior to the Merger, was approximately $<ix:nonFraction id="Fxbrl_20220512125814149" name="cmmb:RetainedEarningsAccumulatedDeficits" contextRef="C_20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember" unitRef="Unit1" scale="6" decimals="-5" format="ixt:numdotdecimal" sign="-">2.5</ix:nonFraction>&#160;million.
The fair value of ordinary shares on the Merger closing date, prior to the Merger, was above the fair value of the Company&#8217;s net
assets. As the Company&#8217;s net assets were predominantly composed of cash offset against current liabilities, the fair value of the
Company&#8217;s net assets as of March 16, 2021, immediately prior to the Merger, was considered to be the best indicator of the fair
value and, therefore, the estimated preliminary purchase consideration.</p>

<p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:110%">The
following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion
of the Merger (in thousands):</span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> <ix:nonNumeric id="Fxbrl_20220504144013751" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" contextRef="C_20220101to20220331" escape="true">

<div style="margin-left:90px">

<table border="0" cellpadding="0" cellspacing="0" style="background:white;border-collapse:collapse;border:0px;font-size:10pt;margin-left:0px;width:90%" width="90%">
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:89%" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Cash
        and cash equivalents</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%">$</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%" valign="bottom"><ix:nonFraction id="FFact_251" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="C_20210316" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,427</ix:nonFraction></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Asset
        held for sale</span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom"><ix:nonFraction id="FFact_252" name="cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" contextRef="C_20210316" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Prepaid
        and other assets</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"><ix:nonFraction id="FFact_253" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="C_20210316" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">236</ix:nonFraction></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Accrued
        liabilities</span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black" valign="bottom">(<ix:nonFraction id="FFact_254" name="cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" contextRef="C_20210316" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal" sign="-">1,187</ix:nonFraction></td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%">)</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td colspan="1" style="padding:0cm;height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Net
        acquired assets</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:left">$</p> </td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"><ix:nonFraction id="FFact_255" name="cmmb:EstimatedFairValueOfNetAssetsAcquired" contextRef="C_20210316" unitRef="Unit1" scale="3" decimals="-3" format="ixt:numdotdecimal">2,476</ix:nonFraction></td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  </table> </div> </ix:nonNumeric>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:1px;width:100%;border:0px">
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">C.
        </span></strong></p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">In connection with the Merger, on
        March 15, 2021, Anchiano entered into Securities Purchase Agreements with certain purchasers for the issuance and sale by Anchiano in
        a private placement (&#8220;Private Placement&#8221;) of approximately $<ix:nonFraction id="Fxbrl_20220512130041910" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="C_20210301to20210315" unitRef="Unit1" scale="6" decimals="-5" format="ixt:numdotdecimal">45.5</ix:nonFraction>
        million of its ADSs and accompanying warrants to purchase ADSs. The warrants have an exercise price of approximately $<ix:nonFraction id="Fxbrl_20220512130048885" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="C_20210315" unitRef="Unit14" scale="0" decimals="2" format="ixt:numdotdecimal">17.35</ix:nonFraction>
        per ADS, expire <ix:nonNumeric id="Fxbrl_20220512130059437" name="cmmb:WarrantsExercisablePeriod" contextRef="C_20210301to20210315" format="ixt-sec:durwordsen">five
        years</ix:nonNumeric> from the date of issuance, and if exercised in full will provide additional proceeds to the Company of $<ix:nonFraction id="Fxbrl_20220512130105431" name="us-gaap:ProceedsFromWarrantExercises" contextRef="C_20210301to20210315" unitRef="Unit1" scale="6" decimals="-5" format="ixt:numdotdecimal">4.5</ix:nonFraction>
        million. The closing of the Private Placement was completed on March 22, 2021.</p> </td> </tr>
  </table>

<div><ix:exclude>

<div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif"><br />8</p> </div>
<hr style="border-top:1.5pt solid #000000;page-break-after:always" />

<div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center">&#160;</p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="text-decoration:underline"><span style="color:black">CHEMOMAB
THERAPEUTICS LTD&#160;AND ITS SUBSIDIARIES</span></span></strong></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">(FORMERLY
ANCHIANO THERAPEUTICS LTD)</span></span></span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">NOTES
TO CONDENSED CONSOLIDATED </span></span></span></strong></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="text-decoration:underline"><span style="color:black">INTERIM&#160;</span></span></strong></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">FINANCIAL
STATEMENTS</span></span></span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>Note
1 - General.</span></strong><strong><span><span style="color:black"> (Cont.)</span></span></strong></span></span></span></p> </div> </ix:exclude></div>

<div>

<p style="margin:0pt">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:1px;width:100%;border:0px">
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">D.
        </span></strong></p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Pursuant to an Asset Purchase and
        Assignment Agreement dated as of March 16, 2021, as amended on March 31, 2021, between the Company&#8217;s wholly owned subsidiary, Anchiano
        Therapeutics, Inc., a Delaware corporation (&#8220;Anchiano Delaware&#8221;) and Kestrel Therapeutics, Inc., a company organized under
        the laws of Delaware (&#8220;Kestrel&#8221;), Anchiano Delaware agreed to sell to Kestrel all of the its rights and obligations in its
        business to the extent related to the research, development and commercialization of the Compounds and Products (as such terms are defined
        in the Collaboration and License Agreement entered into as of September 13, 2019, by and between ADT Pharmaceuticals, LLC and the Anchiano
        Delaware), also known as the pan-RAS and PDE10/&#946;-catenin programs. In consideration of the sale and transfer of the Compounds and
        Products Kestrel paid the Company a total of $<ix:nonFraction id="Fxbrl_20220512130117710" name="cmmb:AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" contextRef="C_20210301to20210315" unitRef="Unit1" scale="6" decimals="-5" format="ixt:numdotdecimal">1.0</ix:nonFraction>
        million.</p> </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">E.</span></strong></p>
        </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">On April 30, 2021, the Company entered
        into an At the Market Offering Agreement (the "ATM agreement") with Cantor Fitzgerald &#38; Co., ("Cantor"). Pursuant to the ATM agreement,
        the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $<ix:nonFraction id="Fxbrl_20220512130127301" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="C_20210401to20210430_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Unit1" scale="6" decimals="-6" format="ixt:numdotdecimal">75</ix:nonFraction>
        million through Cantor or the ATM agreement. From April 30, 2021 through March 31, 2022, the Company issued <ix:nonFraction id="Fxbrl_20220512130133431" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_20210501to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">699,806</ix:nonFraction>
        ADSs at an average price of $<ix:nonFraction id="Fxbrl_20220512130159469" name="us-gaap:SaleOfStockPricePerShare" contextRef="C_20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Unit14" scale="0" decimals="2" format="ixt:numdotdecimal">22.75</ix:nonFraction>
        per ADS through the ATM Prospectus Supplement, resulting in gross proceeds of $<ix:nonFraction id="Fxbrl_20220512130144839" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="C_20210501to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Unit1" scale="6" decimals="-5" format="ixt:numdotdecimal">15.9</ix:nonFraction>
        million. The offer and sale of ADSs under the ATM agreement has been registered under the Company&#8217;s effective registration statement
        on Form S-3 (File No. 333-255658), together with a prospectus forming a part thereof, filed with the SEC under the Securities Act of 1933,
        as amended (the &#8220;Securities Act&#8221;). Sales, if any, of ADS pursuant to the ATM agreement may be made in any transactions that
        are deemed to be &#8220;at the market&#8221; offerings as defined in Rule 415(a)(4) under the Securities Act. The Company is not obligated
        to sell any ADSs under the ATM agreement.</p> </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">On
        April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $<ix:nonFraction id="Fxbrl_20220505140022769" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" unitRef="Unit1" scale="0" decimals="0" format="ixt:numdotdecimal">18,125,000</ix:nonFraction>
        of the Company's ADSs (instead of the amount of $75 million above) in connection with the reactivation of the ATM Facility.</span></p>
        </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">F.</span></strong></p>
        </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">Since
        January 2020, the COVID-19 outbreak has dramatically expanded into a worldwide pandemic creating macro-economic uncertainty and disruption
        in the business and financial markets. Many countries around the world, including Israel, have been taking measures designated to limit
        the continued spread of the Coronavirus, including the closure of workplaces, restricting travel, prohibiting assembling, closing international
        borders and quarantining populated areas. The Company's clinical trial sites have been affected by the COVID-19 pandemic, and as a result,
        commencement of the enrollment of Company&#8217;s clinical trials of CM-101 in PSC was delayed and the enrollment rate has been affected
        as well. As a result, the Company extended patient&#160;recruiting to additional territories with significant recruitment potential. In
        addition, after enrollment in these trials, patients may drop out of the Company's trials because of the COVID-19 possible implications.</span></p>
        </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">Based
        on management&#8217;s assessment, the extent to which the coronavirus will further impact the Company&#8217;s operations will depend on
        future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak,
        and the actions that may be required to contain the coronavirus or treat its impact. The Company is carefully monitoring the restrictions
        due to the COVID-19 outbreak and will adjust activities accordingly.</span></p> </td> </tr>
  </table> </div> </div> </div> </div> </div> </ix:nonNumeric>

<div>

<div>

<p style="margin:0pt">&#160;</p>

<div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif">9</p> </div> <hr style="border-top:1.5pt solid #000000;page-break-after:always" />
</div> </div>

<div>

<p style="margin-top:0px;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center">&#160;</p>

<p style="margin-top:0px;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><strong><span style="text-decoration:underline"><span><span style="color:black">CHEMOMAB
THERAPEUTICS LTD&#160;AND ITS SUBSIDIARIES</span></span></span></strong></span></span></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">(FORMERLY
ANCHIANO THERAPEUTICS LTD)</span></span></span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:center;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span style="text-decoration:underline"><span><span style="color:black">NOTES
TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS</span></span></span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> <ix:nonNumeric id="Fxbrl_20220505134338955" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20220101to20220331" escape="true">

<div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>Note
2 - Basis of Presentation and Significant Accounting Policies </span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p> <ix:nonNumeric id="Fxbrl_20220505104021668" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_20220101to20220331" escape="true">

<div>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>A.&#160;
&#160; &#160; &#160; Basis of Preparation</strong></span></span></span></p>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:47px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and applicable rules
and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal
and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as </span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">of
March 31, 2022, and its results of operations for the three months ended March 31, 2022, and 2021, changes in shareholders&#8217; equity
for the three months ended March 31, 2022 and 2021, and cash flows for the three months ended March 31, 2022 and 2021. The results of
operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending
December 31, 2022 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#8217;s Form 10-K for the year ended December 31, 2021 as filed with the SEC. The
Company&#8217;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2021
included in the Company&#8217;s Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#8217;s
significant accounting policies.</span></span></span></p> </div> </ix:nonNumeric>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
<ix:nonNumeric id="Fxbrl_20220505104106171" name="us-gaap:UseOfEstimates" contextRef="C_20220101to20220331" escape="true">

<div>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>B.&#160;
&#160; &#160; &#160; Use of estimates</strong></span></span></span></p>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.</span></span></span></p> </div> </ix:nonNumeric> </div> </ix:nonNumeric> </div>

<div>

<div style="width:100%;clear:both">

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center"><br />10</p> </div> <hr style="border-top:1.5pt solid #000000" />

<div style="page-break-after:always">&#160;</div> </div>

<div style="background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif;font-size:14pt;font-style:normal;font-variant:normal;text-transform:none">

<div style="line-height:1.25">

<div style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><a id="Item2.MA"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span style="font-weight:bold">Item
2. MA</span></span></strong><strong><span style="font-weight:bold">NAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS</span>&#160;</strong></span></span></div>

<div style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>&#160;</strong></span></span></div></div></div>

<div></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">You
should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated
financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q, as well as our audited consolidated
financial statements and related notes for the year ended December 31, 2021, as filed in our Annual Report on Form 10-K for the year ended
December 31, 2021 (the &#8220;2021 Annual Report&#8221;). Some of the information contained in this discussion and analysis, particularly
with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks
and uncertainties. You should read &#8220;Risk Factors&#8221; in Item 1A of our 2021 Annual Report&#160; for a discussion of important
factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements
contained in the following discussion and analysis.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Overview</span>&#160;</span></span></span></div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div></div>

<div style="line-height:1.25">

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
Company is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and
inflammatory diseases with high unmet need. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and
inflammation, the Company developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has demonstrated the
potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.</span></span></span></div></div>

<div style="line-height:1.25">

<div style="text-align:justify;line-height:1.25">&#160;</div></div>

<div style="line-height:1.25">

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
Company has pioneered the therapeutic targeting of CCL24, a chemokine that promotes various types of cellular processes that regulate
inflammatory and fibrotic activities through the CCR3 receptor. The chemokine is expressed in various types of cells, including immune
cells, endothelial cells and epithelial cells. We have developed a novel CCL24 inhibiting product candidate with dual anti-fibrotic and
anti-inflammatory activity that modulates the complex interplays of both of these inflammatory and fibrotic mechanisms that drive abnormal
states of fibrosis and clinical fibrotic diseases. This innovative approach is being developed for difficult to treat rare diseases, also
known as orphan indications or diseases, such as primary sclerosing cholangitis, or PSC, and systemic sclerosis, or SSc, for which patients
have no established disease modifying standard of care treatment options.</span></span></span></div></div>

<div style="line-height:1.25">

<div style="line-height:1.25">&#160;</div></div>

<div style="line-height:1.25">

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>CM-101,
the Company&#8217;s lead clinical product candidate, is a first-in-class humanized monoclonal antibody that hinders the basic function
of the soluble chemokine CCL24, also known as eotaxin-2, as a regulator of major inflammatory and fibrotic pathways. We have demonstrated
that CM-101 interferes with the underlying biology of inflammation and fibrosis through a novel and differentiated mechanism of action.
Based on these findings, the Company is actively developing CM-101 in Phase 2 clinical studies directed toward two distinct clinical indications
including patients with liver, skin, and/or lung fibrosis. We are currently conducting a Phase 2 clinical study in PSC, a rare obstructive
and cholestatic liver disease. In addition, we are planning a biological and clinical proof of concept study in SSc focused on establishing
biological and clinical proof of concept in this patient population. Although our primary focus relates to these two rare indications,
an additional Phase 2 clinical study is currently ongoing in non-alcoholic steatohepatitis, or NASH. This trial will provide important
safety and PK data to support the development of CM-101 subcutaneous formulation.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Fibrosis
is the abnormal and excessive accumulation of collagen and extracellular matrix, the non-cellular component in all tissues and organs,
that provides structural and biochemical support to surrounding cells. When present in excessive amounts, collagen and extracellular matrix
lead to scarring and thickening of connective tissues, affecting tissue properties and potentially leading to organ failure. Fibrosis
can occur in many different tissues, including lung, liver, kidney, muscle, skin, and the gastrointestinal tract, resulting in a wide
array of progressive fibrotic conditions. Fibrosis and inflammation are intrinsically linked. While a healthy inflammatory response is
necessary for efficient tissue repair; after injury, an excessive, uncontrolled inflammatory response can lead to tissue fibrosis.&#160;</span></span></span></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">11</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div></div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Recent
Developments</span></span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>New
Executive Appointments</span></span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On
February 10, 2022, our shareholders approved the appointment of Dr. Dale Pfost, our Chief Executive Officer, to the additional role of
Chairman of our Board of Directors. This appointment followed the resignation of our previous Chairman of the Board, Dr. Stephen Squinto,
who concurrent with his resignation effective December 19, 2021, became an ad-hoc strategic advisor and consultant to us in connection
with our corporate and business strategy and corporate development.</span></span></span></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On
January 4, 2022, we announced the addition of Jack Lawler, who brings extensive experience managing global clinical trials, as Vice President
of Global Clinical Development Operations.</span></span></span></div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Revisions
to Chemomab&#8217;s Clinical Programs</span></span></span></div>

<div style="text-align:justify;line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On
March 9, 2022, we announced that, following a comprehensive strategic review, we are making revisions to our current clinical programs.
The changes are designed to optimize the clinical development of lead product candidate CM-101 by maximizing the clinical information
obtained, generating additional important data to support future advancement to registration trials, and decreasing the overall risk in
the CM-101 clinical development program in the lead indications of PSC and SSc, as well as potentially in additional indications where
the scientific rationale is strong. The key top-line changes to the clinical development programs include the following:</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Expanding
our commitment to primary sclerosing cholangitis with an enlarged clinical trial that adds an important dose finding component.</span>&#160;We
plan to significantly expand the Phase 2 clinical trial in PSC by implementing a dose finding component to the CM-101 development program.
We will be increasing the size of the study by adding additional dose cohorts, including plans to evaluate both a lower and a higher dose
level of CM-101 to support future potential registrational trials. In addition, we plan to add an open-label extension to the trial to
evaluate the safety, tolerability and durability of effect over longer treatment durations.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Focusing
our clinical efforts in systemic sclerosis on establishing earlier biological and clinical proof of concept.&#160;</span>We plan to focus
our SSc trial towards establishing biological and clinical proof of concept in this patient population. We are revising the design of
our planned SSc trial in a way that we believe should enable an expedited path to proof of concept data, as well as further elucidation
of the different mechanisms of action of CM-101 in treating the skin, lung and vascular damage seen in SSc patients.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Early
completion of enrollment in our safety, pharmacokinetic and biomarker liver fibrosis study, yielding a data readout targeted near the
end of 2022.</span>&#160;We will be completing enrollment in our ongoing safety, tolerability and biomarker trial that is evaluating the
subcutaneous formulation of CM-101 in liver fibrosis patients. We believe the early completion of this study should be sufficient to achieve
our key objectives&#8212;exploring safety and providing the pharmacokinetic data needed to assess next steps in the development of the
subcutaneous formulation&#8212;while allowing us to focus our resources on our lead indications of PSC and SSc.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
expect that the proposed changes to the CM-101 development program will provide important data on the clinical dose response relationship
to inform the broader development program and to identify the optimal dose to advance in later PSC trials. The modifications are also
expected to generate proof of concept data on clinically relevant aspects of SSc, a complex rheumatological disorder, to best inform the
development path for a novel, first-in-class therapeutic like CM-101, along with relevant safety and tolerability data to support the
evaluation of higher doses and inform decisions on next steps in the development of the subcutaneous formulation.</span></span></span></div>

<div style="line-height:1.25;font-family:'Times New Roman',Times,serif">

<div style="line-height:1.25">&#160;</div></div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">12</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Shelf
Registration Statement and ATM Offering</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On
April 30, 2021, we filed a shelf registration statement on Form S-3 with the SEC (File No. 333-255658) for the issuance and sale by us
of up to $200,000,000 of our ordinary shares, ADSs, debt securities, warrants and units comprising any combination of the foregoing securities
(the &#8220;Shelf Registration Statement&#8221;). On the same date, we entered into the sales agreement (the &#8220;Sales Agreement&#8221;)
with Cantor Fitzgerald, pursuant to which we may offer and sell, from time to time, at our option, through or to Cantor Fitzgerald, up
to an aggregate of $75,000,000 of our ADSs (the &#8220;ATM Facility&#8221;). During the period from April 30, 2021 through the date of
this quarterly report on Form 10-Q, we had sold an aggregate of 699,806 ADSs pursuant to the Sales Agreement for a total gross consideration
of approximately $15.9 million.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On
April 25, 2022, we filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000 of our ADSs in connection
with the reactivation of the ATM Facility and pursuant to General Instruction I.B.6 of Form S-3, which, subject to certain exceptions,
limits the amount of securities we are able to offer and sell under such registration statement to one-third of our unaffiliated public
float. Any ADSs offered, or to be offered, and sold under the Sales Agreement were issued and sold, or will be issued and sold, pursuant
to the Shelf Registration Statement and the applicable prospectus or prospectus supplement by methods deemed to be an &#8220;at the market
offering&#8221; as defined in Rule 415(a)(4) promulgated under the Securities Act, or if specified by us, by any other method permitted
by law.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Impact
of COVID-19</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;&#160;&#160;&#160;&#160;
Since </span>March 2020, the COVID-19 pandemic has dramatically expanded into a worldwide pandemic, creating macro-economic uncertainty
and disruption in the business and financial markets. The continuing implications of the COVID-19 pandemic on us remain uncertain and
will depend on future developments, including any adverse impact due to additional variants of the virus; its impact on our employees;
the range of government mandated restrictions and other measures; and the success of the COVID-19 vaccines and their effectiveness against
the virus and related variants. Furthermore, our clinical trial sites have been affected by the COVID-19 pandemic, and as a result, commencement
of the enrollment in our clinical trials of CM-101 in PSC was delayed, and the enrollment rate has been affected as well. As a result,
we expanded our patient recruiting efforts to additional territories. In addition, after enrollment in these trials, patients might still
discontinue participation in these trials because of possible COVID-19 implications.</span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25">

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;&#160;&#160;&#160;&#160;
Based on management&#8217;s assessment, the extent to which the COVID-19 pandemic will further impact our operations will depend on future
developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak,
and the actions that may be required to contain the COVID-19 or treat its impact. We are carefully monitoring the restrictions due to
the COVID-19 pandemic and will adjust activities accordingly.</span></span></span></div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">13</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Corporate
Information</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
were incorporated on September 22, 2011 under the laws of the State of Israel. In March 2021, in connection with the Merger, we changed
our name from Anchiano Therapeutics Ltd. to Chemomab Therapeutics Ltd. Our principal executive offices are located at Kiryat Atidim, Building
7, Tel Aviv, Israel 6158002, and our phone number is +972-77-331-0156. Our website is:&#160;<span style="font-style:italic">www.chemomab.com.</span>&#160;The
information contained on, or that can be accessed through, our website is not incorporated by reference into this prospectus supplement.
We have included our website address as an inactive textual reference only. &#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Components
of Operating Results</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold;font-style:italic">References
to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;Chemomab&#8221; in this &#8220;Components of Operating Results&#8221;
and in the &#8220;Results of Operations&#8221; below refer to the Company after the Merger, and, with respect to historical periods preceding
the Merger, refer to Chemomab Ltd., whose business became the business of the Company upon consummation of the Merger.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold;font-style:italic">Revenues</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>To
date, we have not generated any revenue. We do not expect to generate revenue unless and until we obtain regulatory approval and commercialize
a product candidate, or until we receive revenue from a collaboration such as a co-development or out-licensing agreement. There can be
no assurance that we will receive such regulatory approvals, and if any product candidate is approved, that we will be successful in commercializing
it.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold;font-style:italic">Research
and Development Expenses</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Research
and development expenses consist primarily of costs incurred in connection with the development of our product candidates. These expenses
include:</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;</span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>expenses incurred under agreements with
        contract research organizations or contract manufacturing organizations, as well as investigative sites and consultants that conduct our
        clinical trials, preclinical studies and other scientific development services;</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;</span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>manufacturing scale-up expenses and the
        cost of acquiring and manufacturing preclinical and clinical trial materials;</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;</span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>employee-related expenses, including salaries,
        related benefits, travel and share-based compensation expenses for employees engaged in research and development functions, as well as
        external costs, such as fees paid to outside consultants engaged in such activities;</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;</span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>license maintenance fees and milestone fees
        incurred in connection with various license agreements;</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;</span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>costs related to compliance with regulatory
        requirements; and</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:18pt">&#160;</td>
    <td style="width:18pt;vertical-align:top;align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;</span></span></span></td>
    <td style="width:auto;vertical-align:top;text-align:justify">
        <div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>depreciation and other expenses.</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
recognize external development costs based on an evaluation of the progress to completion of specific tasks using information provided
to us by our service providers.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
do not allocate employee costs or facility expenses, including depreciation or other indirect costs, to specific programs because these
costs are deployed across multiple programs and, as such, are not separately classified. We use our internal resources primarily to oversee
research, as well as for managing our preclinical development, process development, manufacturing and clinical development activities.
Our employees work across multiple programs and, therefore, we do not track costs by program.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Research
and development activities are fundamental to our business. Product candidates in later stages of clinical development generally have
higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage
clinical trials. As a result, we expect that our research and development expenses will increase substantially over the next several quarters
and years as we continue to advance the development of our product candidates. We also expect to incur additional expenses related to
milestone and royalty payments payable to third parties with whom we have entered into license agreements to acquire the rights to its
product candidates.</span></span></span></div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">14</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold;font-style:italic">General
and Administrative Expenses</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>General
and administrative expenses consist primarily of salaries, related benefits and share-based compensation expenses for personnel in executive
and administrative functions. General and administrative expenses also include professional fees for legal, consulting, accounting and
audit services.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:18pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
anticipate that our general and administrative expenses will increase in the future as we increase headcount and general activities to
support our continued research activities and development of our product candidates as well as expanding our presence in the United States.
We also anticipate that we will incur increased headcount, accounting, audit, legal, regulatory, compliance, director and officer insurance
costs, as well as investor and public relations expenses associated with being a public company. We expect that the additional costs for
these services will substantially increase our general and administrative expenses. Additionally, if and when we believe that regulatory
approval of a product candidate appears likely, we expect to incur an increase in payroll and related expenses as a result of our preparation
for commercial operations, especially as it relates to the sales and marketing of any product candidate. &#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Results
of Operations</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold;font-style:italic">Three
Months Ended March 31, 2022 Compared to the Three Months Ended March 31, 2021</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Below
is a summary of our results of operations for the periods indicated:<sup style="vertical-align:text-top;line-height:1;font-size:smaller">3</sup></span></span></span></div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></span></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Three
        months ended</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">March
        31,</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Increase/(decrease)</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>2022</span></strong></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">2021</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;<span style="font-weight:bold">$</span></span></span></span></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">%</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">(in
        thousands)</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Operating expenses:</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;background-color:#CCEEFF" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;width:52%" valign="bottom">
        <div style="text-align:justify;text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Research
        and development</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2,745</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1,157</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1,588</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>137</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>%</span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:middle;background-color:#CCEEFF;width:52%" valign="bottom">
        <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>General
        and administrative</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2,575</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>542</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2,033</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>375</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>%</span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;width:52%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Operating loss</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>5,320</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1,699</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>3,621</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>213</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>%</span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:baseline;background-color:rgb(204, 238, 255);width:52%;padding-bottom:2px">
        <div style="text-indent:10pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financing
        expense (income) , net</span></span></span></div></td>
    <td colspan="1" style="vertical-align:baseline;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(216</span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:baseline;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>5</span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;padding-bottom:2px">&#160;</td>
    <td colspan="1" style="vertical-align:baseline;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(221</span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:baseline;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;border-bottom:2px solid rgb(0, 0, 0)">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25">(<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>4,420</span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:baseline;width:1%;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)%</span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net loss</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>5,104</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>1,704</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>3,400</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>200</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>%</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></span></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Our
results of operations have varied in the past and can be expected to vary in the future due to numerous factors. We believe that period-to-period
comparisons of our operating results are not necessarily meaningful and should not be relied upon as indications of future performance.</span></span></span></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">15</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span style="font-style:italic">Research
and development expenses</span>&#160;</span></strong></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Research
and development expenses increased by approximately $1.6 million, or 137%, for the three months ended March 31, 2022, as compared to the
same period of 2021. The increase was primarily due to increased clinical and pre-clinical activities.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span style="font-style:italic">General
and administrative expenses</span>&#160;</span></strong></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>General
and administrative expenses increased by approximately $2.0 million, or 375%, for the three months ended March 31, 2022, as compared to
the same period of 2021. The increase was primarily due to increase in non-cash share-based expenses as well as expenses incurred as a
result of becoming a public company.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span><span style="font-style:italic">Financing
expenses (income), net</span>&#160;</span></strong></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financing
income, net for the three months ended March 31, 2022 was $216 thousand. Financing expense, net for the three months ended March 31,
2021 was $5 thousand. This reflects an increase in fiance income of $221 thousand, or 4420%, for the three months ended March 31,
2022 from the comparable period of 2021. The increase was primarily related to interest earned on bank deposits and to foreign
currency exchange rate gain.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financing
income, net for the three months ended March 31, 2022 was primarily related to interest earned on bank deposits and to foreign currency
exchange rate gain.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Financing
expense, net for the three months ended March 31, 2021 was primarily related to foreign currency exchange rate loss.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Liquidity
and Capital Resources</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Since
inception, we have not generated any revenue and have incurred significant operating losses and negative cash flows from our operations,
resulting in an accumulated deficit at March 31, 2022 of $41.3 million. We have funded our operations to date primarily with proceeds
from the sale of our ADSs, and, prior to the Merger, other equity securities. Cash in excess of immediate requirements is invested primarily
in bank deposits with a view to liquidity and capital preservation.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>During
the period from April 30, 2021 through March 31, 2022, we sold an aggregate of 699,806 ADSs pursuant to the Sales Agreement for total
gross consideration of approximately $15.9 million. As of March 31, 2022, we had an aggregate of approximately $57.5 million of cash,
cash equivalents and short-term deposits.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Developing
product candidates, conducting clinical trials and commercializing products are expensive, and we will need to raise substantial additional
funds to achieve our strategic objectives. We believe that our existing cash resources, including from the ADSs sold pursuant to the Sales
Agreement, will be sufficient to fund our projected cash requirements through the end of 2023. Nevertheless, we will require significant
additional financing in the future to fund our operations, including if and when we progress into additional clinical trials, obtain regulatory
approval for any of our product candidates and commercialize the same. We believe that we will need to raise significant additional funds
before we have any cash flow from operations, if at all. Our future capital requirements will depend on many factors, including:</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
progress and costs of our preclinical studies, clinical trials and other research and development activities;</span></span></span></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">16</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
scope, prioritization and number of our clinical trials and other research and development programs;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
amount of revenues and contributions we receive under future licensing, development and commercialization arrangements with respect to
our product candidates;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
costs of the development and expansion of our operational infrastructure;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
costs and timing of obtaining regulatory approval for our product candidates;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
costs and timing of securing manufacturing arrangements for clinical or commercial production;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
costs of contracting with third parties to provide sales and marketing capabilities for us;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
costs of acquiring or undertaking development and commercialization efforts for any future products, product candidates or platforms;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the
magnitude of our general and administrative expenses; and</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any
cost that we may incur under future in- and out-licensing arrangements relating to our product candidates.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
currently do not have any commitments for future external funding. In the future, we will need to raise additional funds, and we may decide
to raise additional funds even before we need such funds if the conditions for raising capital are favorable. Until we can generate significant
recurring revenues, we expect to satisfy our future cash needs through debt or equity financings, credit facilities or by out-licensing
applications of our product candidates. The sale of equity or convertible debt securities may result in dilution to our existing shareholders.
The incurrence of indebtedness would result in increased fixed obligations and could also subject us to covenants that restrict our operations.
We cannot be certain that additional funding, whether through grants from the Israel Innovation Authority, financings, credit facilities
or out-licensing arrangements, will be available to us on acceptable terms, if at all. If sufficient funds are not available, we may be
required to delay, reduce the scope of or eliminate research or development plans for, or commercialization efforts with respect to, one
or more applications of our product candidates, or obtain funds through arrangements with collaborators or others that may require us
to relinquish rights to certain potential products that we might otherwise seek to develop or commercialize independently.</span></span></span></div>

<div>&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">17</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold;font-style:italic">Cash
Flows</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
table below shows a summary of our cash flow activities for the periods indicated:</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Three
        months ended</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">March
        31,</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Change</span></strong></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px" valign="bottom">
        <div style="text-align:center;line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>2022</span></strong></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>2021</span></strong></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);text-align:center" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;<span style="font-weight:bold">$</span></span></span></span></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">%</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="6" style="vertical-align:bottom" valign="bottom">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">(in
        thousands)</span></span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="2" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net cash used in
        operating activities</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(3,711</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(1,293</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(2,418</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>187</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>%</span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;width:52%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net cash provided
        by (used in) investing activities</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2,382</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(2</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2,384</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25">(119,200<span style="font-family: Times New Roman,Times,serif; font-size: 10pt"></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)%</span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:#CCEEFF;width:52%;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net cash used in
        financing activities</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>-</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>47,799</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(47,799</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;border-bottom:#000000 solid 2px" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;text-align:right;width:9%;border-bottom:#000000 solid 2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(100</span></span></span></div></td>
    <td colspan="1" style="background-color:#CCEEFF;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)%</span></span></span></div></td></tr>
  <tr>
    <td style="vertical-align:bottom;width:52%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net increase (decrease)
        in cash, cash equivalents and restricted cash</span></span></span></div></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(1,329</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>46,504</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>$</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(47,833</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(103</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>)%</span></span></span></div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">Operating
activities</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net
cash used in operating activities increased by $2.4 million, or 187%, for the three months ended March 31, 2022, compared to the same
period of 2021. The increase is primarily related to the increase in net loss of $3.4 million, as well as an increase in non-cash activities
adjustment to net loss of $0.9 million, offset by an increase of accrued expenses of $0.7 million.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">Investing
activities</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net
cash provided in investing activities for the three months ended March 31, 2022 increased by approximately $2.4 million, as compared to
the same period of 2021. The increase is primarily related to withdrawal of bank deposits.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">Financing
activities</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Net
cash provided by financing activities for the three months ended March 31, 2022 decreased by approximately $48 million, as compared to
the same period of 2021.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Contractual
Commitments</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
Company&#8217;s contractual commitments are as follows at March 31, 2022 (in thousands):</span></span></span></div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></span></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:78%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Remainder of 2022&#160;
        &#160; &#160; &#160; &#160; &#160;&#160; &#160;</span></span></span></div></td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>5,918</span></span></span></p></td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;width:78%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2023</span></span></span></div></td>
    <td style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td style="vertical-align:bottom;width:9%" valign="bottom">&#160;</td>
    <td style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>5,928</span></span></span></div></td>
    <td colspan="1" style="vertical-align:bottom;width:1%" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:78%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2024</span></span></span></div></td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:9%" valign="bottom">&#160;</td>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>140</span></span></span></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;padding-bottom:2px;height:15px;width:78%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>2025-2027</span></span></span></div></td>
    <td style="vertical-align:bottom;padding-bottom:2px;border-bottom:1.5pt solid black;height:15px;width:1%" valign="bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;border-bottom:1.5pt solid black;height:15px;width:9%" valign="bottom">&#160;</td>
    <td style="vertical-align:bottom;padding-bottom:2px;height:15px;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;height:15px;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);height:15px;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);height:15px;width:9%" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;width:1%" valign="bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);padding-bottom:4px;height:15px;width:78%" valign="bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Total</span></span></span></div></td>
    <td style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);border-bottom:4px double black;height:15px;width:1%" valign="bottom"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></td>
    <td style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);border-bottom:4px double black;height:15px;width:9%" valign="bottom">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:right"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>11,986</span></span></span></p></td>
    <td style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);height:15px;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);height:15px;width:1%" valign="bottom">&#160;</td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);height:15px;width:1%" valign="bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);height:15px;width:9%" valign="bottom">
        <div style="line-height:1.25">
        <div style="line-height:1.25">&#160;</div></div></td>
    <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;padding-bottom:4px;width:1%" valign="bottom">&#160;</td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">18</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Critical
Accounting Estimates</span></strong></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
Company&#8217;s financial statements are prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;).
The preparation of the Company&#8217;s financial statements and related disclosures in accordance with GAAP requires it to make estimates
and judgments that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and the disclosure of contingent assets
and liabilities in the Company&#8217;s financial statements. The Company bases its estimates on historical experience, known trends and
events and various other factors that it believes are reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company evaluates
its estimates and assumptions on an ongoing basis. The Company&#8217;s actual results may differ from these estimates under different
assumptions or conditions.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>While
the Company&#8217;s significant accounting policies are described in more detail in Note 2 to the Company&#8217;s consolidated financial
statements included elsewhere in this Annual Report on Form 10-K, the Company believes that the following accounting estimates are those
that include a higher degree of judgment or complexity and are reasonably likely to have a material impact on our financial condition
or results of operations and are therefore considered critical accounting estimates.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Share-Based
Compensation</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
apply Accounting Standard Codification (ASC) 718-10, &#8220;Share-Based Payment,&#8221; which requires the measurement and recognition
of compensation expenses for all share-based payment awards made to employees and directors, including employee options under the Company&#8217;s
option plans based on estimated fair values.</span></span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>ASC
718-10 requires that we estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The
fair value of the award is recognized as an expense over the requisite service periods in the Company&#8217;s statements of comprehensive
loss. The Company recognizes share-based award forfeitures as they occur, rather than estimate by applying a forfeiture rate.</span></span></span></div>

<div style="line-height:1.25;text-align:justify">&#160;</div>

<div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>In
June 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2018-07,
&#8220;Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies
the accounting for nonemployee share-based payment transactions by aligning the measurement and classification guidance, with certain
exceptions, to that for share-based payment awards to employees. The amendments expand the scope of the accounting standard for share-based
payment awards to include share-based payment awards granted to non-employees in exchange for goods or services used or consumed in an
entity&#8217;s own operations and supersedes the guidance related to equity-based payments to non-employees. We adopted these amendments
on January 1, 2019.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
recognize compensation expenses for the fair value of non-employee awards over the requisite service period of each award.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
estimate the fair value of options granted as equity awards using a Black-Scholes options pricing model. The option-pricing model requires
a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from
the grant date until the options are exercised or expire). The Company determines the fair value per share of the underlying stock by
taking into consideration its most recent sales of stock, as well as additional factors that the Company deems relevant. The Company&#8217;s
board determined the fair value of ordinary shares based on valuations performed using the Option Pricing Method subject to relevant facts
and circumstances. The Company has historically been a private company and lacks company-specific historical and implied volatility information
of its stock. Expected volatility is estimated based on volatility of similar companies in the biotechnology sector. The Company has historically
not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental
zero-coupon bonds with an equivalent term. The expected option term is calculated for options granted to employees and directors using
the &#8220;simplified&#8221; method. Grants to non-employees are based on the contractual term. Changes in the determination of each of
the inputs can affect the fair value of the options granted and the results of operations of the Company.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">19</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Recently-Issued
Accounting Pronouncements</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Certain
recently-issued accounting pronouncements are discussed in Note 2, Summary of Significant Accounting Policies, to the audited consolidated
financial statements in our 2021 Annual Report.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><a id="Item3.Q"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
3. Quantitative and Qualitative Disclosures About Market Risk.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:50px;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
are an emerging growth company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
and are not required to provide the information under this item.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
4. Controls and Procedures.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Evaluation
of Disclosure Controls and Procedures</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Disclosure
controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded,
processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is
accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing
similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Under
the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting
officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act, as of March 31, 2022. Based on such evaluation, our principal executive officer and principal financial
officer have concluded that that our disclosure controls and procedures were effective as of March 31, 2022.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Changes
in Internal Control over Financial Reporting</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>We
consummated the Merger on March 16, 2021, which has been accounted for as a reverse capitalization for accounting purposes, and, upon
consummation of the Merger, we reconstituted our Board of Directors and our senior management team. Following consummation of the Merger
the Company&#8217;s management was in the process of strengthening the Company&#8217;s internal control over financial reporting during
the fiscal year ended December 31, 2021, including adopting new policies and procedures appropriate to the Company&#8217;s current business
and management team and onboarding new members to our finance team &#8211; including a new Chief Financial Officer, VP Finance and director
of finance. The foregoing actions were taken solely in connection with the changes effected in connection with the Merger and not as the
result of any material weakness or deficiency in the Company&#8217;s internal control over financial reporting.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>There
have been no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></span></span></div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">20</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25"><a id="PARTII"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;</span></span></span></div>

<div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">PART
II. &#8211; OTHER INFORMATION</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
1.</span>&#160;<span style="font-weight:bold">Legal Proceedings</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>From
time to time, we may become involved in legal proceedings relating to claims arising from the ordinary course of business. Our management
believes that there are currently no claims or actions pending against us, the ultimate disposition of which could have a material adverse
effect on our results of operations, financial condition or cash flows.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
1A.</span>&#160;<span style="font-weight:bold">Risk Factors</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>There
have been no material changes from the information set forth in &#8220;Item 1A. Risk Factors&#8221; in our 2021 Annual Report.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>None.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
3.</span>&#160;<span style="font-weight:bold">Defaults Upon Senior Securities.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Not
applicable.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
4.</span>&#160;<span style="font-weight:bold">Mine Safety Disclosures.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Not
applicable.</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
5.</span>&#160;<span style="font-weight:bold">Other Information.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-indent:36pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>None.</span></span></span></div>

<div style="text-indent:36pt;line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">21</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><a id="Item6.Exhibits."></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Item
6.</span>&#160;<span style="font-weight:bold">Exhibits.</span> </span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>(a) The following
documents are filed as exhibits to this Quarterly Report or incorporated by reference herein.</span></span></span></div>

<div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></span></div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:10%;vertical-align:bottom;border-bottom:#000000 2px solid">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong><span>Exhibit</span></strong></span></span></div>
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Number</span>&#160;</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom;border-bottom:#000000 2px solid">
        <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Description</span>&#160;</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_31-1.htm"><span style="text-decoration:underline">31.1*</span></a></span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">&#160;</td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_31-1.htm"><span style="text-decoration:underline">Certification
        of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act</span></a></span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_31-2.htm"><span style="text-decoration:underline">31.2*</span></a></span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">&#160;</td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_31-2.htm"><span style="text-decoration:underline">Certification
        of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act</span></a></span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_32-1.htm"><span style="text-decoration:underline">32.1**</span></a></span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">&#160;</td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_32-1.htm"><span style="text-decoration:underline">Certification
        of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of </span><span style="text-decoration:underline">the
        Sarbanes-Oxley Act of 2002</span></a></span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_32-2.htm"><span style="text-decoration:underline">32.2**</span></a></span></span></span><br />&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">&#160;</td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><a href="exhibit_32-2.htm"><span style="text-decoration:underline">Certification
        of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the </span><span style="text-decoration:underline">Sarbanes-Oxley
        Act of 2002</span></a></span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>101. INS</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Inline XBRL Instance
        Document</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>101. SCH</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Inline XBRL Taxonomy
        Extension Schema Document</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>101. CAL</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Inline XBRL Taxonomy
        Extension Calculation Linkbase Document</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>101. DEF</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Inline XBRL Taxonomy
        Extension Definition Linkbase Document</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>101. LAB</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Inline XBRL Taxonomy
        Extension Label Linkbase Document</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>101. PRE</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Inline XBRL Taxonomy
        Extension Presentation Linkbase Document</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>104</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Cover Page Interactive
        Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>*</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Filed herewith.</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  <tr>
    <td style="width:10%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>**</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:1%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:89%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Furnished herewith.</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="clear:both;margin-top:10pt;margin-bottom:10pt">

<div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:normal;font-style:normal">22</span></span></span></span></div>

<div style="break-after:page">

<div style="break-after:page"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:center;line-height:1.25"><a id="SIGNATURES"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">SIGNATURES</span>
</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-weight:bold">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.</span>&#160;</span></span></span></div>

<div style="line-height:1.25">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">
  <tr>
    <td style="width:48.41%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="2" style="vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>CHEMOMAB THERAPEUTICS
        LTD.</span></span></span></div>
        <div style="line-height:1.25">&#160;</div></td>
    <td colspan="1" style="width:10%;vertical-align:bottom">&#160;</td></tr>
  <tr>
    <td style="width:48.41%;vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Date: May 12, 2022</span></span></span></div></td>
    <td style="width:4%;vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>By:</span></span></span></div></td>
    <td style="width:35%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">/s/
        Dale Pfost</span>&#160;</span></span></span></div></td>
    <td colspan="1" style="width:10%;vertical-align:top;padding-bottom:2px">&#160;</td></tr>
  <tr>
    <td style="width:48.41%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:4%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Name:</span></span></span></div></td>
    <td style="width:35%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Dale Pfost</span></span></span></div></td>
    <td colspan="1" style="width:10%;vertical-align:bottom">&#160;</td></tr>
  <tr>
    <td style="width:48.41%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:4%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Title:</span></span></span></div></td>
    <td style="width:35%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Chief Executive
        Officer</span></span></span></div></td>
    <td colspan="1" style="width:10%;vertical-align:bottom">&#160;</td></tr>
  <tr>
    <td style="width:48.41%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:4%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:35%;vertical-align:bottom">&#160;</td>
    <td colspan="1" style="width:10%;vertical-align:bottom">&#160;</td></tr>
  <tr>
    <td style="width:48.41%;vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Date: May 12, 2022</span></span></span></div></td>
    <td style="width:4%;vertical-align:bottom;padding-bottom:2px">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>By:</span></span></span></div></td>
    <td style="width:35%;vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0)">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span style="font-style:italic">/s/
        Donald Marvin</span>&#160;</span></span></span></div></td>
    <td colspan="1" style="width:10%;vertical-align:bottom;padding-bottom:2px">&#160;</td></tr>
  <tr>
    <td style="width:48.41%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:4%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Name:</span></span></span></div></td>
    <td style="width:35%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Donald Marvin</span></span></span></div></td>
    <td colspan="1" style="width:10%;vertical-align:bottom">&#160;</td></tr>
  <tr>
    <td style="width:48.41%;vertical-align:bottom">
        <div style="line-height:1.25">&#160;</div></td>
    <td style="width:4%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Title:</span></span></span></div></td>
    <td style="width:35%;vertical-align:bottom">
        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Chief Financial
        Officer</span></span></span></div></td>
    <td colspan="1" style="width:10%;vertical-align:bottom">&#160;</td></tr>
  </table>

<div style="line-height:1.25">&#160;</div>

<div style="line-height:1.25;text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>23</span></span></span></div>

<div style="line-height:1.25"><hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" /></div>

<div style="line-height:1.25">&#160;</div></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT_31-1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><br>
      <u>Exhibit 31.1</u></div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">I, Dale Pfost, certify that:</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">1.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 of Chemomab Therapeutics Ltd.;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">2.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
              circumstances under which such statements were made, not misleading with respect to the period end covered by this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">3.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of
              operations and cash flows of the registrant as of, and for, the period end presented in this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">4.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
              and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; a.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
              registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period end in which this report is being prepared;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; b.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
              regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; c.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
              procedures, as of the end of the period end covered by this report based on such evaluation; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; d.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth
              fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">5.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit
              committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; a.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s
              ability to record, process, summarize and report financial information; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; b.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Date: May 12, 2022</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-style: italic;">/s/ Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Chief Executive Officer</div>
            <div style="line-height: 1.25;">(<font style="font-style: italic;">principal executive officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25;"><font style="font-weight: bold;"> </font>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: right; line-height: 1.25;"><u><font style="font-weight: bold;">Exhibit 31.2</font>&#160;</u></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">I, Donald Marvin, certify that:</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">1.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 of Chemomab Therapeutics Ltd.;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">2.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
              circumstances under which such statements were made, not misleading with respect to the period end covered by this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">3.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of
              operations and cash flows of the registrant as of, and for, the period end presented in this report;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">4.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
              and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; a.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the
              registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period end in which this report is being prepared;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; b.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
              regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; c.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and
              procedures, as of the end of the period end covered by this report based on such evaluation; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; d.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth
              fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">5.</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit
              committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; a.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s
              ability to record, process, summarize and report financial information; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;&#160; b.</div>
          </td>
          <td style="width: 92%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Date: May 12, 2022</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-style: italic;">/s/ Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Chief Financial Officer</div>
            <div style="line-height: 1.25;">(<font style="font-style: italic;">principal financial and accounting officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 32.1</u></div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">18 U.S.C. SECTION 1350,</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Quarterly Report of Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the
      date hereof (the &#8220;Report&#8221;), I, Dale Pfost, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">(1)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">(2)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-style: italic;">/s/ Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Dale Pfost</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Chief Executive Officer</div>
            <div style="line-height: 1.25;">(<font style="font-style: italic;">principal executive officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Chemomab Therapeutics Ltd.</div>
            <div style="line-height: 1.25;"> <br>
            </div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">May 12, 2022</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 8.2.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="line-height: 1.25;">&#160;
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 32.2</u></div>
      <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u> <br>
        </u></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERTIFICATION PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">18 U.S.C. SECTION 1350,</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS ADOPTED PURSUANT TO</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>
    <div style="text-align: center; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In connection with the Quarterly Report of Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the
      date hereof (the &#8220;Report&#8221;), I, Donald Marvin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">(1)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top;">
            <div style="line-height: 1.25;">(2)</div>
          </td>
          <td style="width: 96%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-style: italic;">/s/ Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Donald Marvin</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Chief Financial Officer</div>
            <div style="line-height: 1.25;">(<font style="font-style: italic;">principal financial and accounting officer)</font></div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">Chemomab Therapeutics Ltd.</div>
            <div style="line-height: 1.25;"> <br>
            </div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div style="line-height: 1.25;">May 12, 2022</div>
          </td>
          <td style="width: 60%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cmmb-20220331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:cmmb="http://www.anchiano.com/20220331" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" targetNamespace="http://www.anchiano.com/20220331" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations" id="StatementUnauditedCondensedConsolidatedStatementsOfOperations">
        <link:definition>0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity" id="InterimStatementsOfChangesInEquity">
        <link:definition>0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" id="StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>0006 - Statement - Condensed Interim Statements of Cash flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General." id="General.">
        <link:definition>0008 - Disclosure - General</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies" id="BasisOfPresentationAndSignificantAccountingPolicies">
        <link:definition>0009 - Disclosure - Basis of Presentation and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>0010 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" id="BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
        <link:definition>0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General.Tables" id="General.Tables">
        <link:definition>0012 - Disclosure - General (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General.Details" id="General.Details">
        <link:definition>0013 - Disclosure - General (Detail Textuals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails" id="General.-EstimatedFairValueOfAssetsAcquiredDetails">
        <link:definition>0014 - Disclosure - General - Estimated fair value of assets acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AccruedShareIssuanceExpenses" id="cmmb_AccruedShareIssuanceExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AmericanDepositarySharesMember" id="cmmb_AmericanDepositarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmericanDepositorySharesADSsMember" id="cmmb_AmericanDepositorySharesADSsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" id="cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" id="cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" id="cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CashAcquiredInReverseRecapitalization" id="cmmb_CashAcquiredInReverseRecapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="DrFrostMember" id="cmmb_DrFrostMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfReverseCapitalizationTransaction" id="cmmb_EffectOfReverseCapitalizationTransaction" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EffectOfReverseCapitalizationTransactionShares" id="cmmb_EffectOfReverseCapitalizationTransactionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EstimatedFairValueOfNetAssetsAcquired" id="cmmb_EstimatedFairValueOfNetAssetsAcquired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinanceIncomeExpensesNet" id="cmmb_FinanceIncomeExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="FormerChemomabSecurityHoldersMember" id="cmmb_FormerChemomabSecurityHoldersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesNetOfIssuanceCosts" id="cmmb_IssuanceOfSharesNetOfIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" id="cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" id="cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="MrMarvinMember" id="cmmb_MrMarvinMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NatureOfOperationsDisclosureAbstract" id="cmmb_NatureOfOperationsDisclosureAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfAdsIssuedAndOutstandingAfterMerger" id="cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesConsistedInDS" id="cmmb_NumberOfOrdinarySharesConsistedInDS" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" id="cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfSharesDilutedAfterMerger" id="cmmb_NumberOfSharesDilutedAfterMerger" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OneEmployeeOneOfficerConsultantAndSixBoardMemberMember" id="cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OneEmployeeOneOfficerConsultantAndSixBoardMembersMember" id="cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesMember" id="cmmb_OrdinarySharesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentsForInvestmentInDeposits" id="cmmb_PaymentsForInvestmentInDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ProceedsFromInvestmentInDepositsInvestingActivities" id="cmmb_ProceedsFromInvestmentInDepositsInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromReceivablesOnAccountOfShares" id="cmmb_ProceedsFromReceivablesOnAccountOfShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RetainedEarningsAccumulatedDeficits" id="cmmb_RetainedEarningsAccumulatedDeficits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember" id="cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ShareholdingPercentageImmediatelyFollowingMerger" id="cmmb_ShareholdingPercentageImmediatelyFollowingMerger" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SharesConvertiblePerShareOfAcquireeEntity" id="cmmb_SharesConvertiblePerShareOfAcquireeEntity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantsIssuedDuringPeriodNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="StockAndWarrantsIssuedDuringPeriodValueNewIssues" id="cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TwoThousandFifteenPlanMember" id="cmmb_TwoThousandFifteenPlanMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="WarrantsExercisablePeriod" id="cmmb_WarrantsExercisablePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>cmmb-20220331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_23"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_5" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_5" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_8" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_11" xlink:to="loc_us-gaap_Liabilities_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_12" xlink:to="loc_us-gaap_LiabilitiesCurrent_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_12" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_13" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_14" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_12" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_15" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_12" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_17" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_17" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_17" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_11" xlink:to="loc_us-gaap_CommitmentsAndContingencies_20" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_11" xlink:to="loc_us-gaap_StockholdersEquity_21" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21" xlink:to="loc_us-gaap_CommonStockValue_21" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21" xlink:to="loc_us-gaap_AdditionalPaidInCapital_22" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_23" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_OperatingExpenses_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_cmmb_FinanceIncomeExpensesNet_4" order="10" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromInvestmentInDepositsInvestingActivities" xlink:label="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromReceivablesOnAccountOfShares" xlink:label="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_18"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="50" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2" xlink:to="loc_us-gaap_ShareBasedCompensation_8" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_11" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_11" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14" xlink:to="loc_cmmb_CashAcquiredInReverseRecapitalization_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14" xlink:to="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_17" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_14" xlink:to="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_18" order="40" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cmmb-20220331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#InterimStatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#General.Details" roleURI="http://www.anchiano.com/role/General.Details"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_38"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentType_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCentralIndexKey_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentPeriodEndDate_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalYearFocus_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_AmendmentFlag_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentQuarterlyReport_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_DocumentTransitionReport_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFileNumber_10" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_11" order="100" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_11" xlink:to="loc_us-gaap_StatementClassOfStockAxis_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_11" xlink:to="loc_us-gaap_ClassOfStockDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_11" xlink:to="loc_cmmb_AmericanDepositarySharesMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_11" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_12" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_11" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityRegistrantName_17" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_18" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityTaxIdentificationNumber_19" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine1_20" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressAddressLine2_21" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCityOrTown_22" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressPostalZipCode_23" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityAddressCountry_24" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_CityAreaCode_25" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_LocalPhoneNumber_26" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_27" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_Security12bTitle_28" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_TradingSymbol_29" order="230" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_SecurityExchangeName_30" order="240" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCurrentReportingStatus_31" order="250" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityInteractiveDataCurrent_32" order="260" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityFilerCategory_33" order="270" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntitySmallBusiness_34" order="280" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityEmergingGrowthCompany_35" order="290" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityExTransitionPeriod_36" order="300" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityShellCompany_37" order="310" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_38" order="320" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_18"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_SharesOutstanding_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_5" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransaction_7" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_8" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_9" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_10" order="90" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_10" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_10" xlink:to="loc_us-gaap_EquityComponentDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10" xlink:to="loc_us-gaap_CommonStockMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_11" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_10" xlink:to="loc_us-gaap_RetainedEarningsMember_12" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_10" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_17" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_18" order="110" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.Details">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositorySharesADSsMember" xlink:label="loc_cmmb_AmericanDepositorySharesADSsMember_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_34"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_37"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_38"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Capital" xlink:label="loc_us-gaap_Capital_40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_41"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_45"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_47"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_48"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_49"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_50"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_51"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_52"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_53"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_54"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_55"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_56"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_PlanNameAxis_11" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_11" xlink:to="loc_us-gaap_PlanNameDomain_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_11" xlink:to="loc_cmmb_TwoThousandFifteenPlanMember_11" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_11" xlink:to="loc_us-gaap_PlanNameDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_15" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_15" xlink:to="loc_us-gaap_ClassOfStockDomain_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_15" xlink:to="loc_cmmb_AmericanDepositorySharesADSsMember_15" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_15" xlink:to="loc_cmmb_OrdinarySharesMember_16" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_15" xlink:to="loc_us-gaap_ClassOfStockDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_RangeAxis_20" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_20" xlink:to="loc_srt_RangeMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_20" xlink:to="loc_srt_MinimumMember_20" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_20" xlink:to="loc_srt_MaximumMember_21" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_20" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_25" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_25" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_25" xlink:to="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_25" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_25" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_29" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_29" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_29" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_29" xlink:to="loc_us-gaap_SubsequentEventMember_29" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_29" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_34" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_35" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_36" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_37" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_38" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_NumberOfSharesDilutedAfterMerger_39" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_Capital_40" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_41" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_RetainedEarningsAccumulatedDeficits_42" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_43" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_44" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_45" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensation_46" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_47" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_48" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_49" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_50" order="170" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_51" order="180" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_52" order="190" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_53" order="200" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_WarrantsExercisablePeriod_54" order="210" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_55" order="220" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0" xlink:to="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_56" order="230" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cmmb-20220331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_2"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositorySharesADSsMember" xlink:label="loc_cmmb_AmericanDepositorySharesADSsMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositorySharesADSsMember" xlink:label="loc_cmmb_AmericanDepositorySharesADSsMember_6"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_7"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_8"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_10"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_15"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_16"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_DrFrostMember" xlink:label="loc_cmmb_DrFrostMember_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_DrFrostMember" xlink:label="loc_cmmb_DrFrostMember_19"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_21"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_22"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_23"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_24"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_25"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_31"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_32"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_34"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_35"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_36"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_37"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_MrMarvinMember" xlink:label="loc_cmmb_MrMarvinMember_38"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_MrMarvinMember" xlink:label="loc_cmmb_MrMarvinMember_39"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_40"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_41"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_42"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_43"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_44"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_45"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_46"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_47"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_48"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_49"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_50"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_51"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_52"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_53"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_54"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_55"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_56"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_57"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_58"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_59"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_60"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_PaymentsForInvestmentInDeposits" xlink:label="loc_cmmb_PaymentsForInvestmentInDeposits_61"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromInvestmentInDepositsInvestingActivities" xlink:label="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_62"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromInvestmentInDepositsInvestingActivities" xlink:label="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_63"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromInvestmentInDepositsInvestingActivities" xlink:label="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_64"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromReceivablesOnAccountOfShares" xlink:label="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_65"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromReceivablesOnAccountOfShares" xlink:label="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_66"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_67"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_68"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_69"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember" xlink:label="loc_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_70"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember" xlink:label="loc_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_71"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_72"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_73"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_74"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_75"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_76"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_77"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_78"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_79"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_80"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_81"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_82"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_83"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_84"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_85"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_86"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_87"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_88"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_89"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_90"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_91"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_92"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_93"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_96"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_97"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_98"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_99"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_100"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_101"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_102"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_103"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_104"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_105"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_106"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_107"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_108"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_109"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_110"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_111"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_112"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_113"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_114"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_115"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_116"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_117"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_118"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_119"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_120"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_121"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_122"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_123"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_124"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_125"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Capital" xlink:label="loc_us-gaap_Capital_162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_183"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_184"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_277"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AccruedShareIssuanceExpenses_0" xml:lang="en-US">The amount of accrued issuance expenses non-cash investing and financing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AccruedShareIssuanceExpenses_1" xml:lang="en-US">Accrued share issuance expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmericanDepositarySharesMember_0" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmericanDepositarySharesMember_1" xml:lang="en-US">American Depositary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmericanDepositorySharesADSsMember_0" xml:lang="en-US">American Depository Shares ADSs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmericanDepositorySharesADSsMember_1" xml:lang="en-US">American Depository Shares ADSs [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_0" xml:lang="en-US">Represents the amount of total sale and transfer of compounds and products kestrel paid.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_1" xml:lang="en-US">Amount Of Total Sale And Transfer Of Compounds And Products Kestrel Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_2" xml:lang="en-US">Amount of total sale and transfer of compounds and products kestrel paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_0" xml:lang="en-US">At the Market Offering Agreement with Cantor Fitzgerald &amp; Co. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_1" xml:lang="en-US">At the Market Offering Agreement with Cantor Fitzgerald &amp; Co. [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0" xml:lang="en-US">The amount of of asset held for sale recogized prior to the completion of merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1" xml:lang="en-US">Asset held for sale</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0" xml:lang="en-US">Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1" xml:lang="en-US">Accrued liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_0" xml:lang="en-US">represents cash acquired from acquisition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_CashAcquiredInReverseRecapitalization_1" xml:lang="en-US">Cash acquired in reverse recapitalization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_DrFrostMember_0" xml:lang="en-US">Dr. Frost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_DrFrostMember_1" xml:lang="en-US">Dr. Frost [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_0" xml:lang="en-US">The amount of effect due reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransaction_1" xml:lang="en-US">Effect of reverse capitalization transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0" xml:lang="en-US">The number of shares isued due to effect of reverse capitalization transaction.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1" xml:lang="en-US">Effect of reverse capitalization transaction (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0" xml:lang="en-US">The amount of estimated fair value of the net assets acquired.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1" xml:lang="en-US">Net acquired assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_0" xml:lang="en-US">The net amount of finance income earned and finance expenses incurred during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_1" xml:lang="en-US">Financing expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_2" xml:lang="en-US">Finance Income (Expenses), Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_FinanceIncomeExpensesNet_3" xml:lang="en-US">Financing expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_0" xml:lang="en-US">This represents former Chemomab security holders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_FormerChemomabSecurityHoldersMember_1" xml:lang="en-US">Former Chemomab Security Holders [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_0" xml:lang="en-US">Issuance of shares net, of issuance costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_1" xml:lang="en-US">Issuance of shares net, of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_0" xml:lang="en-US">The amount of liabilities assumed, net of non-cash assets received in reverse merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_1" xml:lang="en-US">Liabilities assumed, net of non-cash assets received in reverse merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_0" xml:lang="en-US">This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1" xml:lang="en-US">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_MrMarvinMember_0" xml:lang="en-US">Mr. Marvin [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_MrMarvinMember_1" xml:lang="en-US">Mr. Marvin [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_0" xml:lang="en-US">No definition available.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NatureOfOperationsDisclosureAbstract_1" xml:lang="en-US">General.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0" xml:lang="en-US">Number of ADS issued and outstanding after the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1" xml:lang="en-US">Number of ADS issued and outstanding after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_0" xml:lang="en-US">Represent the number of ordinary shares consisted in one American depository share (ADS).</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_1" xml:lang="en-US">Number of ordinary shares represented by each ADS (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_0" xml:lang="en-US">Number of shares of common stock for each preferred share converted before merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_1" xml:lang="en-US">Number of common shares for each preferred share converted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_NumberOfSharesDilutedAfterMerger_0" xml:lang="en-US">The number of shares diluted after the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_NumberOfSharesDilutedAfterMerger_1" xml:lang="en-US">Number of shares diluted after the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_0" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_1" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_0" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_1" xml:lang="en-US">OneEmployeeOneOfficerConsultantAndSixBoardMembersMember</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_2" xml:lang="en-US">One employee one officer consultant and six Board [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OrdinarySharesMember_0" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OrdinarySharesMember_1" xml:lang="en-US">Ordinary Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1" xml:lang="en-US">Ordinary Shares, No Par Value Per Share [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_PaymentsForInvestmentInDeposits_0" xml:lang="en-US">The amount of payments for investm,ents in deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_PaymentsForInvestmentInDeposits_1" xml:lang="en-US">Investment in bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_PaymentsForInvestmentInDeposits_2" xml:lang="en-US">Payments for Investment in Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_0" xml:lang="en-US">Represents the proceeds from investment in deposits, investing activities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_1" xml:lang="en-US">Proceeds From Investment In Deposits, Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_2" xml:lang="en-US">Investment in deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ProceedsFromReceivablesOnAccountOfShares_0" xml:lang="en-US">The amount of receivables on account of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ProceedsFromReceivablesOnAccountOfShares_1" xml:lang="en-US">Proceeds from receivables on account of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_0" xml:lang="en-US">The cumulative amount of the reporting entity's undistributed earnings or deficits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_RetainedEarningsAccumulatedDeficits_2" xml:lang="en-US">Retained Earnings Accumulated Deficits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_0" xml:lang="en-US">Represent sthe information pertaining to Securities Purchase Agreements with certain purchasers for the offering and sale by Anchiano .</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_1" xml:lang="en-US">Securities Purchase Agreements for the offering and sale by Anchiano [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0" xml:lang="en-US">shareholding percentage immediately following the merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1" xml:lang="en-US">Shareholding percentage immediately following the merger</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_0" xml:lang="en-US">Represents the shares convertible in merger.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_1" xml:lang="en-US">Number of shares after merger for each share of Chemomab</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_0" xml:lang="en-US">it represents number of shares and warrants issued during period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_1" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs (In shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_0" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_TwoThousandFifteenPlanMember_1" xml:lang="en-US">2015 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_cmmb_WarrantsExercisablePeriod_0" xml:lang="en-US">Represent the warrants exercisable period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_cmmb_WarrantsExercisablePeriod_1" xml:lang="en-US">Warrants exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_cmmb_WarrantsExercisablePeriod_2" xml:lang="en-US">Warrants exercisable period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0" xml:lang="en-US">Change in other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_OperatingExpenses_0" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpenses_1" xml:lang="en-US">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingExpenses_2" xml:lang="en-US">Total operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding_0" xml:lang="en-US">Ending balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding_1" xml:lang="en-US">Beginning balance (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding_2" xml:lang="en-US">Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_2" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_3" xml:lang="en-US">Total shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode_0" xml:lang="en-US">City Area Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentQuarterlyReport_0" xml:lang="en-US">Document Quarterly Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport_0" xml:lang="en-US">Document Transition Report</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine2_0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus_0" xml:lang="en-US">Entity Current Reporting Status</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany_0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod_0" xml:lang="en-US">Entity Ex Transition Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory_0" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode_0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInformationFormerLegalOrRegisteredName_0" xml:lang="en-US">Entity Information, Former Legal or Registered Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent_0" xml:lang="en-US">Entity Interactive Data Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany_0" xml:lang="en-US">Entity Shell Company</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness_0" xml:lang="en-US">Entity Small Business</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber_0" xml:lang="en-US">Entity Tax Identification Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber_0" xml:lang="en-US">Local Phone Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle_0" xml:lang="en-US">Title of 12(b) Security</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName_0" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol_0" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent_0" xml:lang="en-US">Trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_0" xml:lang="en-US">Accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital_0" xml:lang="en-US">Additional paid in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional paid in capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Adjustments for operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments for operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">Total assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">Total current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">Current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">Total non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">Non-current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0" xml:lang="en-US">Basis of Preparation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_0" xml:lang="en-US">Business Acquisition [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0" xml:lang="en-US">Prepaid and other assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Capital_0" xml:lang="en-US">Market capitalization amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">Change in cash, cash equivalents and restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" xml:lang="en-US">Warrant exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies_0" xml:lang="en-US">Commitments and contingent liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockNoParValue_0" xml:lang="en-US">Common Stock, No Par Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of September 30, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 227,956,060 ordinary shares at September 30, 2021 and 9,274,838 ordinary shares at December 31, 2020</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2022 and as of December 31, 2021; Issued and outstanding: 228,090,300 ordinary shares at March 31, 2022 as of December 31, 2021</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent_0" xml:lang="en-US">Short term bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent_0" xml:lang="en-US">Long term deposit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted_0" xml:lang="en-US">Basic and diluted loss per Ordinary Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0" xml:lang="en-US">Employee and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">General and administrative</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0" xml:lang="en-US">Change in trade payables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0" xml:lang="en-US">Change in accrued expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0" xml:lang="en-US">Change in employees and related expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1" xml:lang="en-US">Change in operating lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2" xml:lang="en-US">Change in operating lease liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities_1" xml:lang="en-US">Total liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">Total liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">Total current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">Current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">Total non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">Non-current liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations_0" xml:lang="en-US">Nature of Operations [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NatureOfOperations_1" xml:lang="en-US">General.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">Cash flows from financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">Cash flows from investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Cash flows from operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract_0" xml:lang="en-US">Operating expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_0" xml:lang="en-US">Operating lease liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Operating lease liabilities - long term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis_0" xml:lang="en-US">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xml:lang="en-US">Other receivables and prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseNoncurrent_0" xml:lang="en-US">Long term prepaid expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromOtherEquity_0" xml:lang="en-US">Proceeds from Other Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromOtherEquity_1" xml:lang="en-US">Issuance of shares and warrants, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_0" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_0" xml:lang="en-US">Proceeds from Warrant Exercises</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises_1" xml:lang="en-US">Proceeds from exercise of warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss_0" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProfitLoss_1" xml:lang="en-US">Net loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">Research and development</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashNoncurrent_0" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_0" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Accumulated deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0" xml:lang="en-US">Aggregate offering price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_0" xml:lang="en-US">Gross proceeds from sale under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0" xml:lang="en-US">Shares issued under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockPricePerShare_0" xml:lang="en-US">Average price of shares issued under agreement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0" xml:lang="en-US">Schedule of net assets acquired based on their estimated fair value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0" xml:lang="en-US">Share based payment options vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0" xml:lang="en-US">Expected term (years)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0" xml:lang="en-US">Risk-free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0" xml:lang="en-US">Number of shares authorized, increase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" xml:lang="en-US">Options to purchase ADs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0" xml:lang="en-US">Exercise price per ADs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US">Value of ADS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis_0" xml:lang="en-US">Class of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_0" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1" xml:lang="en-US">Isuuance and sale value of ADSs and warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0" xml:lang="en-US">Shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0" xml:lang="en-US">Reverse stock split conversion ratio</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0" xml:lang="en-US">Option to purchase shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0" xml:lang="en-US">Issuance of shares, net of issuance costs, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Issuance of shares, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0" xml:lang="en-US">Exercise of Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventLineItems_0" xml:lang="en-US">Subsequent Event [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember_0" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract_0" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_0" xml:lang="en-US">Subsequent Events</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTable_0" xml:lang="en-US">Subsequent Event [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_0" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfArrangementAxis_0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates_0" xml:lang="en-US">Use of estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_0" xml:lang="en-US">Weighted average number of Ordinary Shares outstanding, basic, and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccruedShareIssuanceExpenses_1" xlink:to="lab_cmmb_AccruedShareIssuanceExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AccruedShareIssuanceExpenses_2" xlink:to="lab_cmmb_AccruedShareIssuanceExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_3" xlink:to="lab_cmmb_AmericanDepositarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositarySharesMember_4" xlink:to="lab_cmmb_AmericanDepositarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesADSsMember_5" xlink:to="lab_cmmb_AmericanDepositorySharesADSsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmericanDepositorySharesADSsMember_6" xlink:to="lab_cmmb_AmericanDepositorySharesADSsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_7" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_8" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_9" xlink:to="lab_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_10" xlink:to="lab_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_11" xlink:to="lab_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_12" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_13" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_14" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_15" xlink:to="lab_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_16" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_CashAcquiredInReverseRecapitalization_17" xlink:to="lab_cmmb_CashAcquiredInReverseRecapitalization_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_DrFrostMember_18" xlink:to="lab_cmmb_DrFrostMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_DrFrostMember_19" xlink:to="lab_cmmb_DrFrostMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_20" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransaction_21" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_22" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_23" xlink:to="lab_cmmb_EffectOfReverseCapitalizationTransactionShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_24" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_25" xlink:to="lab_cmmb_EstimatedFairValueOfNetAssetsAcquired_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_26" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_27" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_28" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FinanceIncomeExpensesNet_29" xlink:to="lab_cmmb_FinanceIncomeExpensesNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_30" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_FormerChemomabSecurityHoldersMember_31" xlink:to="lab_cmmb_FormerChemomabSecurityHoldersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_32" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_33" xlink:to="lab_cmmb_IssuanceOfSharesNetOfIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_34" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_35" xlink:to="lab_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_36" xlink:to="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_37" xlink:to="lab_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MrMarvinMember_38" xlink:to="lab_cmmb_MrMarvinMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_MrMarvinMember_39" xlink:to="lab_cmmb_MrMarvinMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_40" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_41" xlink:to="lab_cmmb_NatureOfOperationsDisclosureAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_42" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_43" xlink:to="lab_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_44" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_45" xlink:to="lab_cmmb_NumberOfOrdinarySharesConsistedInDS_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_46" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_47" xlink:to="lab_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfSharesDilutedAfterMerger_48" xlink:to="lab_cmmb_NumberOfSharesDilutedAfterMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_NumberOfSharesDilutedAfterMerger_49" xlink:to="lab_cmmb_NumberOfSharesDilutedAfterMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_50" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_51" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_52" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_53" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_54" xlink:to="lab_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesMember_55" xlink:to="lab_cmmb_OrdinarySharesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesMember_56" xlink:to="lab_cmmb_OrdinarySharesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_57" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_OrdinarySharesNoParValuePerShareMember_58" xlink:to="lab_cmmb_OrdinarySharesNoParValuePerShareMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsForInvestmentInDeposits_59" xlink:to="lab_cmmb_PaymentsForInvestmentInDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsForInvestmentInDeposits_60" xlink:to="lab_cmmb_PaymentsForInvestmentInDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_PaymentsForInvestmentInDeposits_61" xlink:to="lab_cmmb_PaymentsForInvestmentInDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_62" xlink:to="lab_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_63" xlink:to="lab_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_64" xlink:to="lab_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_65" xlink:to="lab_cmmb_ProceedsFromReceivablesOnAccountOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_66" xlink:to="lab_cmmb_ProceedsFromReceivablesOnAccountOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_67" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_68" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_RetainedEarningsAccumulatedDeficits_69" xlink:to="lab_cmmb_RetainedEarningsAccumulatedDeficits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_70" xlink:to="lab_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_71" xlink:to="lab_cmmb_SecuritiesPurchaseAgreementsForOfferingAndSaleByAnchianoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_72" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_73" xlink:to="lab_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_74" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_75" xlink:to="lab_cmmb_SharesConvertiblePerShareOfAcquireeEntity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_76" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_77" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_78" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_79" xlink:to="lab_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_80" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_TwoThousandFifteenPlanMember_81" xlink:to="lab_cmmb_TwoThousandFifteenPlanMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_82" xlink:to="lab_cmmb_WarrantsExercisablePeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_83" xlink:to="lab_cmmb_WarrantsExercisablePeriod_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cmmb_WarrantsExercisablePeriod_84" xlink:to="lab_cmmb_WarrantsExercisablePeriod_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_85" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_86" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_87" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_88" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_89" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_90" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_91" xlink:to="lab_us-gaap_OperatingExpenses_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_92" xlink:to="lab_us-gaap_OperatingExpenses_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_93" xlink:to="lab_us-gaap_OperatingExpenses_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_94" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_96" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_97" xlink:to="lab_us-gaap_SharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_98" xlink:to="lab_us-gaap_SharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding_99" xlink:to="lab_us-gaap_SharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_100" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_101" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_102" xlink:to="lab_us-gaap_StockholdersEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_103" xlink:to="lab_us-gaap_StockholdersEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_104" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_105" xlink:to="lab_dei_CityAreaCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_106" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_107" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_108" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_109" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport_110" xlink:to="lab_dei_DocumentQuarterlyReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport_111" xlink:to="lab_dei_DocumentTransitionReport_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_112" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_113" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2_114" xlink:to="lab_dei_EntityAddressAddressLine2_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_115" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_116" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_117" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_118" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_119" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_120" xlink:to="lab_dei_EntityCurrentReportingStatus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_121" xlink:to="lab_dei_EntityEmergingGrowthCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod_122" xlink:to="lab_dei_EntityExTransitionPeriod_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_123" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_124" xlink:to="lab_dei_EntityFilerCategory_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_125" xlink:to="lab_dei_EntityIncorporationStateCountryCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationFormerLegalOrRegisteredName_126" xlink:to="lab_dei_EntityInformationFormerLegalOrRegisteredName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent_127" xlink:to="lab_dei_EntityInteractiveDataCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_128" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany_129" xlink:to="lab_dei_EntityShellCompany_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness_130" xlink:to="lab_dei_EntitySmallBusiness_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_131" xlink:to="lab_dei_EntityTaxIdentificationNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_132" xlink:to="lab_dei_LocalPhoneNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_133" xlink:to="lab_dei_Security12bTitle_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_134" xlink:to="lab_dei_SecurityExchangeName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_135" xlink:to="lab_dei_TradingSymbol_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_136" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_137" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_138" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_139" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_140" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent_141" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_142" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_143" xlink:to="lab_us-gaap_AdditionalPaidInCapital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_144" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_145" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_146" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_147" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_148" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_149" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_150" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_151" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_152" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_153" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_154" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_155" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_156" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_157" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_158" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_159" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_160" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_161" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Capital_162" xlink:to="lab_us-gaap_Capital_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_163" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_164" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_165" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_166" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_167" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_168" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_169" xlink:to="lab_us-gaap_CommitmentsAndContingencies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_170" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue_171" xlink:to="lab_us-gaap_CommonStockNoParValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_172" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_173" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_174" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_175" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_176" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent_177" xlink:to="lab_us-gaap_DepositsAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent_178" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_179" xlink:to="lab_us-gaap_Depreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted_180" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_181" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_182" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_183" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_184" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_185" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_186" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_187" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_188" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_189" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_190" xlink:to="lab_us-gaap_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_191" xlink:to="lab_us-gaap_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_192" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_193" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_194" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_195" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_196" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_197" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_198" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_199" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_200" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_201" xlink:to="lab_us-gaap_NatureOfOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_202" xlink:to="lab_us-gaap_NatureOfOperations_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_203" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_204" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_205" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_206" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_207" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_208" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_209" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_210" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_211" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_212" xlink:to="lab_us-gaap_OperatingExpensesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_213" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_214" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_215" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_216" xlink:to="lab_us-gaap_PlanNameAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_217" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseNoncurrent_218" xlink:to="lab_us-gaap_PrepaidExpenseNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity_219" xlink:to="lab_us-gaap_ProceedsFromOtherEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherEquity_220" xlink:to="lab_us-gaap_ProceedsFromOtherEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_221" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_222" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises_223" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_224" xlink:to="lab_us-gaap_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_225" xlink:to="lab_us-gaap_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_226" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_227" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent_228" xlink:to="lab_us-gaap_RestrictedCashNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_229" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_230" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_231" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_232" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_233" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_234" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare_235" xlink:to="lab_us-gaap_SaleOfStockPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_236" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_237" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_238" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_239" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_240" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_241" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_242" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_243" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_244" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_245" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_246" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_247" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_248" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_249" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_250" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_251" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_252" xlink:to="lab_us-gaap_StatementClassOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_253" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_254" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_255" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_256" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_257" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_258" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_259" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_260" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_261" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_262" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_263" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_264" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_265" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_266" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_267" xlink:to="lab_us-gaap_SubsequentEventLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_268" xlink:to="lab_us-gaap_SubsequentEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract_269" xlink:to="lab_us-gaap_SubsequentEventsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_270" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_271" xlink:to="lab_us-gaap_SubsequentEventTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_272" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_273" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_274" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis_275" xlink:to="lab_us-gaap_TypeOfArrangementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates_276" xlink:to="lab_us-gaap_UseOfEstimates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_277" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cmmb-20220331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#BalanceSheetsParenthetical" roleURI="http://www.anchiano.com/role/BalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfOperations" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#InterimStatementsOfChangesInEquity" roleURI="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#StatementUnauditedCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#General." roleURI="http://www.anchiano.com/role/General."/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#BasisOfPresentationAndSignificantAccountingPolicies" roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#SubsequentEvents" roleURI="http://www.anchiano.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" roleURI="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#General.Tables" roleURI="http://www.anchiano.com/role/General.Tables"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#General.Details" roleURI="http://www.anchiano.com/role/General.Details"/>
  <roleRef xlink:type="simple" xlink:href="cmmb-20220331.xsd#General.-EstimatedFairValueOfAssetsAcquiredDetails" roleURI="http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/DocumentDocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositarySharesMember" xlink:label="loc_cmmb_AmericanDepositarySharesMember_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_dei_DocumentQuarterlyReport_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_dei_EntityInformationFormerLegalOrRegisteredName_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_36"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1" xlink:to="loc_us-gaap_ClassOfStockDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_AmericanDepositarySharesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1" xlink:to="loc_cmmb_OrdinarySharesNoParValuePerShareMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentType_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCentralIndexKey_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_CurrentFiscalYearEndDate_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentFiscalYearFocus_9" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_AmendmentFlag_11" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentQuarterlyReport_12" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_DocumentTransitionReport_13" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityFileNumber_14" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityRegistrantName_15" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_16" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityTaxIdentificationNumber_17" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine1_18" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressAddressLine2_19" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressCityOrTown_20" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressPostalZipCode_21" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityAddressCountry_22" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_CityAreaCode_23" order="180" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_LocalPhoneNumber_24" order="190" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityInformationFormerLegalOrRegisteredName_25" order="200" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_Security12bTitle_26" order="210" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_TradingSymbol_27" order="220" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_SecurityExchangeName_28" order="230" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCurrentReportingStatus_29" order="240" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityInteractiveDataCurrent_30" order="250" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityFilerCategory_31" order="260" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntitySmallBusiness_32" order="270" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityEmergingGrowthCompany_33" order="280" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityExTransitionPeriod_34" order="290" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityShellCompany_35" order="300" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_36" order="310" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaap_PrepaidExpenseNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_31"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_6" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6" xlink:to="loc_us-gaap_PrepaidExpenseNoncurrent_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_9" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_10" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_6" xlink:to="loc_us-gaap_AssetsNoncurrent_11" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_15" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_16" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_18" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_15" xlink:to="loc_us-gaap_LiabilitiesCurrent_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_21" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_21" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_CommitmentsAndContingencies_24" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_Liabilities_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_CommonStockValue_26" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_AdditionalPaidInCapital_27" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_28" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_26" xlink:to="loc_us-gaap_StockholdersEquity_29" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_15" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_31" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNoParValue" xlink:label="loc_us-gaap_CommonStockNoParValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockNoParValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FinanceIncomeExpensesNet" xlink:label="loc_cmmb_FinanceIncomeExpensesNet_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_8"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1" xlink:to="loc_us-gaap_OperatingExpenses_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_cmmb_FinanceIncomeExpensesNet_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_NetIncomeLoss_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_7" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_8" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/InterimStatementsOfChangesInEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransaction" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransaction_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EffectOfReverseCapitalizationTransactionShares" xlink:label="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_14"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues" xlink:label="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_18"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockholdersEquity_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_SharesOutstanding_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_10" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_11" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransaction_12" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_cmmb_EffectOfReverseCapitalizationTransactionShares_13" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_14" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues_15" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_NetIncomeLoss_16" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockholdersEquity_17" order="110" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_SharesOutstanding_18" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromInvestmentInDepositsInvestingActivities" xlink:label="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_17"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_CashAcquiredInReverseRecapitalization" xlink:label="loc_cmmb_CashAcquiredInReverseRecapitalization_18"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ProceedsFromReceivablesOnAccountOfShares" xlink:label="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_19"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_IssuanceOfSharesNetOfIssuanceCosts" xlink:label="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger" xlink:label="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_27"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AccruedShareIssuanceExpenses" xlink:label="loc_cmmb_AccruedShareIssuanceExpenses_28"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_6" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_7" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_8" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_9" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_10" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities_13" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_14" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_cmmb_CashAcquiredInReverseRecapitalization_18" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_cmmb_ProceedsFromReceivablesOnAccountOfShares_19" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_cmmb_IssuanceOfSharesNetOfIssuanceCosts_20" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_21" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_17" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_22" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_25" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_27" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_27" xlink:to="loc_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger_27" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_27" xlink:to="loc_cmmb_AccruedShareIssuanceExpenses_28" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.">
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_NatureOfOperations_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_UseOfEstimates_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.Tables">
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.Details">
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember" xlink:label="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_FormerChemomabSecurityHoldersMember" xlink:label="loc_cmmb_FormerChemomabSecurityHoldersMember_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_5"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember" xlink:label="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_9"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_TwoThousandFifteenPlanMember" xlink:label="loc_cmmb_TwoThousandFifteenPlanMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmericanDepositorySharesADSsMember" xlink:label="loc_cmmb_AmericanDepositorySharesADSsMember_12"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_OrdinarySharesMember" xlink:label="loc_cmmb_OrdinarySharesMember_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember" xlink:label="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_ShareholdingPercentageImmediatelyFollowingMerger" xlink:label="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_26"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger" xlink:label="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_28"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfOrdinarySharesConsistedInDS" xlink:label="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_29"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger" xlink:label="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_30"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NumberOfSharesDilutedAfterMerger" xlink:label="loc_cmmb_NumberOfSharesDilutedAfterMerger_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Capital" xlink:label="loc_us-gaap_Capital_32"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_SharesConvertiblePerShareOfAcquireeEntity" xlink:label="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_33"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_RetainedEarningsAccumulatedDeficits" xlink:label="loc_cmmb_RetainedEarningsAccumulatedDeficits_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_35"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_36"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_37"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_38"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_39"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_40"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_41"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_42"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_43"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_44"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_45"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_WarrantsExercisablePeriod" xlink:label="loc_cmmb_WarrantsExercisablePeriod_46"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_47"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid" xlink:label="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_48"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1" xlink:to="loc_cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_FormerChemomabSecurityHoldersMember_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember_6" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_PlanNameAxis_9" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9" xlink:to="loc_us-gaap_PlanNameDomain_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9" xlink:to="loc_cmmb_TwoThousandFifteenPlanMember_9" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_12" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_12" xlink:to="loc_us-gaap_ClassOfStockDomain_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_12" xlink:to="loc_cmmb_AmericanDepositorySharesADSsMember_12" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_12" xlink:to="loc_cmmb_OrdinarySharesMember_13" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_srt_RangeAxis_16" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_16" xlink:to="loc_srt_RangeMember_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16" xlink:to="loc_srt_MinimumMember_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16" xlink:to="loc_srt_MaximumMember_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_20" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_20" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_20" xlink:to="loc_cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember_20" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_23" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_23" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_23" xlink:to="loc_us-gaap_SubsequentEventMember_23" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_26" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_ShareholdingPercentageImmediatelyFollowingMerger_26" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger_27" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_28" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_NumberOfOrdinarySharesConsistedInDS_29" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger_30" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_NumberOfSharesDilutedAfterMerger_31" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_Capital_32" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_SharesConvertiblePerShareOfAcquireeEntity_33" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_RetainedEarningsAccumulatedDeficits_34" order="80" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_35" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_36" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_37" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_ShareBasedCompensation_38" order="120" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_39" order="130" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_40" order="140" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_41" order="150" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_42" order="160" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_43" order="170" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_44" order="180" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_45" order="190" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_WarrantsExercisablePeriod_46" order="200" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_47" order="210" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_26" xlink:to="loc_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid_48" order="220" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails">
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_NatureOfOperationsDisclosureAbstract" xlink:label="loc_cmmb_NatureOfOperationsDisclosureAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_4"/>
    <loc xlink:type="locator" xlink:href="cmmb-20220331.xsd#cmmb_EstimatedFairValueOfNetAssetsAcquired" xlink:label="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cmmb_NatureOfOperationsDisclosureAbstract_0" xlink:to="loc_cmmb_EstimatedFairValueOfNetAssetsAcquired_5" order="40" use="optional"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419733589192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 11, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab
Therapeutics Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3676773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat
        Atidim<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building
        7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel
        Aviv<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,404,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember', window );">American Depositary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American
        Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary Shares, No Par Value Per Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary
        shares, no par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">n/a<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Name of Exchange on which Security is Registered</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419736775576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,827<span></span>
</td>
<td class="nump">$ 15,186<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short term bank deposits</a></td>
<td class="nump">43,579<span></span>
</td>
<td class="nump">45,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Other receivables and prepaid expenses</a></td>
<td class="nump">1,934<span></span>
</td>
<td class="nump">1,527<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">59,340<span></span>
</td>
<td class="nump">62,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseNoncurrent', window );">Long term prepaid expenses</a></td>
<td class="nump">864<span></span>
</td>
<td class="nump">908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">1,616<span></span>
</td>
<td class="nump">1,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">60,956<span></span>
</td>
<td class="nump">64,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">1,487<span></span>
</td>
<td class="nump">1,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">1,248<span></span>
</td>
<td class="nump">555<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee and related expenses</a></td>
<td class="nump">666<span></span>
</td>
<td class="nump">653<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,517<span></span>
</td>
<td class="nump">2,650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - long term</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,720<span></span>
</td>
<td class="nump">2,887<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2022 and as of December 31, 2021; Issued and outstanding: 228,090,300 ordinary shares at March 31, 2022 as of December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">98,513<span></span>
</td>
<td class="nump">97,639<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(41,277)<span></span>
</td>
<td class="num">(36,173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">57,236<span></span>
</td>
<td class="nump">61,466<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 60,956<span></span>
</td>
<td class="nump">$ 64,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Number and type of equity instruments reflects the capital of the legal parent (the Company).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419736724104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common Stock, No Par Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">650,000,000<span></span>
</td>
<td class="nump">650,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="nump">228,090,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419733389240">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,745<span></span>
</td>
<td class="nump">$ 1,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,575<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,320<span></span>
</td>
<td class="nump">1,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_FinanceIncomeExpensesNet', window );">Financing expenses (income), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(216)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,104<span></span>
</td>
<td class="nump">$ 1,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per Ordinary Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0.022<span></span>
</td>
<td class="nump">$ 0.011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of Ordinary Shares outstanding, basic, and diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="nump">156,751,771<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Number of shares has been retroactively adjusted based on the equivalent number of shares received
                    by the accounting acquirer&#8217;s shareholders in the reverse recapitalization transaction (refer to Note 1B).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_FinanceIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of finance income earned and finance expenses incurred during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_FinanceIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419733626968">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary shares [Member]</div></th>
<th class="th"><div>Additional paid in capital [Member]</div></th>
<th class="th"><div>Accumulated deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 34,497<span></span>
</td>
<td class="num">$ (23,695)<span></span>
</td>
<td class="nump">$ 10,802<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,274,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_EffectOfReverseCapitalizationTransaction', window );">Effect of reverse capitalization transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">-<span></span>
</td>
<td class="text">2,476<span></span>
</td>
<td class="text">-<span></span>
</td>
<td class="text">2,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_EffectOfReverseCapitalizationTransactionShares', window );">Effect of reverse capitalization transaction (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">152,299,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues', window );">Issuance of shares and warrants, net of issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 43,547<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 43,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues', window );">Issuance of shares and warrants, net of issuance costs (In shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52,385,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">80,563<span></span>
</td>
<td class="num">(25,399)<span></span>
</td>
<td class="nump">55,164<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">213,959,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">97,639<span></span>
</td>
<td class="num">(36,173)<span></span>
</td>
<td class="nump">61,466<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
<td class="num">(5,104)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 98,513<span></span>
</td>
<td class="num">$ (41,277)<span></span>
</td>
<td class="nump">$ 57,236<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">228,090,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Number of shares has been retroactively adjusted to reflect the share reverse split effected on
                    March 16, 2021 (refer to Note 1B).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Number and type of equity instruments reflects the capital of the legal parent (the Company).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EffectOfReverseCapitalizationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of effect due reverse capitalization transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EffectOfReverseCapitalizationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EffectOfReverseCapitalizationTransactionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares isued due to effect of reverse capitalization transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EffectOfReverseCapitalizationTransactionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>it represents number of shares and warrants issued during period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419733639720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Interim Statements of Cash flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss for the period</a></td>
<td class="num">$ (5,104)<span></span>
</td>
<td class="num">$ (1,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Change in other receivables and prepaid expenses</a></td>
<td class="num">(363)<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Change in operating lease liability</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Change in trade payables</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Change in accrued expenses</a></td>
<td class="nump">693<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Change in employees and related expenses</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">874<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Adjustments for operating activities</a></td>
<td class="nump">1,393<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(3,711)<span></span>
</td>
<td class="num">(1,293)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities', window );">Investment in deposits</a></td>
<td class="nump">2,396<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">2,382<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_CashAcquiredInReverseRecapitalization', window );">Cash acquired in reverse recapitalization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Issuance of shares and warrants, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">45,372<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">47,799<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash, cash equivalents and restricted cash</a></td>
<td class="num">(1,329)<span></span>
</td>
<td class="nump">46,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">15,241<span></span>
</td>
<td class="nump">11,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">13,912<span></span>
</td>
<td class="nump">58,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger', window );">Liabilities assumed, net of non-cash assets received in reverse merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_AccruedShareIssuanceExpenses', window );">Accrued share issuance expenses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AccruedShareIssuanceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accrued issuance expenses non-cash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AccruedShareIssuanceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_CashAcquiredInReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>represents cash acquired from acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_CashAcquiredInReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities assumed, net of non-cash assets received in reverse merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ProceedsFromInvestmentInDepositsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the proceeds from investment in deposits, investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ProceedsFromInvestmentInDepositsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419736986536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>General.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">General.</a></td>
<td class="text">

<div>

<div>

<div><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>Note 1 - General.</span></strong></span></span></span></div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman,Times,serif;font-size:10pt;margin-left:1px;width:100%">
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="font-family:Times New Roman, Times, serif;line-height:normal">A.
        </span></strong></p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">Chemomab
        Therapeutics Ltd. (hereinafter - "the Company") is an Israeli based company incorporated under the laws of the State of Israel in September
        2011. The Company&#8217;s registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company
        discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.</span></span></td>
        </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"><strong>B.</strong></td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">On March&#160;16, 2021, the Company,
        then known as Anchiano Therapeutics Ltd. (&#8220;Anchiano&#8221;), completed its merger with Chemomab Ltd., a privately-held Israeli limited
        company (&#8220;Chemomab Ltd.&#8221;). Pursuant to the Agreement and Plan of merger (the &#8220;Merger Agreement&#8221;) dated as of December&#160;14,
        2020, by and among Anchiano, CMB Acquisition Ltd., an Israeli limited company and wholly-owned subsidiary of Anchiano (&#8220;Merger Sub&#8221;),
        and Chemomab Ltd. Upon completion of the merger transaction, pursuant to which Merger Sub merged with and into Chemomab Ltd., with Chemomab
        Ltd. being the surviving entity and a wholly owned subsidiary of Anchiano (the &#8220;Merger&#8221;), the Company changed its name from
        &#8220;Anchiano Therapeutics Ltd.&#8221; to &#8220;Chemomab Therapeutics Ltd.&#8221; and the business conducted by Chemomab Ltd. became
        the primarily business conducted by the Company.</p> </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:normal">For
        accounting purposes, Chemomab Ltd. is considered to have acquired Anchiano based upon the terms of the Merger as well as other factors
        including; (i) Chemomab Ltd.'s former shareholders owned approximately 90% of the combined Company&#8217;s outstanding ordinary shares
        immediately following the closing of the Merger, and (ii) Chemomab Ltd. management holds key management positions of the combined Company.
        The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as
        the assets acquired and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets
        acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date
        of completion of the Merger.</span></p>
        <p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">Immediately
        prior to the effective date of the Merger, all preferred shares of Chemomab Ltd. were converted into ordinary shares of Chemomab Ltd.
        on a one-for-one basis.</span></p> </td> </tr>
  </table>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">In
connection with the Merger, and following the effective time of the Merger, the Company effected a reverse share split of its ordinary
shares at a ratio of 4:1
(the &#8220;Reverse Split&#8221;) and increased the number of ordinary shares underlying each American Depositary Share ("ADS") from 5
to 20. At the effective time of the Merger, each Chemomab Ltd. ordinary share outstanding immediately prior to the effective time of the
Merger automatically converted into the right to receive approximately 12.86
ADSs, each representing 20
ordinary shares of the Company, plus a warrant to purchase ADSs that may become exercisable only under certain circumstances (the &#8220;exchange
ratio&#8221;).</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify">The
exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd.
The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and unvested, under the Chemomab Share Incentive
Plan (the &#8220;2015 Plan&#8221;), with such options representing the right to purchase a number of ADSs equal to approximately 12.86
multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.</p> </div>

<div>

<div/>

<div>

<div>

<p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:110%">The
accompanying unaudited condensed consolidated financial statements and notes to the unaudited condensed consolidated financial statements
give retroactive effect to the exchange ratio and the Reverse Split for all periods presented.</span></span></span><br/>&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
equity structure reflects the legal acquirer's equity structure. The balance sheet has been adjusted to reflect the par value of the outstanding
shares of the legal acquirer, including the number of shares issued in the Merger. Any difference is recognized as an adjustment to the
additional paid in capital.</span></span></span></p>

<p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">Immediately
after completion of the Merger, on March 16, 2021, the Company had 8,078,727
ADS issued and outstanding (9,003,357
on a fully diluted basis). In addition, immediately after the Merger, Chemomab Ltd. former shareholders owned approximately 90%
of the number of issued and outstanding ordinary shares of the Company and the shareholders of the Company immediately prior to the Merger
owned approximately 10% of the number of issued and outstanding ordinary shares of the Company (all on a fully diluted basis). </span></span></span></p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">On
March 16, 2021, immediately prior to the effectiveness of the Merger, Anchiano had 65,675,904
ordinary shares outstanding (prior to the effect of the Reverse Split) and a market capitalization of $58.7&#160;million.
The estimated fair value of the net assets of Anchiano on March 16, 2021, prior to the Merger, was approximately $2.5&#160;million.
The fair value of ordinary shares on the Merger closing date, prior to the Merger, was above the fair value of the Company&#8217;s net
assets. As the Company&#8217;s net assets were predominantly composed of cash offset against current liabilities, the fair value of the
Company&#8217;s net assets as of March 16, 2021, immediately prior to the Merger, was considered to be the best indicator of the fair
value and, therefore, the estimated preliminary purchase consideration.</p>

<p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:110%">The
following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion
of the Merger (in thousands):</span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<div style="margin-left:90px">

<table border="0" cellpadding="0" cellspacing="0" style="background:white;border-collapse:collapse;border:0px;font-size:10pt;margin-left:0px;width:90%" width="90%">
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:89%" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Cash
        and cash equivalents</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%">$</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%" valign="bottom">2,427</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Asset
        held for sale</span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">1,000</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Prepaid
        and other assets</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">236</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Accrued
        liabilities</span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black" valign="bottom">(1,187</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%">)</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td colspan="1" style="padding:0cm;height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Net
        acquired assets</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:left">$</p> </td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">2,476</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  </table> </div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:1px;width:100%;border:0px">
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">C.
        </span></strong></p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">In connection with the Merger, on
        March 15, 2021, Anchiano entered into Securities Purchase Agreements with certain purchasers for the issuance and sale by Anchiano in
        a private placement (&#8220;Private Placement&#8221;) of approximately $45.5
        million of its ADSs and accompanying warrants to purchase ADSs. The warrants have an exercise price of approximately $17.35
        per ADS, expire five
        years from the date of issuance, and if exercised in full will provide additional proceeds to the Company of $4.5
        million. The closing of the Private Placement was completed on March 22, 2021.</p> </td> </tr>
  </table>

<div/>

<div>

<p style="margin:0pt">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:1px;width:100%;border:0px">
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">D.
        </span></strong></p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Pursuant to an Asset Purchase and
        Assignment Agreement dated as of March 16, 2021, as amended on March 31, 2021, between the Company&#8217;s wholly owned subsidiary, Anchiano
        Therapeutics, Inc., a Delaware corporation (&#8220;Anchiano Delaware&#8221;) and Kestrel Therapeutics, Inc., a company organized under
        the laws of Delaware (&#8220;Kestrel&#8221;), Anchiano Delaware agreed to sell to Kestrel all of the its rights and obligations in its
        business to the extent related to the research, development and commercialization of the Compounds and Products (as such terms are defined
        in the Collaboration and License Agreement entered into as of September 13, 2019, by and between ADT Pharmaceuticals, LLC and the Anchiano
        Delaware), also known as the pan-RAS and PDE10/&#946;-catenin programs. In consideration of the sale and transfer of the Compounds and
        Products Kestrel paid the Company a total of $1.0
        million.</p> </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">E.</span></strong></p>
        </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">On April 30, 2021, the Company entered
        into an At the Market Offering Agreement (the "ATM agreement") with Cantor Fitzgerald &amp; Co., ("Cantor"). Pursuant to the ATM agreement,
        the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75
        million through Cantor or the ATM agreement. From April 30, 2021 through March 31, 2022, the Company issued 699,806
        ADSs at an average price of $22.75
        per ADS through the ATM Prospectus Supplement, resulting in gross proceeds of $15.9
        million. The offer and sale of ADSs under the ATM agreement has been registered under the Company&#8217;s effective registration statement
        on Form S-3 (File No. 333-255658), together with a prospectus forming a part thereof, filed with the SEC under the Securities Act of 1933,
        as amended (the &#8220;Securities Act&#8221;). Sales, if any, of ADS pursuant to the ATM agreement may be made in any transactions that
        are deemed to be &#8220;at the market&#8221; offerings as defined in Rule 415(a)(4) under the Securities Act. The Company is not obligated
        to sell any ADSs under the ATM agreement.</p> </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">On
        April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000
        of the Company's ADSs (instead of the amount of $75 million above) in connection with the reactivation of the ATM Facility.</span></p>
        </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><strong><span style="line-height:normal;font-family:Times New Roman, Times, serif">F.</span></strong></p>
        </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">Since
        January 2020, the COVID-19 outbreak has dramatically expanded into a worldwide pandemic creating macro-economic uncertainty and disruption
        in the business and financial markets. Many countries around the world, including Israel, have been taking measures designated to limit
        the continued spread of the Coronavirus, including the closure of workplaces, restricting travel, prohibiting assembling, closing international
        borders and quarantining populated areas. The Company's clinical trial sites have been affected by the COVID-19 pandemic, and as a result,
        commencement of the enrollment of Company&#8217;s clinical trials of CM-101 in PSC was delayed and the enrollment rate has been affected
        as well. As a result, the Company extended patient&#160;recruiting to additional territories with significant recruitment potential. In
        addition, after enrollment in these trials, patients may drop out of the Company's trials because of the COVID-19 possible implications.</span></p>
        </td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;text-align:justify">&#160;</td> </tr>
  <tr>
    <td style="font-size:10pt;padding:0px;width:45px">&#160;</td>
    <td style="font-size:10pt;padding:0px;vertical-align:top;width:45px">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p> </td>
    <td style="font-size:10pt;padding:0px;text-align:justify">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%">Based
        on management&#8217;s assessment, the extent to which the coronavirus will further impact the Company&#8217;s operations will depend on
        future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak,
        and the actions that may be required to contain the coronavirus or treat its impact. The Company is carefully monitoring the restrictions
        due to the COVID-19 outbreak and will adjust activities accordingly.</span></p> </td> </tr>
  </table> </div> </div> </div> </div> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419736597160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Significant Accounting Policies</a></td>
<td class="text">

<div>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>Note
2 - Basis of Presentation and Significant Accounting Policies </span></strong></span></span></span></p>

<p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<div>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>A.&#160;
&#160; &#160; &#160; Basis of Preparation</strong></span></span></span></p>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:47px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and applicable rules
and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal
and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as </span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">of
March 31, 2022, and its results of operations for the three months ended March 31, 2022, and 2021, changes in shareholders&#8217; equity
for the three months ended March 31, 2022 and 2021, and cash flows for the three months ended March 31, 2022 and 2021. The results of
operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending
December 31, 2022 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#8217;s Form 10-K for the year ended December 31, 2021 as filed with the SEC. The
Company&#8217;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2021
included in the Company&#8217;s Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#8217;s
significant accounting policies.</span></span></span></p> </div>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>


<div>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>B.&#160;
&#160; &#160; &#160; Use of estimates</strong></span></span></span></p>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.</span></span></span></p> </div>  </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419736471576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Preparation</a></td>
<td class="text">

<div>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>A.&#160;
&#160; &#160; &#160; Basis of Preparation</strong></span></span></span></p>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>

<p style="margin-top:0pt;margin-left:47px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and applicable rules
and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal
and recurring nature that are necessary for a fair statement of the Company&#8217;s financial position as </span></span></span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="line-height:normal">of
March 31, 2022, and its results of operations for the three months ended March 31, 2022, and 2021, changes in shareholders&#8217; equity
for the three months ended March 31, 2022 and 2021, and cash flows for the three months ended March 31, 2022 and 2021. The results of
operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending
December 31, 2022 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#8217;s Form 10-K for the year ended December 31, 2021 as filed with the SEC. The
Company&#8217;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2021
included in the Company&#8217;s Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#8217;s
significant accounting policies.</span></span></span></p> </div> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">

<div>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong>B.&#160;
&#160; &#160; &#160; Use of estimates</strong></span></span></span></p>

<p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.</span></span></span></p> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419736679288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>General.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of net assets acquired based on their estimated fair value</a></td>
<td class="text">

<div style="margin-left:90px">

<table border="0" cellpadding="0" cellspacing="0" style="background:white;border-collapse:collapse;border:0px;font-size:10pt;margin-left:0px;width:90%" width="90%">
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:89%" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Cash
        and cash equivalents</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%">$</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%" valign="bottom">2,427</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Asset
        held for sale</span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom">1,000</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Prepaid
        and other assets</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">236</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  <tr style="background-color:rgb(255, 255, 255)">
    <td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top">
        <p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Accrued
        liabilities</span></span></span></p> </td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;width:1%">&#160;</td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black" valign="bottom">(1,187</td>
    <td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%">)</td>
        </tr>
  <tr style="background-color:rgb(204, 238, 255)">
    <td colspan="1" style="padding:0cm;height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top">
        <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">Net
        acquired assets</span></span></span></p> </td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%">&#160;</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">
        <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:left">$</p> </td>
    <td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%">2,476</td>
    <td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%">&#160;</td>
        </tr>
  </table> </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419735076600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Detail Textuals)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 15, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 25, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger', window );">Number of common shares for each preferred share converted | shares</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Reverse stock split conversion ratio</a></td>
<td class="nump">0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Capital', window );">Market capitalization amount</a></td>
<td class="nump">$ 58,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 874,000<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Isuuance and sale value of ADSs and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_WarrantsExercisablePeriod', window );">Warrants exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid', window );">Amount of total sale and transfer of compounds and products kestrel paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesADSsMember', window );">American Depository Shares ADSs [Member] | At the Market Offering Agreement with Cantor Fitzgerald &amp; Co. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued under agreement | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Average price of shares issued under agreement | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross proceeds from sale under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesADSsMember', window );">American Depository Shares ADSs [Member] | At the Market Offering Agreement with Cantor Fitzgerald &amp; Co. [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross proceeds from sale under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=cmmb_FormerChemomabSecurityHoldersMember', window );">Former Chemomab Security Holders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_ShareholdingPercentageImmediatelyFollowingMerger', window );">Shareholding percentage immediately following the merger</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger', window );">Number of common shares for each preferred share converted | shares</a></td>
<td class="nump">65,675,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_RetainedEarningsAccumulatedDeficits', window );">Accumulated deficit</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember', window );">Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfOrdinarySharesConsistedInDS', window );">Number of ordinary shares represented by each ADS (in shares) | shares</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger', window );">Number of ADS issued and outstanding after the merger | shares</a></td>
<td class="nump">12.86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NumberOfSharesDilutedAfterMerger', window );">Number of shares diluted after the merger | shares</a></td>
<td class="nump">8,078,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_SharesConvertiblePerShareOfAcquireeEntity', window );">Number of shares after merger for each share of Chemomab | shares</a></td>
<td class="nump">9,003,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of total sale and transfer of compounds and products kestrel paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of ADS issued and outstanding after the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfOrdinarySharesConsistedInDS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the number of ordinary shares consisted in one American depository share (ADS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfOrdinarySharesConsistedInDS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock for each preferred share converted before merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NumberOfSharesDilutedAfterMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares diluted after the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NumberOfSharesDilutedAfterMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_RetainedEarningsAccumulatedDeficits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_RetainedEarningsAccumulatedDeficits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_ShareholdingPercentageImmediatelyFollowingMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shareholding percentage immediately following the merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_ShareholdingPercentageImmediatelyFollowingMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_SharesConvertiblePerShareOfAcquireeEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the shares convertible in merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_SharesConvertiblePerShareOfAcquireeEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_WarrantsExercisablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the warrants exercisable period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_WarrantsExercisablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Capital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of total capital as defined by regulatory framework.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117337116&amp;loc=SL5958568-112826<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Capital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesADSsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositorySharesADSsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cmmb_FormerChemomabSecurityHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cmmb_FormerChemomabSecurityHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140419739478968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General - Estimated fair value of assets acquired (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 16, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_NatureOfOperationsDisclosureAbstract', window );"><strong>General.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale', window );">Asset held for sale</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued liabilities</a></td>
<td class="num">(1,187)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cmmb_EstimatedFairValueOfNetAssetsAcquired', window );">Net acquired assets</a></td>
<td class="nump">$ 2,476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of of asset held for sale recogized prior to the completion of merger.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_EstimatedFairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated fair value of the net assets acquired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_EstimatedFairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cmmb_NatureOfOperationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cmmb_NatureOfOperationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cmmb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>zk2227748_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://www.anchiano.com/20220331"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cmmb-20220331.xsd" xlink:type="simple"/>
    <context id="C_20220101to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-05-11</instant>
        </period>
    </context>
    <context id="C_20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="C_20210314to20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cmmb:MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-14</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="C_20210314to20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:FormerChemomabSecurityHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-14</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="C_20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-25</endDate>
        </period>
    </context>
    <context id="C_20210314to20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-03-14</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="C_20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cmmb:FormerChemomabSecurityHoldersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="C_20210301to20210315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-15</endDate>
        </period>
    </context>
    <context id="C_20210315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <instant>2021-03-15</instant>
        </period>
    </context>
    <context id="C_20210401to20210430_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="C_20210501to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositorySharesADSsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cmmb:AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit1">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit12">
        <measure>shares</measure>
    </unit>
    <unit id="Unit14">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="C_20220101to20220331" id="FFact_288">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="C_20220101to20220331" id="FFact_289">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="C_20220101to20220331" id="FFact_290">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_20220101to20220331" id="FFact_292">0001534248</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_20220101to20220331" id="FFact_1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="C_20220101to20220331" id="FFact_2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="C_20220101to20220331" id="FFact_3">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_20220101to20220331"
      id="Fxbrl_20220509210752112">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_20220101to20220331" id="FFact_4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_20220101to20220331" id="FFact_5">001-38807</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_20220101to20220331" id="FFact_6">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_20220101to20220331" id="FFact_7">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_20220101to20220331" id="FFact_8">81-3676773</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_20220101to20220331" id="FFact_9">Kiryat         Atidim</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_20220101to20220331" id="FFact_10">Building         7</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_20220101to20220331" id="FFact_11">Tel         Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="C_20220101to20220331" id="FFact_12">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="C_20220101to20220331" id="FFact_13">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_20220101to20220331" id="FFact_14">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_20220101to20220331" id="FFact_15">77-331-0156</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="FFact_16">American         Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="FFact_17">CMMB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositarySharesMember"
      id="FFact_18">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="FFact_19">Ordinary         shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="FFact_20">n/a</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_20220101to20220331_usgaapStatementClassOfStockAxis_cmmbOrdinarySharesNoParValuePerShareMember"
      id="FFact_21">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="C_20220101to20220331" id="FFact_22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_20220101to20220331" id="FFact_23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_20220101to20220331" id="FFact_24">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_20220101to20220331" id="FFact_25">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_20220101to20220331" id="FFact_26">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_20220101to20220331" id="FFact_27">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="C_20220101to20220331" id="FFact_28">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_20220511"
      decimals="INF"
      id="FFact_29"
      unitRef="Unit12">11404515</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_30"
      unitRef="Unit1">13827000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_31"
      unitRef="Unit1">15186000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_32"
      unitRef="Unit1">43579000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_33"
      unitRef="Unit1">45975000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_34"
      unitRef="Unit1">1934000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_35"
      unitRef="Unit1">1527000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_36"
      unitRef="Unit1">59340000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_37"
      unitRef="Unit1">62688000</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20220504175928392"
      unitRef="Unit1">864000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_40"
      unitRef="Unit1">908000</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_42"
      unitRef="Unit1">358000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_43"
      unitRef="Unit1">357000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_44"
      unitRef="Unit1">85000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_45"
      unitRef="Unit1">55000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_46"
      unitRef="Unit1">309000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_47"
      unitRef="Unit1">345000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_48"
      unitRef="Unit1">1616000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_49"
      unitRef="Unit1">1665000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_50"
      unitRef="Unit1">60956000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_51"
      unitRef="Unit1">64353000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_52"
      unitRef="Unit1">1487000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_53"
      unitRef="Unit1">1336000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_54"
      unitRef="Unit1">1248000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_55"
      unitRef="Unit1">555000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_56"
      unitRef="Unit1">666000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_57"
      unitRef="Unit1">653000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_58"
      unitRef="Unit1">116000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_59"
      unitRef="Unit1">106000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_60"
      unitRef="Unit1">3517000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_61"
      unitRef="Unit1">2650000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_62"
      unitRef="Unit1">203000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_63"
      unitRef="Unit1">237000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_64"
      unitRef="Unit1">203000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_65"
      unitRef="Unit1">237000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20220331"
      id="Fxbrl_20220505111616330"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_20211231"
      id="Fxbrl_20220505111621715"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:Liabilities
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_66"
      unitRef="Unit1">3720000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_67"
      unitRef="Unit1">2887000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_680"
      unitRef="Unit14">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="C_20220331"
      decimals="INF"
      id="FFact_68"
      unitRef="Unit14">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_700"
      unitRef="Unit12">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20220331"
      decimals="INF"
      id="FFact_70"
      unitRef="Unit12">650000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_742"
      unitRef="Unit12">228090300</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_741"
      unitRef="Unit12">228090300</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20220331"
      decimals="INF"
      id="FFact_740"
      unitRef="Unit12">228090300</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20220331"
      decimals="INF"
      id="FFact_74"
      unitRef="Unit12">228090300</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20220505093047469"
      unitRef="Unit1">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220505093055381"
      unitRef="Unit1">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_78"
      unitRef="Unit1">98513000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_79"
      unitRef="Unit1">97639000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_80"
      unitRef="Unit1">-41277000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_81"
      unitRef="Unit1">-36173000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_82"
      unitRef="Unit1">57236000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_83"
      unitRef="Unit1">61466000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_84"
      unitRef="Unit1">60956000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_85"
      unitRef="Unit1">64353000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_88"
      unitRef="Unit1">2745000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_89"
      unitRef="Unit1">1157000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_92"
      unitRef="Unit1">2575000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_93"
      unitRef="Unit1">542000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_96"
      unitRef="Unit1">5320000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_97"
      unitRef="Unit1">1699000</us-gaap:OperatingExpenses>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_100"
      unitRef="Unit1">216000</cmmb:FinanceIncomeExpensesNet>
    <cmmb:FinanceIncomeExpensesNet
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_101"
      unitRef="Unit1">-5000</cmmb:FinanceIncomeExpensesNet>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_104"
      unitRef="Unit1">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_105"
      unitRef="Unit1">-1704000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_20220101to20220331"
      decimals="INF"
      id="FFact_108"
      unitRef="Unit14">0.022</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_20210101to20210331"
      decimals="INF"
      id="FFact_109"
      unitRef="Unit14">0.011</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_20220101to20220331"
      decimals="INF"
      id="FFact_112"
      unitRef="Unit12">228090300</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_20210101to20210331"
      decimals="INF"
      id="FFact_113"
      unitRef="Unit12">156751771</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504161436664"
      unitRef="Unit12">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093740414"
      unitRef="Unit1">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504161607482"
      unitRef="Unit1">97639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504161812745"
      unitRef="Unit1">-36173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220504161847247"
      unitRef="Unit1">61466000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093821193"
      unitRef="Unit1">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504161917493"
      unitRef="Unit1">874000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220505093815054"
      unitRef="Unit1">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504161939600"
      unitRef="Unit1">874000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093843525"
      unitRef="Unit1">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220505093847704"
      unitRef="Unit1">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162015389"
      unitRef="Unit1">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504162029289"
      unitRef="Unit1">-5104000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504162054050"
      unitRef="Unit12">228090300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093917037"
      unitRef="Unit1">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504162134224"
      unitRef="Unit1">98513000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162140381"
      unitRef="Unit1">-41277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20220504162145961"
      unitRef="Unit1">57236000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504162107281"
      unitRef="Unit12">9274838</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505093940758"
      unitRef="Unit1">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504162206824"
      unitRef="Unit1">34497000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162211985"
      unitRef="Unit1">-23695000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220504162217288"
      unitRef="Unit1">10802000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505094011117"
      unitRef="Unit1">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504162242016"
      unitRef="Unit1">43000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220505094006095"
      unitRef="Unit1">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="Fxbrl_20220504162250216"
      unitRef="Unit1">43000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <cmmb:EffectOfReverseCapitalizationTransactionShares
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220509163550193"
      unitRef="Unit12">152299702</cmmb:EffectOfReverseCapitalizationTransactionShares>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20220509172328807">-</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20220509172946846">2,476</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      id="Fxbrl_20220509164008995">-</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:EffectOfReverseCapitalizationTransaction
      contextRef="C_20210101to20210331"
      id="Fxbrl_20220509163651908">2,476</cmmb:EffectOfReverseCapitalizationTransaction>
    <cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220509163909641"
      unitRef="Unit12">52385400</cmmb:StockAndWarrantsIssuedDuringPeriodNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220509165714258"
      unitRef="Unit1">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220509163916692"
      unitRef="Unit1">43547000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220509164000245"
      unitRef="Unit1">0</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="Fxbrl_20220509163919739"
      unitRef="Unit1">43547000</cmmb:StockAndWarrantsIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505094033172"
      unitRef="Unit1">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220505094023997"
      unitRef="Unit1">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162305425"
      unitRef="Unit1">-1704000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="Fxbrl_20220504162313633"
      unitRef="Unit1">-1704000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220504162109962"
      unitRef="Unit12">213959940</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220505094051101"
      unitRef="Unit1">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220504162332928"
      unitRef="Unit1">80563000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220504162338080"
      unitRef="Unit1">-25399000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331"
      decimals="-3"
      id="Fxbrl_20220504162343720"
      unitRef="Unit1">55164000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_193"
      unitRef="Unit1">-5104000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_194"
      unitRef="Unit1">-1704000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_195"
      unitRef="Unit1">13000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_196"
      unitRef="Unit1">7000</us-gaap:Depreciation>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_197"
      unitRef="Unit1">363000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_198"
      unitRef="Unit1">-57000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504154909746"
      unitRef="Unit1">12000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="Fxbrl_20220504154924941"
      unitRef="Unit1">0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_199"
      unitRef="Unit1">151000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_200"
      unitRef="Unit1">281000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_201"
      unitRef="Unit1">693000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_202"
      unitRef="Unit1">-62000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_203"
      unitRef="Unit1">13000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_204"
      unitRef="Unit1">85000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_205"
      unitRef="Unit1">874000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_206"
      unitRef="Unit1">43000</us-gaap:ShareBasedCompensation>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_207"
      unitRef="Unit1">1393000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_208"
      unitRef="Unit1">411000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_209"
      unitRef="Unit1">-3711000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_210"
      unitRef="Unit1">-1293000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cmmb:ProceedsFromInvestmentInDepositsInvestingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_211"
      unitRef="Unit1">2396000</cmmb:ProceedsFromInvestmentInDepositsInvestingActivities>
    <cmmb:ProceedsFromInvestmentInDepositsInvestingActivities
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_212"
      unitRef="Unit1">1000</cmmb:ProceedsFromInvestmentInDepositsInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_215"
      unitRef="Unit1">14000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_216"
      unitRef="Unit1">3000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_217"
      unitRef="Unit1">2382000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_218"
      unitRef="Unit1">-2000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <cmmb:CashAcquiredInReverseRecapitalization
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220504155015779"
      unitRef="Unit1">0</cmmb:CashAcquiredInReverseRecapitalization>
    <cmmb:CashAcquiredInReverseRecapitalization
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_221"
      unitRef="Unit1">2427000</cmmb:CashAcquiredInReverseRecapitalization>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_227"
      unitRef="Unit1">0</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_228"
      unitRef="Unit1">45372000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_229"
      unitRef="Unit1">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_230"
      unitRef="Unit1">47799000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="FFact_231"
      unitRef="Unit1">-1329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_232"
      unitRef="Unit1">46504000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_233"
      unitRef="Unit1">15241000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_234"
      unitRef="Unit1">11727000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20220331"
      decimals="-3"
      id="FFact_235"
      unitRef="Unit1">13912000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20210331"
      decimals="-3"
      id="FFact_236"
      unitRef="Unit1">58231000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cmmb:LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220505095521944"
      unitRef="Unit1">0</cmmb:LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger>
    <cmmb:LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_237"
      unitRef="Unit1">49000</cmmb:LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger>
    <cmmb:AccruedShareIssuanceExpenses
      contextRef="C_20220101to20220331"
      decimals="-3"
      id="Fxbrl_20220505095540169"
      unitRef="Unit1">0</cmmb:AccruedShareIssuanceExpenses>
    <cmmb:AccruedShareIssuanceExpenses
      contextRef="C_20210101to20210331"
      decimals="-3"
      id="FFact_239"
      unitRef="Unit1">1825000</cmmb:AccruedShareIssuanceExpenses>
    <us-gaap:NatureOfOperations
      contextRef="C_20220101to20220331"
      id="Fxbrl_20220505134250696">

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;Note 1 - General.&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman,Times,serif;font-size:10pt;margin-left:1px;width:100%"&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="font-family:Times New Roman, Times, serif;line-height:normal"&gt;A.
        &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:normal"&gt;Chemomab
        Therapeutics Ltd. (hereinafter - "the Company") is an Israeli based company incorporated under the laws of the State of Israel in September
        2011. The Company&#x2019;s registered office is located in Kiryat Atidim, Tel Aviv, Israel. The Company is a clinical-stage biotech company
        discovering and developing innovative therapeutics for conditions with high-unmet medical need that involve inflammation and fibrosis.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&lt;strong&gt;B.&lt;/strong&gt;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;On March&#160;16, 2021, the Company,
        then known as Anchiano Therapeutics Ltd. (&#x201c;Anchiano&#x201d;), completed its merger with Chemomab Ltd., a privately-held Israeli limited
        company (&#x201c;Chemomab Ltd.&#x201d;). Pursuant to the Agreement and Plan of merger (the &#x201c;Merger Agreement&#x201d;) dated as of December&#160;14,
        2020, by and among Anchiano, CMB Acquisition Ltd., an Israeli limited company and wholly-owned subsidiary of Anchiano (&#x201c;Merger Sub&#x201d;),
        and Chemomab Ltd. Upon completion of the merger transaction, pursuant to which Merger Sub merged with and into Chemomab Ltd., with Chemomab
        Ltd. being the surviving entity and a wholly owned subsidiary of Anchiano (the &#x201c;Merger&#x201d;), the Company changed its name from
        &#x201c;Anchiano Therapeutics Ltd.&#x201d; to &#x201c;Chemomab Therapeutics Ltd.&#x201d; and the business conducted by Chemomab Ltd. became
        the primarily business conducted by the Company.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:normal"&gt;For
        accounting purposes, Chemomab Ltd. is considered to have acquired Anchiano based upon the terms of the Merger as well as other factors
        including; (i) Chemomab Ltd.'s former shareholders owned approximately 90% of the combined Company&#x2019;s outstanding ordinary shares
        immediately following the closing of the Merger, and (ii) Chemomab Ltd. management holds key management positions of the combined Company.
        The Merger has been accounted for as an asset acquisition (reverse recapitalization transaction) rather than a business combination, as
        the assets acquired and the liabilities assumed by Chemomab Ltd. do not meet the definition of a business under U.S. GAAP. The net assets
        acquired in connection with the Merger were recorded at their estimated acquisition date fair market value as of March 16, 2021, the date
        of completion of the Merger.&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%"&gt;Immediately
        prior to the effective date of the Merger, all preferred shares of Chemomab Ltd. were converted into ordinary shares of Chemomab Ltd.
        on a one-for-one basis.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;In
connection with the Merger, and following the effective time of the Merger, the Company effected a reverse share split of its ordinary
shares at a ratio of 4:1
(the &#x201c;Reverse Split&#x201d;) and increased the number of ordinary shares underlying each American Depositary Share ("ADS") from 5
to 20. At the effective time of the Merger, each Chemomab Ltd. ordinary share outstanding immediately prior to the effective time of the
Merger automatically converted into the right to receive approximately 12.86
ADSs, each representing 20
ordinary shares of the Company, plus a warrant to purchase ADSs that may become exercisable only under certain circumstances (the &#x201c;exchange
ratio&#x201d;).&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:justify"&gt;The
exchange ratio was calculated by a formula that was determined through arms-length negotiations between the Company and Chemomab Ltd.
The combined Company assumed all of the outstanding options of Chemomab Ltd., vested and unvested, under the Chemomab Share Incentive
Plan (the &#x201c;2015 Plan&#x201d;), with such options representing the right to purchase a number of ADSs equal to approximately 12.86
multiplied by the number of Chemomab Ltd. ordinary shares previously represented by such options.&lt;/p&gt; &lt;/div&gt;

&lt;div&gt;

&lt;div/&gt;

&lt;div&gt;

&lt;div&gt;

&lt;p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:110%"&gt;The
accompanying unaudited condensed consolidated financial statements and notes to the unaudited condensed consolidated financial statements
give retroactive effect to the exchange ratio and the Reverse Split for all periods presented.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The
equity structure reflects the legal acquirer's equity structure. The balance sheet has been adjusted to reflect the par value of the outstanding
shares of the legal acquirer, including the number of shares issued in the Merger. Any difference is recognized as an adjustment to the
additional paid in capital.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:normal"&gt;Immediately
after completion of the Merger, on March 16, 2021, the Company had 8,078,727
ADS issued and outstanding (9,003,357
on a fully diluted basis). In addition, immediately after the Merger, Chemomab Ltd. former shareholders owned approximately 90%
of the number of issued and outstanding ordinary shares of the Company and the shareholders of the Company immediately prior to the Merger
owned approximately 10% of the number of issued and outstanding ordinary shares of the Company (all on a fully diluted basis). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;On
March 16, 2021, immediately prior to the effectiveness of the Merger, Anchiano had 65,675,904
ordinary shares outstanding (prior to the effect of the Reverse Split) and a market capitalization of $58.7&#160;million.
The estimated fair value of the net assets of Anchiano on March 16, 2021, prior to the Merger, was approximately $2.5&#160;million.
The fair value of ordinary shares on the Merger closing date, prior to the Merger, was above the fair value of the Company&#x2019;s net
assets. As the Company&#x2019;s net assets were predominantly composed of cash offset against current liabilities, the fair value of the
Company&#x2019;s net assets as of March 16, 2021, immediately prior to the Merger, was considered to be the best indicator of the fair
value and, therefore, the estimated preliminary purchase consideration.&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:96px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:90px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:110%"&gt;The
following table summarizes the net assets acquired based on their estimated fair values as of March 16, 2021, immediately prior to completion
of the Merger (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;div style="margin-left:90px"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="background:white;border-collapse:collapse;border:0px;font-size:10pt;margin-left:0px;width:90%" width="90%"&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:89%" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%"&gt;$&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%" valign="bottom"&gt;2,427&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Asset
        held for sale&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom"&gt;1,000&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Prepaid
        and other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;236&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Accrued
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black" valign="bottom"&gt;(1,187&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%"&gt;)&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td colspan="1" style="padding:0cm;height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Net
        acquired assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:left"&gt;$&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;2,476&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:1px;width:100%;border:0px"&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span style="line-height:normal;font-family:Times New Roman, Times, serif"&gt;C.
        &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;In connection with the Merger, on
        March 15, 2021, Anchiano entered into Securities Purchase Agreements with certain purchasers for the issuance and sale by Anchiano in
        a private placement (&#x201c;Private Placement&#x201d;) of approximately $45.5
        million of its ADSs and accompanying warrants to purchase ADSs. The warrants have an exercise price of approximately $17.35
        per ADS, expire five
        years from the date of issuance, and if exercised in full will provide additional proceeds to the Company of $4.5
        million. The closing of the Private Placement was completed on March 22, 2021.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;div/&gt;

&lt;div&gt;

&lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:1px;width:100%;border:0px"&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;strong&gt;&lt;span style="line-height:normal;font-family:Times New Roman, Times, serif"&gt;D.
        &lt;/span&gt;&lt;/strong&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;Pursuant to an Asset Purchase and
        Assignment Agreement dated as of March 16, 2021, as amended on March 31, 2021, between the Company&#x2019;s wholly owned subsidiary, Anchiano
        Therapeutics, Inc., a Delaware corporation (&#x201c;Anchiano Delaware&#x201d;) and Kestrel Therapeutics, Inc., a company organized under
        the laws of Delaware (&#x201c;Kestrel&#x201d;), Anchiano Delaware agreed to sell to Kestrel all of the its rights and obligations in its
        business to the extent related to the research, development and commercialization of the Compounds and Products (as such terms are defined
        in the Collaboration and License Agreement entered into as of September 13, 2019, by and between ADT Pharmaceuticals, LLC and the Anchiano
        Delaware), also known as the pan-RAS and PDE10/&#x3b2;-catenin programs. In consideration of the sale and transfer of the Compounds and
        Products Kestrel paid the Company a total of $1.0
        million.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="line-height:normal;font-family:Times New Roman, Times, serif"&gt;E.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;On April 30, 2021, the Company entered
        into an At the Market Offering Agreement (the "ATM agreement") with Cantor Fitzgerald &amp;amp; Co., ("Cantor"). Pursuant to the ATM agreement,
        the Company may offer and sell, from time to time, its ADSs having an aggregate offering price of up to $75
        million through Cantor or the ATM agreement. From April 30, 2021 through March 31, 2022, the Company issued 699,806
        ADSs at an average price of $22.75
        per ADS through the ATM Prospectus Supplement, resulting in gross proceeds of $15.9
        million. The offer and sale of ADSs under the ATM agreement has been registered under the Company&#x2019;s effective registration statement
        on Form S-3 (File No. 333-255658), together with a prospectus forming a part thereof, filed with the SEC under the Securities Act of 1933,
        as amended (the &#x201c;Securities Act&#x201d;). Sales, if any, of ADS pursuant to the ATM agreement may be made in any transactions that
        are deemed to be &#x201c;at the market&#x201d; offerings as defined in Rule 415(a)(4) under the Securities Act. The Company is not obligated
        to sell any ADSs under the ATM agreement.&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%"&gt;On
        April 25, 2022, the Company filed a prospectus supplement with the SEC for the issuance and sale of up to $18,125,000
        of the Company's ADSs (instead of the amount of $75 million above) in connection with the reactivation of the ATM Facility.&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;strong&gt;&lt;span style="line-height:normal;font-family:Times New Roman, Times, serif"&gt;F.&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
        &lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%"&gt;Since
        January 2020, the COVID-19 outbreak has dramatically expanded into a worldwide pandemic creating macro-economic uncertainty and disruption
        in the business and financial markets. Many countries around the world, including Israel, have been taking measures designated to limit
        the continued spread of the Coronavirus, including the closure of workplaces, restricting travel, prohibiting assembling, closing international
        borders and quarantining populated areas. The Company's clinical trial sites have been affected by the COVID-19 pandemic, and as a result,
        commencement of the enrollment of Company&#x2019;s clinical trials of CM-101 in PSC was delayed and the enrollment rate has been affected
        as well. As a result, the Company extended patient&#160;recruiting to additional territories with significant recruitment potential. In
        addition, after enrollment in these trials, patients may drop out of the Company's trials because of the COVID-19 possible implications.&lt;/span&gt;&lt;/p&gt;
        &lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="font-size:10pt;padding:0px;width:45px"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;vertical-align:top;width:45px"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="font-size:10pt;padding:0px;text-align:justify"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif;line-height:110%"&gt;Based
        on management&#x2019;s assessment, the extent to which the coronavirus will further impact the Company&#x2019;s operations will depend on
        future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak,
        and the actions that may be required to contain the coronavirus or treat its impact. The Company is carefully monitoring the restrictions
        due to the COVID-19 outbreak and will adjust activities accordingly.&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; </us-gaap:NatureOfOperations>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_20210314to20210316"
      decimals="2"
      id="Fxbrl_20220512125515025"
      unitRef="Pure">0.04</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger
      contextRef="C_20210314to20210316"
      decimals="INF"
      id="Fxbrl_20220512125522757"
      unitRef="Unit12">1</cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger>
    <cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger
      contextRef="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="INF"
      id="Fxbrl_20220512125459632"
      unitRef="Unit12">12.86</cmmb:NumberOfAdsIssuedAndOutstandingAfterMerger>
    <cmmb:NumberOfOrdinarySharesConsistedInDS
      contextRef="C_20210314to20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="INF"
      id="Fxbrl_20220512125506799"
      unitRef="Unit12">20</cmmb:NumberOfOrdinarySharesConsistedInDS>
    <cmmb:NumberOfSharesDilutedAfterMerger
      contextRef="C_20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="INF"
      id="FFact_245"
      unitRef="Unit12">8078727</cmmb:NumberOfSharesDilutedAfterMerger>
    <cmmb:SharesConvertiblePerShareOfAcquireeEntity
      contextRef="C_20210314to20210316_usgaapBusinessAcquisitionAxis_cmmbMergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember"
      decimals="INF"
      id="FFact_246"
      unitRef="Unit12">9003357</cmmb:SharesConvertiblePerShareOfAcquireeEntity>
    <cmmb:ShareholdingPercentageImmediatelyFollowingMerger
      contextRef="C_20210314to20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember"
      decimals="2"
      id="FFact_247"
      unitRef="Pure">0.90</cmmb:ShareholdingPercentageImmediatelyFollowingMerger>
    <cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger
      contextRef="C_20210314to20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember"
      decimals="INF"
      id="Fxbrl_20220512125752182"
      unitRef="Unit12">65675904</cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger>
    <us-gaap:Capital
      contextRef="C_20210316"
      decimals="-5"
      id="Fxbrl_20220512125807117"
      unitRef="Unit1">58700000</us-gaap:Capital>
    <cmmb:RetainedEarningsAccumulatedDeficits
      contextRef="C_20210316_srtTitleOfIndividualAxis_cmmbFormerChemomabSecurityHoldersMember"
      decimals="-5"
      id="Fxbrl_20220512125814149"
      unitRef="Unit1">-2500000</cmmb:RetainedEarningsAccumulatedDeficits>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="C_20220101to20220331"
      id="Fxbrl_20220504144013751">

&lt;div style="margin-left:90px"&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="background:white;border-collapse:collapse;border:0px;font-size:10pt;margin-left:0px;width:90%" width="90%"&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255);width:89%" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Cash
        and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%"&gt;$&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:8%" valign="bottom"&gt;2,427&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Asset
        held for sale&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="bottom"&gt;1,000&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Prepaid
        and other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom"&gt;236&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(255, 255, 255)"&gt;
    &lt;td style="padding:0cm;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(255, 255, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-left:16px;margin-bottom:0pt;text-indent:-12pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Accrued
        liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;border-bottom:1.5pt solid black;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(255, 255, 255);border-bottom:1.5pt solid black" valign="bottom"&gt;(1,187&lt;/td&gt;
    &lt;td style="background-color:rgb(255, 255, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left;vertical-align:bottom;width:1%"&gt;)&lt;/td&gt;
        &lt;/tr&gt;
  &lt;tr style="background-color:rgb(204, 238, 255)"&gt;
    &lt;td colspan="1" style="padding:0cm;height:5px;font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="top"&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;Net
        acquired assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;
        &lt;p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt;text-align:left"&gt;$&lt;/p&gt; &lt;/td&gt;
    &lt;td colspan="1" style="font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;background-color:rgb(204, 238, 255);width:1%"&gt;2,476&lt;/td&gt;
    &lt;td style="background-color:rgb(204, 238, 255);font-size:10pt;font-family:Times New Roman, Times, serif;text-align:right;vertical-align:bottom;width:1%"&gt;&#160;&lt;/td&gt;
        &lt;/tr&gt;
  &lt;/table&gt; &lt;/div&gt; </us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_251"
      unitRef="Unit1">2427000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_252"
      unitRef="Unit1">1000000</cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_253"
      unitRef="Unit1">236000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_254"
      unitRef="Unit1">-1187000</cmmb:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <cmmb:EstimatedFairValueOfNetAssetsAcquired
      contextRef="C_20210316"
      decimals="-3"
      id="FFact_255"
      unitRef="Unit1">2476000</cmmb:EstimatedFairValueOfNetAssetsAcquired>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="C_20210301to20210315"
      decimals="-5"
      id="Fxbrl_20220512130041910"
      unitRef="Unit1">45500000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_20210315"
      decimals="2"
      id="Fxbrl_20220512130048885"
      unitRef="Unit14">17.35</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cmmb:WarrantsExercisablePeriod
      contextRef="C_20210301to20210315"
      id="Fxbrl_20220512130059437">P5Y</cmmb:WarrantsExercisablePeriod>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20210301to20210315"
      decimals="-5"
      id="Fxbrl_20220512130105431"
      unitRef="Unit1">4500000</us-gaap:ProceedsFromWarrantExercises>
    <cmmb:AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid
      contextRef="C_20210301to20210315"
      decimals="-5"
      id="Fxbrl_20220512130117710"
      unitRef="Unit1">1000000.0</cmmb:AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_20210401to20210430_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-6"
      id="Fxbrl_20220512130127301"
      unitRef="Unit1">75000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20210501to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="INF"
      id="Fxbrl_20220512130133431"
      unitRef="Unit12">699806</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="2"
      id="Fxbrl_20220512130159469"
      unitRef="Unit14">22.75</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="C_20210501to20220331_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="-5"
      id="Fxbrl_20220512130144839"
      unitRef="Unit1">15900000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="C_20220401to20220425_usgaapStatementClassOfStockAxis_cmmbAmericanDepositorySharesADSsMember_usgaapSubsequentEventTypeAxis_usgaapSubsequentEventMember_usgaapSubsidiarySaleOfStockAxis_cmmbAtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember"
      decimals="0"
      id="Fxbrl_20220505140022769"
      unitRef="Unit1">18125000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_20220101to20220331"
      id="Fxbrl_20220505134338955">

&lt;div&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;Note
2 - Basis of Presentation and Significant Accounting Policies &lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;div&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;A.&#160;
&#160; &#160; &#160; Basis of Preparation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:47px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:normal"&gt;The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;) and applicable rules
and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal
and recurring nature that are necessary for a fair statement of the Company&#x2019;s financial position as &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:normal"&gt;of
March 31, 2022, and its results of operations for the three months ended March 31, 2022, and 2021, changes in shareholders&#x2019; equity
for the three months ended March 31, 2022 and 2021, and cash flows for the three months ended March 31, 2022 and 2021. The results of
operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending
December 31, 2022 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#x2019;s Form 10-K for the year ended December 31, 2021 as filed with the SEC. The
Company&#x2019;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2021
included in the Company&#x2019;s Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#x2019;s
significant accounting policies.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;


&lt;div&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;B.&#160;
&#160; &#160; &#160; Use of estimates&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt;  &lt;/div&gt; </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_20220101to20220331"
      id="Fxbrl_20220505104021668">

&lt;div&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;A.&#160;
&#160; &#160; &#160; Basis of Preparation&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:47px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:normal"&gt;The
condensed interim consolidated financial statements included in this quarterly report are unaudited. These financial statements have been
prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;) and applicable rules
and regulations of the SEC regarding interim financial reporting and reflect, in the opinion of management, all adjustments of a normal
and recurring nature that are necessary for a fair statement of the Company&#x2019;s financial position as &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="line-height:normal"&gt;of
March 31, 2022, and its results of operations for the three months ended March 31, 2022, and 2021, changes in shareholders&#x2019; equity
for the three months ended March 31, 2022 and 2021, and cash flows for the three months ended March 31, 2022 and 2021. The results of
operations for the three months ended March 31, 2022 are not necessarily indicative of the results to be expected for the year ending
December 31, 2022 or for any other future annual or interim period. These financial statements should be read in conjunction with the
audited financial statements included in the Company&#x2019;s Form 10-K for the year ended December 31, 2021 as filed with the SEC. The
Company&#x2019;s significant accounting policies are disclosed in the audited financial statements for the year ended December 31, 2021
included in the Company&#x2019;s Form 10-K. Since the date of such financial statements, there have been no changes to the Company&#x2019;s
significant accounting policies.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt; </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_20220101to20220331"
      id="Fxbrl_20220505104106171">

&lt;div&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;B.&#160;
&#160; &#160; &#160; Use of estimates&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ materially from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt; &lt;/div&gt; </us-gaap:UseOfEstimates>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#FFact_108"
          xlink:label="FFact_108"
          xlink:type="locator"/>
        <link:footnote id="FN20220505093535462" xlink:label="FN20220505093535462" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Number of shares has been retroactively adjusted based on the equivalent number of shares received
                    by the accounting acquirer&#x2019;s shareholders in the reverse recapitalization transaction (refer to Note 1B).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_108"
          xlink:to="FN20220505093535462"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_109"
          xlink:label="FFact_109"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_109"
          xlink:to="FN20220505093535462"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_112"
          xlink:label="FFact_112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_112"
          xlink:to="FN20220505093535462"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_113"
          xlink:label="FFact_113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_113"
          xlink:to="FN20220505093535462"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504161436664"
          xlink:label="Fxbrl_20220504161436664"
          xlink:type="locator"/>
        <link:footnote id="FN20220505094619846" xlink:label="FN20220505094619846" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Number and type of equity instruments reflects the capital of the legal parent (the Company).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504161436664"
          xlink:to="FN20220505094619846"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504161607482"
          xlink:label="Fxbrl_20220504161607482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504161607482"
          xlink:to="FN20220505094619846"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504161812745"
          xlink:label="Fxbrl_20220504161812745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504161812745"
          xlink:to="FN20220505094619846"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504161847247"
          xlink:label="Fxbrl_20220504161847247"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504161847247"
          xlink:to="FN20220505094619846"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504162107281"
          xlink:label="Fxbrl_20220504162107281"
          xlink:type="locator"/>
        <link:footnote id="FN20220505094749710" xlink:label="FN20220505094749710" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Number of shares has been retroactively adjusted to reflect the share reverse split effected on
                    March 16, 2021 (refer to Note 1B).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504162107281"
          xlink:to="FN20220505094749710"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504162206824"
          xlink:label="Fxbrl_20220504162206824"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504162206824"
          xlink:to="FN20220505094749710"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504162211985"
          xlink:label="Fxbrl_20220504162211985"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504162211985"
          xlink:to="FN20220505094749710"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220504162217288"
          xlink:label="Fxbrl_20220504162217288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220504162217288"
          xlink:to="FN20220505094749710"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220505093740414"
          xlink:label="Fxbrl_20220505093740414"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220505093740414"
          xlink:to="FN20220505094619846"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220505093940758"
          xlink:label="Fxbrl_20220505093940758"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220505093940758"
          xlink:to="FN20220505094749710"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>24
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ()"K%0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " ""0JQ4F"([(.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*';)8";-I66G#08K;.QF;+4UC1UC:R1]^R5>FS*V!]C1TN]/
MGT"-#E+W$5]B'S"2Q70WNLXGJ<.:'8F"!$CZB$ZE<DKXJ;GOHU,T/>,!@M(G
M=4 0574/#DD910IF8!$6(FL;HZ6.J*B/%[S1"SY\QB[#C ;LT*&G!+SDP-IY
M8CB/70,WP PCC"Y]%] LQ%S]$YL[P"[),=DE-0Q#.:QR;MJ!P_OSTVM>M[ ^
MD?(:IU_)2CH'7+/KY+?59KM[9*VHA"BJNN!BQX7D#[*N/V;7'WXW8=<;N[?_
MV/@JV#;PZR[:+U!+ P04    " ""0JQ4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M ()"K%0[$U:]X04  )@9   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MK5E=<YLX%'UN?X7&3^U,'(/P5SJ.9QPGV<TT2=/8VYWNSCXH(!NF@%@AXOC?
M[Q5?<E-\H;O;AP8,]W!TKSCG2LQV0GY+?<X5>8G".#WO^4HE'P:#U/5YQ-)3
MD? 8KFR$C)B"4[D=I(GDS,N#HG! +6L\B%@0]^:S_+<'.9^)3(5!S!\D2;,H
M8G)_P4.Q.^_9O>J'QV#K*_W#8#Y+V):ON/HM>9!P-JA1O"#B<1J(F$B^.>\M
M[ ]+9ZH#\CN^!'R7'AP3/90G(;[IDQOOO&=I1CSDKM(0#/X\\R4/0XT$//XN
M07OU,W7@X7&%?IT/'@;SQ%*^%.'O@:?\\]ZT1SR^85FH'L7N5UX.:*3Q7!&F
M^?]D5]P[/.L1-TN5B,I@8! %<?&7O92). B86D<":!E 7P78SI$ IPQP\H$6
MS/)A73+%YC,I=D3JNP%-'^2YR:-A-$&LR[A2$JX&$*?FE\+-H"J*L-@C5[$*
MU)[<Q,7TT&GND]1GDJ>S@8*GZ9B!6R)?%,CT"+)#[D2L_!10/>Y]'S\ EC55
M6E&]H"C@'9.GQ+%/"+4H;>"S; O?$[LQ^CLV3ITX)X=SVA*WWB>\*3MXN&WU
M/R,LAC6+(0I35FP)1"0+H7(>?R$?^;Z)$(YD698]<H9T.$5HC6I:HV[)>> R
M$'IB>02F9V.><*2JZ&_?O&DIW+CF-D81EYF4FMIUD+J0LJ^<290?CM;OV[3O
MV BO2<UKTBUGA\2NX<?&=P_':DG5M*8T_2E*936/DL+1/F-9.JLIG:$@"^#C
M%9Q"MFTB@<=O6)ARA(=M&>&TNB7G<\:DXC+<DT>>"*D:I1+'4C)#21VHN=U1
ME20#J\TE'&&%@[7FBAI:M(M,70<A)_=9],1E(QT<! 2J[TRGU@2C9.3;Q@6X
MI/3(MT$*V@DINV=1HP"T "VAL1(1>WJ[]KED"<]4X*;D5GFG&$\C\'8GA;^)
M72&ACKDKGY"5 K4B0I*ER$#ZP0&$UTP>1[]U,))&[FU<I4N2:_9";CR8?L$F
M<(O^ :DV#CF%8H\GX\D$96A$W\9UNF2X\#QH9M*3ZH#<PGWD4]R<.QSR8R#W
M3+TEY;^%"J#!Q<@:)[!Q^4;)KG>BD2P.>9$%H1?$VYHN^A89@[!Q37_-=*G/
M8%JNQ2YN9(G#K7EH\OD</&,<C6/8N.2_YO@@4@5F]D>0'']K<,2Q/9I:%N:P
MU-@(Q:7_APP6+W03JQ:DFUN,D+$0BJM^7L(%+ F/9J<%X&R"9L:8!L7U_E;D
M/8<O8LPT6D FD[[CV'WH;<<8*6,;M)-M5$UDX:WP7N6*W-P5M2!^?;VX^IZ9
M,0K:T2B@%RD6Q[JE91751F8X8@LSXPZTDSMH]P?# N/:BB,3',>Y%W&?N2X'
M& #Q"D",H7$'VLD=5A$+0W*1I7 Y;:XECM/2QU'C +23 UQ%7&[U[/H%$)0/
M;V24L+@Y=SA@&S.C^+23XE^]'+:8Q<*@D1:.UM9B4J/RM)/*KWP.)<3R]-_6
M!XX1=J>3L .5"#*T4L+]!GU;OIE"/F4*/"C6AMRTD5$B#W-DO1'W/+?MH34<
MV:/9X+F)E5%W!Q=G6#])Z,UB<@G*!=5C<E^1^O..:Y']"QN]$6\'U]UUH*#7
M%QMBTW=/[\F*NYF$=#1NE.!(%>.Z,?B!^0GAS/6)Y F<Z.X37ABU@X,]>4>M
M]]"/0*+U[6EY>RQ( HOK9Q9FG"0@2OD%;-P'NT*XFL-+X>5VL(^>1-@XW);E
MQ-W=!<;$^(&#J[=>SN@"7+VX/HNW<!R3G1] HJIBD" MUS]<OMZA*[FV/&*Q
MNEQ@VUB.\0@'U_9/58VJDMX+\@ U^I+7"/2EN-!IDAK9=W"Y_IE)BB-5].M)
M^N^GFO$(!Y?T#E,-!X@'#"-B+,'!1?Q_F6DMCS@ZTP8'>]_:+?-/ BEQ=1M=
M;(/7O]:?'1;Y9OO W%Y\L[ACVFQ3$O(-A%JG$YBRLO@,4)PHD>0[Z4]"*1'E
MASYG'I?Z!KB^$4)5)_H!]<>8^3]02P,$%     @ @D*L5$,TC:;Z!0  O!<
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M@)6PY(W$6[WY#%T]8\=7:&G]/]NTL>EIP(K&HJX[,"FHA6J?_+'KPQ9@.#H
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MH<3(HGU8#+0XY.VN1Z&U2//'/:,1DP8 W[<"\ED.S 15$W?Q+U!+ P04
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M4IV@/21;HX_?!2UB;EA\A<;H^]-G]/'#%?J N$!_)++05,1Z/3$ RIJ>1!6
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M'\)OI%.P)SCQT:)RNW7V.X2FN!:7T_]()\(EEYI6[,(Q*BO IJ'#A'7X0][
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MME"J[*K&E(8(HL]Z%019=F9&3_09PSS-KSMTGL^#4TRRFTDV'#=#'>S+O2]
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M\DIZY87-Q=*1)Q-DXRN3B1NU-BI7J31!+-+4UB8HLQ9+JU6JR(OONJ]7YY,
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M@HD=#*H;'9UA9./:=2L--K];5CAM05D'/"^E-$?#3H!A?F=_ 5!+ P04
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M]AS<.X^B]3D5;?XCF?P"4$L#!!0    ( ()"K%27BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ @D*L5$!4P_() @
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ()"K%0[$U:]X04  )@9   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " ""0JQ40S2-IOH%  "\%P  &               @($D#@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ @D*L5.FG#\!Q @  G@8
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M965T-RYX;6Q02P$"% ,4    " ""0JQ4?O['"=0$  "S#   &
M    @($P-P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M@D*L5$R-$9OA!   V@P  !@              ("!.CP  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( ()"K%0W]7D.8 (   ,%   9
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M  !X;"]S='EL97,N>&UL4$L! A0#%     @ @D*L5)>*NQS     $P(   L
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64$L%!@     4 !0 0P4  ,M5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>39</ContextCount>
  <ElementCount>120</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>10</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Interim Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/InterimStatementsOfChangesInEquity</Role>
      <ShortName>Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - Condensed Interim Statements of Cash flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Interim Statements of Cash flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0008 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0009 - Disclosure - Basis of Presentation and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies</ParentRole>
      <Position>9</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0012 - Disclosure - General (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.Tables</Role>
      <ShortName>General (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/General.</ParentRole>
      <Position>10</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0013 - Disclosure - General (Detail Textuals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.Details</Role>
      <ShortName>General (Detail Textuals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.anchiano.com/role/General.Tables</ParentRole>
      <Position>11</Position>
    </Report>
    <Report instance="zk2227748.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0014 - Disclosure - General - Estimated fair value of assets acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails</Role>
      <ShortName>General - Estimated fair value of assets acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="zk2227748.htm">zk2227748.htm</File>
    <File>cmmb-20220331.xsd</File>
    <File>cmmb-20220331_cal.xml</File>
    <File>cmmb-20220331_def.xml</File>
    <File>cmmb-20220331_lab.xml</File>
    <File>cmmb-20220331_pre.xml</File>
    <File>exhibit_31-1.htm</File>
    <File>exhibit_31-2.htm</File>
    <File>exhibit_32-1.htm</File>
    <File>exhibit_32-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="155">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="34">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>30
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zk2227748.htm": {
   "axisCustom": 0,
   "axisStandard": 6,
   "contextCount": 39,
   "dts": {
    "calculationLink": {
     "local": [
      "cmmb-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cmmb-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2227748.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 190,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 4,
    "total": 4
   },
   "keyCustom": 21,
   "keyStandard": 99,
   "memberCustom": 6,
   "memberStandard": 4,
   "nsprefix": "cmmb",
   "nsuri": "http://www.anchiano.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001 - Document - Document and Entity Information",
     "role": "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0012 - Disclosure - General (Tables)",
     "role": "http://www.anchiano.com/role/General.Tables",
     "shortName": "General (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20210314to20210316",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0013 - Disclosure - General (Detail Textuals)",
     "role": "http://www.anchiano.com/role/General.Details",
     "shortName": "General (Detail Textuals)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20210314to20210316",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cmmb:NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20210316",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0014 - Disclosure - General - Estimated fair value of assets acquired (Details)",
     "role": "http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails",
     "shortName": "General - Estimated fair value of assets acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20210316",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "strong",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "strong",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220331",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockNoParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit14",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.anchiano.com/role/BalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockNoParValue",
       "span",
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220331",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockNoParValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit14",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "strong",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0004 - Statement - Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "role": "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations",
     "shortName": "Condensed Consolidated Interim Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "strong",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "strong",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0005 - Statement - Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)",
     "role": "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
     "shortName": "Condensed Consolidated Interim Statements of Changes in Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "strong",
       "span",
       "span",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "strong",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0006 - Statement - Condensed Interim Statements of Cash flows (Unaudited)",
     "role": "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Interim Statements of Cash flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "strong",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0008 - Disclosure - General",
     "role": "http://www.anchiano.com/role/General.",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0009 - Disclosure - Basis of Presentation and Significant Accounting Policies",
     "role": "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0011 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)",
     "role": "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227748.htm",
      "contextRef": "C_20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 10,
   "tag": {
    "cmmb_AccruedShareIssuanceExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accrued issuance expenses non-cash investing and financing activities.",
        "label": "Accrued share issuance expenses"
       }
      }
     },
     "localname": "AccruedShareIssuanceExpenses",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AmericanDepositarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares [Member]",
        "label": "American Depositary Shares [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_AmericanDepositorySharesADSsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depository Shares ADSs [Member]",
        "label": "American Depository Shares ADSs [Member]"
       }
      }
     },
     "localname": "AmericanDepositorySharesADSsMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of total sale and transfer of compounds and products kestrel paid.",
        "label": "Amount Of Total Sale And Transfer Of Compounds And Products Kestrel Paid",
        "terseLabel": "Amount of total sale and transfer of compounds and products kestrel paid"
       }
      }
     },
     "localname": "AmountOfTotalSaleAndTransferOfCompoundsAndProductsKestrelPaid",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At the Market Offering Agreement with Cantor Fitzgerald &amp; Co. [Member]",
        "label": "At the Market Offering Agreement with Cantor Fitzgerald &amp; Co. [Member]"
       }
      }
     },
     "localname": "AtTheMarketOfferingAgreementWithCantorFitzgeraldAndCoMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of of asset held for sale recogized prior to the completion of merger.",
        "label": "Asset held for sale"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetHeldForSale",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accrued liabilities to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_CashAcquiredInReverseRecapitalization": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "represents cash acquired from acquisition",
        "label": "Cash acquired in reverse recapitalization"
       }
      }
     },
     "localname": "CashAcquiredInReverseRecapitalization",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_EffectOfReverseCapitalizationTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of effect due reverse capitalization transaction.",
        "label": "Effect of reverse capitalization transaction"
       }
      }
     },
     "localname": "EffectOfReverseCapitalizationTransaction",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "cmmb_EffectOfReverseCapitalizationTransactionShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares isued due to effect of reverse capitalization transaction.",
        "label": "Effect of reverse capitalization transaction (in shares)"
       }
      }
     },
     "localname": "EffectOfReverseCapitalizationTransactionShares",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_EstimatedFairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated fair value of the net assets acquired.",
        "label": "Net acquired assets"
       }
      }
     },
     "localname": "EstimatedFairValueOfNetAssetsAcquired",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_FinanceIncomeExpensesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of finance income earned and finance expenses incurred during the period.",
        "label": "Finance Income (Expenses), Net",
        "negatedLabel": "Financing expenses (income), net",
        "terseLabel": "Financing expenses (income), net"
       }
      }
     },
     "localname": "FinanceIncomeExpensesNet",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_FormerChemomabSecurityHoldersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents former Chemomab security holders.",
        "label": "Former Chemomab Security Holders [Member]"
       }
      }
     },
     "localname": "FormerChemomabSecurityHoldersMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_IssuanceOfSharesNetOfIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 40.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of shares net, of issuance costs.",
        "label": "Issuance of shares net, of issuance costs"
       }
      }
     },
     "localname": "IssuanceOfSharesNetOfIssuanceCosts",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liabilities assumed, net of non-cash assets received in reverse merger.",
        "label": "Liabilities assumed, net of non-cash assets received in reverse merger"
       }
      }
     },
     "localname": "LiabilitiesAssumedNetOfNonCashAssetsReceivedInReverseMerger",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents Merger Agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company inclued proposed merger of CMB Acquisition Ltd, wholly owned subsidiary of our company.",
        "label": "Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]"
       }
      }
     },
     "localname": "MergerAgreementWithCmbAcquisitionLtdSubsidiaryOfOursAndChemombMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_NatureOfOperationsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "General."
       }
      }
     },
     "localname": "NatureOfOperationsDisclosureAbstract",
     "nsuri": "http://www.anchiano.com/20220331",
     "xbrltype": "stringItemType"
    },
    "cmmb_NumberOfAdsIssuedAndOutstandingAfterMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADS issued and outstanding after the merger.",
        "label": "Number of ADS issued and outstanding after the merger"
       }
      }
     },
     "localname": "NumberOfAdsIssuedAndOutstandingAfterMerger",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfOrdinarySharesConsistedInDS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the number of ordinary shares consisted in one American depository share (ADS).",
        "label": "Number of ordinary shares represented by each ADS (in shares)"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesConsistedInDS",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock for each preferred share converted before merger.",
        "label": "Number of common shares for each preferred share converted"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesForEachPreferredShareConvertedPriorToDateOfMerger",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_NumberOfSharesDilutedAfterMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares diluted after the merger.",
        "label": "Number of shares diluted after the merger"
       }
      }
     },
     "localname": "NumberOfSharesDilutedAfterMerger",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One employee one officer consultant and six Board [Member]",
        "label": "One employee one officer consultant and six Board [Member]"
       }
      }
     },
     "localname": "OneEmployeeOneOfficerConsultantAndSixBoardMemberMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OneEmployeeOneOfficerConsultantAndSixBoardMembersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One employee one officer consultant and six Board [Member]",
        "label": "OneEmployeeOneOfficerConsultantAndSixBoardMembersMember",
        "verboseLabel": "One employee one officer consultant and six Board [Member]"
       }
      }
     },
     "localname": "OneEmployeeOneOfficerConsultantAndSixBoardMembersMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares [Member]",
        "label": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ordinary Shares, No Par Value Per Share [Member]",
        "label": "Ordinary Shares, No Par Value Per Share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_ProceedsFromInvestmentInDepositsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the proceeds from investment in deposits, investing activities.",
        "label": "Proceeds From Investment In Deposits, Investing Activities",
        "terseLabel": "Investment in deposits"
       }
      }
     },
     "localname": "ProceedsFromInvestmentInDepositsInvestingActivities",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_ProceedsFromReceivablesOnAccountOfShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables on account of shares.",
        "label": "Proceeds from receivables on account of shares"
       }
      }
     },
     "localname": "ProceedsFromReceivablesOnAccountOfShares",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_RetainedEarningsAccumulatedDeficits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficits.",
        "label": "Retained Earnings Accumulated Deficits",
        "negatedLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficits",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_ShareholdingPercentageImmediatelyFollowingMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shareholding percentage immediately following the merger.",
        "label": "Shareholding percentage immediately following the merger"
       }
      }
     },
     "localname": "ShareholdingPercentageImmediatelyFollowingMerger",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "percentItemType"
    },
    "cmmb_SharesConvertiblePerShareOfAcquireeEntity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the shares convertible in merger.",
        "label": "Number of shares after merger for each share of Chemomab"
       }
      }
     },
     "localname": "SharesConvertiblePerShareOfAcquireeEntity",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_StockAndWarrantsIssuedDuringPeriodNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "it represents number of shares and warrants issued during period",
        "label": "Issuance of shares and warrants, net of issuance costs (In shares)"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodNewIssues",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cmmb_StockAndWarrantsIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Issuance of shares and warrants, net of issuance costs"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cmmb_TwoThousandFifteenPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Plan [Member]",
        "label": "2015 Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandFifteenPlanMember",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_WarrantsExercisablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the warrants exercisable period.",
        "label": "Warrants exercisable period",
        "terseLabel": "Warrants exercisable period"
       }
      }
     },
     "localname": "WarrantsExercisablePeriod",
     "nsuri": "http://www.anchiano.com/20220331",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "durationItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Name of Exchange on which Security is Registered"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r125",
      "r128",
      "r137",
      "r139",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r209",
      "r210",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r125",
      "r128",
      "r137",
      "r139",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r209",
      "r210",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r125",
      "r128",
      "r135",
      "r137",
      "r139",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r209",
      "r210",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r125",
      "r128",
      "r135",
      "r137",
      "r139",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r209",
      "r210",
      "r217",
      "r218"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r100",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r6",
      "r32"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r23",
      "r149",
      "r183"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r60",
      "r61",
      "r62",
      "r146",
      "r147",
      "r148",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional paid in capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Adjustments for operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r58",
      "r92",
      "r94",
      "r98",
      "r102",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r158",
      "r162",
      "r168",
      "r181",
      "r183",
      "r196",
      "r203"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Default Label]",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r38",
      "r58",
      "r102",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r158",
      "r162",
      "r168",
      "r181",
      "r183"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r58",
      "r102",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r158",
      "r162",
      "r168",
      "r181"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Preparation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r136",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r136",
      "r138",
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepaid and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.-EstimatedFairValueOfAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Capital": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of total capital as defined by regulatory framework.",
        "label": "Market capitalization amount"
       }
      }
     },
     "localname": "Capital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r30",
      "r54"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r49",
      "r54",
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r49",
      "r169"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosure of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r57",
      "r58",
      "r72",
      "r73",
      "r74",
      "r76",
      "r78",
      "r80",
      "r81",
      "r82",
      "r102",
      "r114",
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r126",
      "r127",
      "r129",
      "r130",
      "r168",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r36",
      "r113",
      "r198",
      "r207"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingent liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r60",
      "r61",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Ordinary shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r22",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/BalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r22",
      "r183"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Ordinary shares no par value - Authorized: 650,000,000 shares as of September 30, 2021 and 500,000,000 shares as of December 31, 2020; Issued and outstanding: 227,956,060 ordinary shares at September 30, 2021 and 9,274,838 ordinary shares at December 31, 2020",
        "terseLabel": "Ordinary shares no par value - Authorized: 650,000,000 shares as of March 31, 2022 and as of December 31, 2021; Issued and outstanding: 228,090,300 ordinary shares at March 31, 2022 as of December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Short term bank deposits"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Long term deposit"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r52",
      "r104"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Basic and diluted loss per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r41",
      "r42",
      "r43",
      "r60",
      "r61",
      "r62",
      "r64",
      "r69",
      "r71",
      "r79",
      "r103",
      "r131",
      "r133",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r211",
      "r212",
      "r213",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 30.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Change in trade payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 40.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Change in accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 50.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Change in employees and related expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r51",
      "r179"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Change in operating lease liability",
        "verboseLabel": "Change in operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Change in other receivables and prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r33",
      "r58",
      "r95",
      "r102",
      "r114",
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r159",
      "r162",
      "r163",
      "r168",
      "r181",
      "r182"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r58",
      "r102",
      "r168",
      "r183",
      "r197",
      "r205"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r58",
      "r102",
      "r114",
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r159",
      "r162",
      "r163",
      "r168",
      "r181",
      "r182",
      "r183"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r18",
      "r19",
      "r58",
      "r102",
      "r114",
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r159",
      "r162",
      "r163",
      "r168",
      "r181",
      "r182"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r83",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "General."
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General."
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r49",
      "r50",
      "r53"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r39",
      "r40",
      "r43",
      "r44",
      "r53",
      "r58",
      "r63",
      "r65",
      "r66",
      "r67",
      "r68",
      "r70",
      "r71",
      "r75",
      "r92",
      "r93",
      "r96",
      "r97",
      "r99",
      "r102",
      "r114",
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r167",
      "r168",
      "r199",
      "r208"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net loss for the period",
        "negatedTotalLabel": "Net loss for the period"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r178"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 30.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r178"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liabilities - long term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r141",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r3",
      "r28",
      "r29"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Other receivables and prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 30.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.",
        "label": "Long term prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 30.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the issuance of equity classified as other.",
        "label": "Proceeds from Other Equity",
        "verboseLabel": "Issuance of shares and warrants, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r47",
      "r145"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r39",
      "r40",
      "r43",
      "r48",
      "r58",
      "r63",
      "r70",
      "r71",
      "r92",
      "r93",
      "r96",
      "r97",
      "r99",
      "r102",
      "r114",
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r157",
      "r160",
      "r161",
      "r164",
      "r165",
      "r167",
      "r168",
      "r200"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "verboseLabel": "Net loss for the period"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r13",
      "r14",
      "r105",
      "r183",
      "r201",
      "r206"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 40.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r150",
      "r194",
      "r219"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r5",
      "r17",
      "r55",
      "r216"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r133",
      "r149",
      "r183",
      "r204",
      "r214",
      "r215"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r60",
      "r61",
      "r62",
      "r64",
      "r69",
      "r71",
      "r103",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r166",
      "r211",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Aggregate offering price"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.",
        "label": "Gross proceeds from sale under agreement"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Shares issued under agreement"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Average price of shares issued under agreement"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of net assets acquired based on their estimated fair value"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 60.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based compensation expense",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details",
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share based payment options vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Number of shares authorized, increase"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Options to purchase ADs"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Exercise price per ADs",
        "verboseLabel": "Value of ADS"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r56",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r57",
      "r58",
      "r72",
      "r73",
      "r74",
      "r76",
      "r78",
      "r80",
      "r81",
      "r82",
      "r102",
      "r114",
      "r118",
      "r119",
      "r120",
      "r123",
      "r124",
      "r126",
      "r127",
      "r129",
      "r130",
      "r131",
      "r168",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r37",
      "r41",
      "r42",
      "r43",
      "r60",
      "r61",
      "r62",
      "r64",
      "r69",
      "r71",
      "r79",
      "r103",
      "r131",
      "r133",
      "r146",
      "r147",
      "r148",
      "r151",
      "r152",
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r211",
      "r212",
      "r213",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r60",
      "r61",
      "r62",
      "r79",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/DocumentDocumentAndEntityInformation",
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of preferred stock and warrants for common stock issued.",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "terseLabel": "Isuuance and sale value of ADSs and warrants"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r21",
      "r22",
      "r131",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Issuance of shares, net of issuance costs, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r21",
      "r22",
      "r131",
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Issuance of shares, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r21",
      "r22",
      "r133",
      "r140",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r131",
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Exercise of Options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r22",
      "r25",
      "r26",
      "r58",
      "r101",
      "r102",
      "r168",
      "r183"
     ],
     "calculation": {
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/InterimStatementsOfChangesInEquity",
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Reverse stock split conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r176",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r176",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r176",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r184",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/General.Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r84",
      "r85",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted average number of Ordinary Shares outstanding, basic, and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.anchiano.com/role/StatementUnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)(1)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=117337116&loc=SL5958568-112826"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r221": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r222": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r223": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r224": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r225": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r226": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r227": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>31
<FILENAME>0001178913-22-001919-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-22-001919-xbrl.zip
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M(_CH[P)_?P:.,8Z=1+Y;O97[X3>3BU+E,J%""?@2\QU'-I/#*(IS>YB"B17
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MU;*0]"S\8?!",^H#_]93)CK90F 0:K,;FE^=WOH:Y-9ZWH7IP.1CSXVY#.I
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M_O@IA:/[]QMO+<NO#\"]R@_61EX03AE4EYC+KO&<+/^%_T=9F+LPGB%HH<:
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M+IHY/-VS95U%@ZM++IY'I"'\@O1Y0L9XKGK 13/I;/N&>T0I\#2867:NB=6
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M*L"!QN)^]+,HPQ.JE3G84OY_QU[RC_#TSPV,W H ?C1642]3EM+'6F;3+1K
M@,9N]GKWBPPN=@M3WNV#H3YI[/Q76Y]=DR8-L3[5J"@DU=F[KH?X2/! [=/X
M5>TK(<7*1]>$3SV>HL#TW-5C#*/\Q.=\"?9"'!AOQ.^@#^R^P--#,AZA?NHT
MB!>A.!DE-SEN_)S)*VI:JFE_0*"^O\ #2E]T?=.=@3J/TV=T6>'75?(R3%Z
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M(N4Q)F%M#)+M5 ZP);HQI@7E->/]T*T6!'QI['\)ILP+"G^4SDM<=&_<UF*
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M:8*O%3RIX2D5(O0O*S/>L.NLH;^4K?[UWE?G5KC/HUC=9-6$%Z4\*48'DY^
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MZG2I1\?W=U$N[F QVN&:'#'>LY=@AI>$RK&DGH#3*DN$&_PN=-YOE_/[- ;
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MGA6SM[(I^V+L9^ 9J]0?8WX3/<QRE0"$74.[L^++3'V;'4%E6%WMS0K\ FO
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M. 1&)9_&GA_;(#T$[..I3H97"E:T9\MNU!L&'Q7#[\?7J<JQO.)E]SA=](?
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MY]<",-C_SW_]-_@#?F+8PU__/U!+ P04    " ""0JQ4 !^F \,9  "C>0$
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M5S.:AIZ*E*/:6A%95Z(*$:7V>R(L0;+QLK')H>_,]IUJD[=G(9HY(>76(U8
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MBEQ'/G89B9.;Q[:P3(/#S_);? V(=8^F+R$TF*(,DTQ"\=\6L486S%Z!;\&
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MF-G]!!/O2I5Z#>9[;0-)6\*AOB@V&_UU?=R1P@DQKX*AG84M>"'BM'#:FT3
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M"&Z>U;A4]!3#5ZCY<!NNM&^Z5'88VKA4E$T_L5FE9"S\!ZQRE#2-_(]!^M>
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M7OW/'WNP?\ :^X?;; <^GY_V^C#XN0>7O9//_;/!6>\2>K^?_-P]_]"#[LD
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M+NZ^RMU<+4NJ4:^M[EOUH+PR_A=02P,$%     @ @D*L5,CONP[1!   <Q8
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MR&/3C[\,/;QCXZ?"E=? Q:?"E7?$[_)4.+=&V6KMZ'=:TY@^-?\'4$L#!!0
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M%3S#/#ZR9P3]X:T$XJ8G(KI"%+2C2':2%IUWOMB@_49XR17JHH!OS!3\^DK
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M-,>O2,8TU=!P3 17'$QKR+%PJR9-,V2Z-CR*YA-B>::2'RX!O-04Z.$P[:Q
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M>B],=8Y-57M=\X20Y7Z6>X20B/G9<.+BO^1XM(19&=2U-:MHN-QJ:$K"V!5
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MRY!!%*G*TQIU6MU!MS]:LX5MY.9.EQ#P)S$-!5NS!E7S13*1(%D P_ZR@6*
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M]UL^-4DT0H\J\X@]Z/GU+ 0/&0R_8 2]U=%7;,HS/DE2OXFHUZR)0J@0JAX
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MK.V/A=>J$^D.=@HCZUH_/EH-%1S9HUM P!$ %S&."*O$_$Z*)WY^#P]SM!:
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M8##2M#O;,+WIH30='[F1K[K"" 4X-4S":0ZD"":!9MNPQ?+/=KTW,?C8,/I
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MP\2P!\'/9G 0,L,_>%]C>#(\^HG[OMWA^&<;SH)^-26ZM@?P3^PH"=,\<'9
M=!'>%NYYNQ/E5G\,NK8E FK7!]1NI^46#WOPZE2Z1R;\ ,JK N+UBW';Q1A>
MY1PZ<%X$Q'N,KUF%R P>8X,*Q%?:6^AH23*V8,%RT@IDQD9%1OIK<7^0YG#+
MZ\?@,I=[VACAF#-$SPV6^-W_8D0M;4?%P"U1E6[Y.YV$DXO0O$8+\/$CQ>LW
M5[\7SO.OZ.IO5@UI-&H.6TE=;7P[A!UDVDQV8?.A/<Q]@4TIJCU0WD9KUHH=
M-GHE_A+K+U1W-;8Z"&VWS]:*HWL0ZDN5)X2@-5H+(MN.A1Z<Q4+C$$[-#=KP
M@W621T]PCQ4<':9?Q6YWV%FWBHF "ZMZ"#*WG:;=.QNE/>4,;;;4LO':O 1-
M9R(8'!3CA;V6-HTR/<LYT?X/FHKQVUU3RB_/'&FG2(M>H8?3#CKYK (E-\89
MZG0ZI^U>K]\;TK;6QA-AB6V\\S;E-(\GZ5PP-8#6 K9Y&21C"IH#/$@)HF8>
MKBY"Q(8B8<:\X)HTZG3"+<0#OT>XM4[T>T$7=LH)H+JI4\3:2?&9C+02CT\G
M;R<%/Q1"18AN5J'NK[SG5(@@9H23N5\:RJ6(]TIUR\)Y7;@]+8B5^'%-=_J.
M>P<FMROU3O"[D^Z[E?/!N2/805E36-=!$=8H/0<'O6L=YPC#KJ0C+MAB"5=F
MJJ#!E5?+V]M0Y!S7<-N])%66(UH$_"Q_0XXBW>J0O?06$6S1W1;\-EBK9FVW
M0;=]DPA^:_>RWZ#)'PX\Y^H'_//XNB#L(8E7][RU1_2WUOJ=?=B4@#&2"A-$
MFEN'6.:OKJ5\0NL;$JQXES%S&3(U;=#S[3!6C?'=JD[=)F$]%"(.48KRG[%,
M\[=>5_3.+CL$"M"OGC?O<PV]>7EM+@\JP'\PEO^+=8<6 @7D;;F[R^V_KB]/
MI1$M2\RB]YB>KY@XZ/E+7H VQ3_!0<^&J2G/-&Z4?3Y7942[(C-C<(YETS@E
M@" &_=S1W8!RFY_N**IE.@M>1]*CR3U*\D^Y6(-OOY\+UVRM,_25[H$R!2Z3
MZJF89>BP;S)ZPOT\KBT3$ZW)(YZ9R6+C[XPZ@BV'EJM5"#T(]8[/:'W4D*YM
ML\:>M#4F=1U9"S,$G1<&,!S^H9J.M=Q!A :-TK8G<"=0])V%OEO,4 :*9=YH
MTP2*-%H1UYBI$Y5]1A/[YJ!<ZT]-/^Y4I<Y;GF"+M=!!( L1X#/T!ZPCIC0R
M;Z>Q<+N?8MJ>.J+ PR8@P]/I6L+[68L<E;;6"28'>UW1W;Z=/DMXR\O#B*E-
MY)K](4N)'2[J;EBL.TE$-PU-\SY9M@RCU/!>J%]/I99$.>'NX<+MUZKA5[>V
M_-(C3>KH#3K#N,1';+=G,$M8E6"?X*AOG!Z@4H9>P!2S% 0*M":138>O"67S
M("0:UL*D"@=E.]Y)%7A'G5)EA)["LF\QRA8&/9B%0=$SQ!!!?D,%WD0A-!;.
M^Q9QYZ+I460Q\U QC065R_BV[D[=A,C8L8*:R?["&99%6UP@=;[0:.%@MX&J
MV*'%#BW,LG0[YZ^TA'+$2P7?PD]^SA+#,@K>EL4]HJ'0#,"/YYDJS]RMQ-\R
M>-;%U#&9,PN$$[M]K)8QTEBX)I7[%84L"(T2":'*U&%-MD+!'C 8_E;J+)K!
M4%AC<B^CBY=GU:DO9\)+HZL,]'G:EZ%/84-G*2/174UQ0L$=%FU)0+MV!=VV
MF,X0]IRY@!UV8WF^+I.XR>RLHK3.R%J>(6JY4F6"G?/Q&8KYHV08(.\=,C=T
MALQ>$VMOKX4W!R0I#O&S66+:#J6733%OV\7H_L%=833+BI:Y?](BULVJO(YH
M(\-5/Q+R<[>+7=QSLL@HA^[62YT@WQ[D&Q7?]Y4T4CQ9.8;_AO_--@([D\22
M-%'#(M-!Y)[4<47>S#UQ\S:0G^N BDYUV'Z#V:"/0T_J=#N=X:@7RT=^""RU
ML<R<!S3_&W8D&3;X#-HS[#?SH\B<CS8Z1;_2#FU4][OC37 #Q3 TSRB8:.3-
M=$*P?0DS:3;BN%:WU9;Z_6&L9B:=(]I2,L)MK_S?HCB.Y9=TA]7MB..SX/B,
MK\KQ$?^)HC_"'+G '$&S8;+"IG"+7D?=0757=O41@-OM*.CPS;R@ZCQ%PW!N
MLGK=FH$CJ'<4O@P6(O"%8=K,)/:[B#.#TB+)S_+]HL='"\94_+'<&&2'J3P(
M)4"Y!=B?LKK08.1//"N.]DN599KDX#>0IN=^\!<[X[3\;))O9P]GZ._C\5TD
M?P4OF->..O!,!QY[?$0_-<D3=?(RJ]JUO^E9+XU\95:J/U_!L/C@>92LXC7.
M;GHD&0M5=T_S M=&DR6I!#VLV;LPXDOD$4);I=&GZICY()B-3V=8)S*Q+'K
MP-JF\VY3_MRN:NT6T,M.=MF>$MXRTF7&YL:5QM1KJ1F$F+*R&C2#AWF7V1R%
M7#;>\;L],PFA/@I[9B'N<4YZ$ _>YKWH6?9/N'NK.TMNNW3:#"SELT./]COS
M3#7C>0/R_$=P#TPPV..C;4;+6<2P?3:!M?$ZV]% ,9<]O-?P."?RLN"'$]YK
M: D4^GC6X?T2GL3RB/QWP%V,]VB"%_.RN7XRK.L.S;0Q?3%9L/HL:[' FAF.
MIG#7%5;<H_'_.GKT;!RD@N-*&G"*LS\+?I-:I_^(#1&^LSQ B8I&/+:-C2+>
MEC!\4!$&+$\M8U%EJD6/G0+ZU@XF#8G'1ZF'?(;8 66D> U+/4MZN=OD,'1R
MI1N^V$3+U7AO.CYZ8PK.5BH):UUV950>TNBL_W][W_J<1I+M^9T(_H<*[\P=
M^RY2"R3YT=[I"%FV9S37K['LVWL_;120B&H754P])#-__9[?.9E965 @D  A
MJ3;N]EA05&:>/.]G^^!Y^\5,BOOW5'T>F":-5>UX:MVT2C=]LU@W_2Z!.3-[
M,;UG>NF&^PHPOQH76CM -8=]<G0":;[99!VZEXY"I([2TVP0^QCY/XJYJ;K/
M&GI5CYU AD2;M9B";H40-6=3B9ZDQW#23YVN[2;S02<(\).27W#!);KV1\U&
MZ5=9B2WRU-=*KFA"+E4[2M2EBG*]!Z5;:R.H4X1,C(IHY.%)+\NAZADYW&,9
MV \X6QRP0>R9H*R[CI'H**"V.CN]YO.9 (E!-Z=S0B\D883.J<,G4R1TXSX-
M55Y!IH?VP8WB'FX7+/.+>:$0R]0K@B%VM25:D1=?'+0\_-^S%=RB#CR.K!L/
M:Y?RM2Y)AR/!:CYCJ$EQ-'V VZR89%J*M.YWCF>?V&2PV&>Y>$:TT]G_>$(?
M_.(3C#?!Y.:V0>%W7 D NJ3D/_D-VVDV.OO>QY-Y[M@JS_'LBSZ=_(V=NUK]
M.??>GIV??C\_/_O\R4,TY>33R8?_.3\[]SZ_=WS"<!Z??=//-!M?WYU___"-
MG_G\Y=W7$WQCO,6V U"U)*M"53>$N4% +[$S][]%$[[*35=(4G>@R.%S0J]9
M1-YL%*[\8J;%(*,]]I[\]C]Q3IJN&"MLJ;"PL&.C(7OR-#7.6A)[X43[S>(\
M<:0*?"^!=>I6&[?E6AS\OO#8N)X:,E6KQ'DAK"1AC>Q!Y=A(*DS5%6OYQI7S
M3^O*^2JN'%,O1/;#/ULFVXL;2]!>C/&RY$[*NUC&N&D5!ACM$$N>B&4YN[LJ
M@V[69&V7*HSX@](;G2JC>&0U@2"25''<E4ZE<-Q?<RZ\Q35202\/?8)GL\$W
M2+<\9ITFYM.,0V+?DNR!FBUU(;X<?%7*T#20TZ!%]J*^1(;CE9_T]\(XYK1+
M!^BL107191RB,BQ(?VCG5I$H"J/,(X3V7'S6T/E*/T#&>1:+8P3%3G1F\$^O
M?6+PN0J&K)&+4\H!#EJECO" #QUP("^6/8K6(^EU/FM$KF-BKC94N"\($+TD
MZ&H\2205KTBRG \C=H&Z%[H$*>]/\^<J):R*T<TR,5?[N/[I+;*\DJ3[?*F2
MRT!=K>_<JT'FIF_=,<'B>HV06>7;[%R2,"C+[@;$&7O#B'3)BXEMG32("0FE
M)Q2;*(24,5V(SO%VV@^!P*(HOA0'7^;T8V)B' 3=)*:_Q/@AGA;Z(Z*IF-Y$
M[U1^:C)ND<U&/&*DX#R$ Y^S\\SZ>13\*Y<BIW%PR1UUDCBTO)($00Y?^IC6
M4D11IZ<?.D>>M/P9Q6S[\$8@$LL;X:1=-W-8GXV6EI1E]),:Q5%,IATRA9&0
MW8W[$YU?KHLU@TCRF+N(_.G5=9K99-_D/G/6O:)W"=OMBV/19A2S?XOSXD8H
MNR:#5Y+QE#8V!VH/_E?I9711 JQ7"==YEMJ:D?OQ41$N<DR(H[A 6ASC%NV]
MC+1AE>G>THP*W))L2#=/8D"'4@0O:5785W%.$F<RUFX#4G4@O:76'LFG\@L=
M&U)31"2E% 85BLQ&M\;_]/3K(4(Z:DP_T>VO[7:((M3/<8*56!A5;JA4"1&,
M1GF$,)Y\04H/W/ A:Y?X2!P1XZ#TX;[WNW;K%@2&F!/]VU*K+9@82QLK)+/V
M6<$3%M'/-0'NE;D*?U2&BJ8]G9M*;PO9XR.IJ&CJ_5."!*0+3?B4\"UH;I(J
M;SZ(1PKNZ" =Z6OI)V![?M=$SU+Q0+&KJV X146$?9&E4KJ/('5Y*/?J]WM#
M7$U7L4I@00:6"LT$&EY6<(Q$N_GYC=(;K=FPS='B9$Q[MG$8CBXFSN/LC@=.
M)\$(D;VT%ZI$RE1ZPYBTQ0NZ%GJ.?O3E_%2\4>DDS;@NR#PLWY^?]UJ\24E3
M-K4.S09?/<95I$BE#=*AZIL=X'Z(OK6*%/5)9V*\PYGX>")GQE,E#NMC:H^"
M@VEIUFQ416M":. 61V?(KR6*PR!(4NQ_KX?J76^8CW1WQ2KYR-0QQ&$3H;NN
MGQ*Z#'1HK=F8$MT%1S(\L]3@3Y',_TE+=UJF2HG989Q(;/L/COK-(UI"PR$<
M;RX3*N0P0$)[M15*Q!9(\S=ZB6@?2-AC#"5MB?4D5GL*':)8#Q1OF*]A<.(=
MACW!HAZRW_(1=BHS2/:;#5?GD8@E.&XZW?!(^!LF>6C.@)TY%5;<%K137&B:
M$>>&4SA()-*:Q;!,O.P*=@[A9H3;-D\[?,+$^9@IF[HE!DM(ZR?$.NC&F"'\
M0A<0YHZ>Q;#FYIXR!C*<L!<AES(YOWJ3$UT@!HG)/"WNTB7E?%JQ(L&0P$-P
MK;P'PT6XJ6-1AW4EB\/6C61!N3E>JL21"=MA5;+#'B*RV @Q,U</MJR+X])+
MO\Y8[!I^II*/>[2<A-F0,87M<LU^>4EM?9NH)^K'Z+(8)L[]M  4MY!M'E13
MYQKBZ"+677VB."(6U8N'B)5ZJ"#/XJ'"3@W#_W1R_G<MHJ2TL#15Q#&M4W^@
M= GHE_]"2,/G[B'YF'TF;$.4K0:-KVG>[>7T"A7K5B\&.!LS<7>,,;_7!$.T
M)HS2*!,ZH ,ED-6"7B\WP!'\"D.RWR+]&/$RJSH23TJ"G\(U<,7V"^@^I+=*
M62*R@#+NGJ8;U*);;MK2[%!?<>H) >:)WA#A/5BU()>Y75QTPL$*5AJTPC=4
M,, XCQ3K.4>1Z%7K^C,T&RR:L #I XG)<R*"ZOT0.T@H+=*=B/1Y6CJ,QR$P
M_@CG&:,H3Q_6FEU$$%A"UX0R#)#4%.8)L93B;D@6>C'= ,0,PHJ3@J$7BQ;,
M$JRP99CDCZ ?J4F+[#HH2P[3Y NZ\.'0AM@!(^:B6;\WW7[+]U"-3=2>)-Q#
M47K9:G!:.6>=NVFQ];)]R***>0A!-TIU^3=A^P^8W+\/T9O)]X;*)\8T*4M4
M>!%C]/T%.,II8 H*:5" PN/A[\EK70T;1'_DZ OM.SC0@C^0" 5ULJH_9R4
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M0V,Y_U>.+BBD!UT-N8A9:\[&39V6%BB:(-JH'UK=F^D)/7_$$QG]_MXP[IF
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MZ6/IRH]@P "<+54)BFK*5OG-7>LW(WM3U+ ".,PG@I7J^1X2G:8*&JHP;K=
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MF>=GT[P((NFHO7]H-$YV5O$>!SG32GD=4 4/TBSHA4>(D@+;4ZJ?-AM6.&&
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M-V4!L?\5W))+N2*71+LEWE6%-3=]U_VI:KI'U5*;%!2=V[4HV3*-WW>=D/C
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M[=?/]IL-9);)HGX6Q!$"WOCM<AOF2E+)/^L':2^,TSR1]:?WCE7IV7_E 3_
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M_0"&$XI#M:N1'XQB,$N2)HI]AV(109Y"?RJ>EQ62(/VQ-X"/(T!82 'K ,3
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M+GAS9%!+ 0(4 Q0    ( ()"K%1GC+*Z>@<  &)<   5              "
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M   0              "  3N!  !E>&AI8FET7S,Q+3(N:'1M4$L! A0#%
M  @ @D*L5*+QH#>X!   .Q8  !               ( !%XH  &5X:&EB:71?
M,S(M,2YH=&U02P$"% ,4    " ""0JQ4R.^[#M$$  !S%@  $
M    @ ']C@  97AH:6)I=%\S,BTR+FAT;5!+ 0(4 Q0    ( ()"K%3G?N/:
M ZL  #"H"0 -              "  ?R3  !Z:S(R,C<W-#@N:'1M4$L%!@
0   *  H ?@(  "H_ 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
